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Bacterial resistance to antibiotics is a common and important clinical problem. Beta 
lactam resistance in Gram negative bacilli is mediated predominantly by beta lactamases, 
enzymes able to hydrolyse the beta lactam ring. The commonest plasmid mediated beta 
lactamases in the Enterobacteriaceae are those related to either TEM-1 or SHY-1. 
Although TEM-1, TEM-2 and SHY-1 do not have activity against extended spectrum 
beta lactams, their derivatives (TEM-3 and SHY-2 onwards) are able to confer resistance 
to one or more of these antibiotics. A problem encountered in clinical microbiology 
laboratories is the lack of a reliable method for the detection of ESBLs, along with the 
lack of a quick, reliable method of differentiating TEM-related genes from SHY -related 
genes. The primary aim of this study was to evaluate two molecular techniques for the 
detection of SHY and TEM-related genes in clinical isolates. 
The study sample consisted of 209 clinical isolates of enteric Gram negative bacilli, 
isolated at Groote Schuur Hospital microbiology laboratory. The isolates had all been 
selected on the basis of resistance to one or more of the extended spectrum beta lactams. 
These isolates were all identified, and the susceptibility of each to a variety of beta lactam 
antibiotics determined. Using this information, 45 isolates, belonging to different genera 
and with differing antimicrobial sensitivity patterns, were selected for this pilot study. 
These 45 isolates consisted of 24 Klebsiella spp., 14 Enterobacter spp., 3 Citrobacter 
spp., 2 Salmonella spp., 1 Pantoea agglomerans and 1 Serratia marcescens. 
ESBL production was determined in these 45 isolates usmg both the double disc 
diffusion test and the Etest ESBL test. Of the 45 isolates, 27 were shown to be ESBL 
producers - 24 by the double disc test and 26 by the Etest ESBL test. All 23 of the K. 
pneumoniae isolates produced ESBLs, in addition, 2 Salmonella spp. and 2 E. cloacae 
isolates produced ESBLs. 
xiii 
A probe specific for TEM-related genes, prepared by PCR, was hybridised to genomic 
DNA of all the isolates that had been transferred to a nylon membrane using a slot blot 
apparatus. These hybridisations showed that 12 ofthe 45 isolates contained TEM-related 
genes. These 12 consisted of 8 strains of K. pneumoniae, 2 Salmonella spp., 1 S. 
marcescens and 1 P. agglomerans. Hybridisaton of the probe to colony blots of the 
isolates was also carried out, but the results did not correlate with the hybridisation to 
genomic DNA. 
Two probes for SHV -related genes were used - an oligoprobe and a probe prepared by 
PCR amplification from an SHV -1 producing control strain. The results of hybridisation 
of both probes to genomic DNA showed that all the K. pneumoniae isolates contained 
SHV -related genes. This was felt to be due to the fact that K. pneumoniae contains a 
chromosomal beta lactamase gene with a high degree of homology to the plasmid 
mediated SHV-1 gene. SHY-related genes were detected in 4 other isolates- 2 E. cloacae 
and 2 Salmonella spp. Hybridisation of the colony blots again resulted in no correlation 
with the hybridisation to genomic DNA. 
PCR assays, using templates prepared by boiling colonies in water, were designed to 
detect either SHV- or TEM-related genes. The assays using the TEM specific primers 
detected TEM-related genes in all of the isolates shown by hybridisation to contain TEM-
related genes. This assay was reproducible for all the isolates except one, where the 
TEM-related gene was detected in only 2 ofthe 3 assays. Contamination was found to be 
a problem with this assay, and was overcome by predigesting the PCR mixture with 
A vall. 
The assay for the detection of the SHV -related genes was not entirely successful, for two 
reasons. Firstly, conditions compatible with a reliable, reproducible assay could not be 
determined and secondly the assay, when it did work, detected SHV-related genes in all 
the K. pneumoniae isolates. The assay did, however, detect the SHV -related genes that 
had been demonstrated by hybridisation in the non-Klebsiella isolates. 
xiv 
Conjugation studies, using E. coli J53 (NaiR) as a recipient were performed on all the 
isolates that had been shown to contain either SHV- or TEM-related genes. Resistance to 
ampicillin was transferred from all of the 29 donors, although 9 of the transconjugants 
could not be cultured further in selective media. Antibiotic susceptibilities were 
performed on the remaining 20 transconjugants. ESBL activity, determined using the 
Etest ESBL test, was detected in 9 of the transconjugants. Plasmids were extracted from 
19 of the transconjugants and TEM- and SHV-related genes detected in these plasmids 
using Southern hybridisation of Bamm digested plasmid DNA The results of the 
hybridisation to the plasmid and the original donor were discrepant for one of the 
transconjugants, and the results pertaining to this transconjugant were ignored. TEM- and 
SHV -related genes were detected in 7 and 13 of the plasmids, respectively: both genes 
were detected in 2 of the plasmids. 
This study shows that TEM- and SHV-related genes are present in clinical isolates of 
Gram negative bacilli at Groote Schuur Hospital, and are most common in, but not 
confined to, isolates of K. pneumoniae. PCR as an epidemiological tool for the detection 
ofTEM- and SHV-related genes shows promise, but more work needs to be done on the 
PCR assay for SHV -related genes. The transmissibility of resistance from all the isolates 
is worrying, although probably not surprising, in light of the already monumental 





The discovery of antimicrobial agents has been arguably one of the most significant events, 
and the development of antibiotics one of the most important avenues of research, in the 
field of medicine. These agents have made a significant contribution to the reduced 
- mortality and morbidity associated with infectious disease (Sabath, 1980). 
Among the multitude of antibiotics currently in use world-wide, the largest group consists 
of the beta lactam compounds, comprising the penicillins, cephalosporins, carbapenems 
and monobactams. There are well over a hundred antibiotics in this group; their spectrum 
of activity includes Gram positive, Gram negative, aerobic and anaerobic bacteria, making 
beta lactam antibiotics one of the most commonly used groups of drugs (Neu, 1992). 
Although resistance to antibiotic agents can be due to either active efllux of the antibiotic, 
reduction in permeability or alterations in the target site (Dever, 1991; Livermore, 1991), 
the most common cause of bacterial resistance to beta lactams is mediated by the 
__ production of beta lactamase enzymes, which inactivate beta lactam compounds (Jacoby & 
Archer, 1991; Sanders, 1992; Livermore & Yuan, 1996; Livrelli et al, 1996). 
1.2 BETA LACTAMS 
Penicillin, the first of the beta lactams, was described by Alexander Fleming in 1929 and it 
was effective against almost all staphylococcal infections when first used clinically. Shortly 
after the introduction of penicillin resistance to this antibiotic emerged, resulting in a 
decrease in efficacy of this drug against staphylococci. This led to the development of 
compounds such as cloxacillin, which is resistant to the effects of the staphylococcal 
p~nicillinase. Penicillinase mediated resistance to penicillin has resulted in the majority of 
staphylococci world-wide being resistant to penicillin at present (Waldvogel, 1985). 
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Similarly, the emergence of antibiotic resistance in other bacterial species resulted in the 
development of various penicillin derivatives, such as the antipseudomonal drug 
................... 
piperacillin and amoxycillin, used to treat infections caused by Haemophilus influenzae. 
Although penicillin and its derivatives are used predominantly for the treatment of Gram 
positive infections, they do remain effective against most species of the Neisseriaceae as 
well as strains of Pseudomonas and Haemophilus (Nathwani & Wood, 1993). 
The cephalosporins, a group of beta lactam antibiotics derived from the orgarusm 
Cephalosporium acremonium, were first developed in the mid-1960's (Quintiliani eta!, 
1982). The first cephalosporins were more effective than penicillins again~t Gram negative 
organisms. Subsequent generations of cephalosporins (Table1.1) have increased clinical 
efficacy against Gram negative organisms (Neu, 1990a). This has however been associated 
with some reduction in their usefulness in treating infections caused by Gram positive 
bacteria, (Quintiliani et al, 1982) although this is not an absolute rule. The antibacterial 
activity of the various cephalosporins is a complex issue, which will not be dealt with in 
any great detail in this discussion. 
Table 1.1 
Examples of cephalosporins in the various "generations" of this class of antibiotic 












*Some may consider cefepime to be a 3rd generation cephalosporin 
Cefepime * 
One of the reasons for the improved efficacy against Gram negative bacteria is that the 
cephalosporins are more resistant to the beta lactamases of Gram negative bacteria. The 
third generation cephalosporins in particular were considered to be resistant to the effects 
of the beta lactamases that had rendered penicillins useless against many of the 
Enterobacteriaceae (Cunha & Ristuccia, 1982; Neu, 1990a). 
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The monobactams and carbapenems are the most recent additions to the beta lactam class 
of antibiotics. Aztreonam, a monobactam, is effective against Gram negative aerobic 
bacteria only, while the carbapenems, imipenem and meropenem, are active against both 
Gram positive and Gram negative organisms. While resistance has been reported to the 
. carbapenems it is fortunately still uncommon (Drusano, 1998; Greenhalgh & Edwards, 
1998). 
1.2.1 Structure of Beta Lactams 
All beta lactams consist of a central ring structure (the beta lactam ring) which is essential 
to their activity (Fig 1.1). The different properties of the various beta lactam antibiotics are 
the result of a variety of side chains and ring structures that have been added to the beta 
lactam ring. These may either alter the antibacterial range of the drug or render it less 
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Use: Gram positive cocci 
Limited Gram negative use 
T pallidum, anaerobes 
Use: Gram positive cocci 1 
Gram negative bacilli 2 
Less anaerobic cover 
Use: Most Gram negative aerobel 
Use: Gram positive and Gram 
negative aerobes and anaerobes 
3 = exception's - some Enterobacter spp, Pseudomonas spp, Legione/la, Acinetobacter spp 
Fig I .2 Basic structures of the four major classes of beta lactam (Condemi & Sheehan, 1996 ). 
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The diagrams on the previous page illustrate the major structural differences between the 
penicillins, cephalosporins, monobactams and carbapenems. A detailed discourse on the 
structure of each individual antibiotic is beyond the scope of this review, and the 
information provides a general background only. 
1.2.2 Mechanism of Action of Beta Lactams 
The construction of bacterial cell walls involves the linking of alternating N-
acetylglucosamine (NAG) and N-acetylmuramic acid (NAMA) residues. These amino 
sugars are arranged in a latticework and held together by beta 1,4 linkages. These bonds 
occur between amino groups attached to adjacent NAMA molecules, or between adjacent 
NAG and NAMA molecules (Boyd & Marr, 1980a). A number of membrane bound 
proteins - transpeptidases and carboxypeptidases - are involved in the process of linking 
the residues. These enzymes are the targets of beta lactam antibiotics and for this reason 
they have been called penicillin binding proteins (PBPs) (Richmond, 1978; Malouin & 
Bryan, 1986; Stratton, 1988). The high molecular weight PBPs (eg PBPs I, II and III) are 
usually present at lower concentrations than the lower MW PBPs. It is the higher MW 
PBPs however, that are more essential for cell growth and viability (Waxman & 
Strominger, 1983). Beta lactam molecules bind to PBPs to form acyl enzyme 
intermediates that are relatively long lived with resultant inactivation of the PBPs, 
disruption of cell wall synthesis and death of the organism (Sanders, 1992; Stratton, 
1996a). 
It is known that different PBPs play different roles in cell wall synthesis and the inhibition 
of specific PBPs has characteristic effects on the cell wall (Curtis et al., 1980). Inhibition 
of PBP I results in cell wall lysis, while inhibition of PBP II leads to disruption of the cell 
shape with the formation of round forms. PBP III is involved in aspects of cell division and 
septum formation and inhibition of this PBP causes the formation of filamentous forms 
(Spratt, 1975; Waxman & Strominger, 1983). What is also interesting is that certain beta 
lactams have affinities for specific PBPs which may influence the effect the antibiotic has 
on the organism. For example, cefotaxime binds strongly to PBPs 1B and II, while 
cefoxitin binds preferentially to PBPs V and VI (Richmond 1981, Neu 1985). Mecillinam, 
5 
1.3.1 Mechanism of Action of Beta Lactamases 
Beta lactamases hydrolyse the beta lactam ring at the cyclic amide bond, rendering the 
antibiotic irreversibly inactive via the formation of an acyl intermediate. This is analogous 
to the inactivation of PBPs by beta lactams, with one important difference: during beta 
lactam hydrolysis the beta lactamase-beta lactam acyl intermediate is short lived resulting 
in the beta lactamase being released to act on other beta lactam molecules. This is in 
contrast to the PBP-beta lactam acyl intermediate, which is long lived, thereby preventing 
the PBP from carrying out its role in cell wall synthesis (Stratton, 1988; Sanders, 1992; 
Livermore, 1995). With this in mind, it is interesting that sequence similarities have been 
found between at least some of the genes encoding PBPs and beta lactamase genes 
(Waxman eta!., 1982). 
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Fig l.3 Hydrolysis of a beta lactam ring by a beta lactamase enzyme, showing the steps of binding 
of the enzyme to the beta lactam, acylation of the complex and ultimate hydrolysis of the 
beta lactam (Livermore, 1993). 
a penicillin derivative, binds exclusively to PBP II (Spratt, 1975) while cephaloridine has a 
high affinity for PBP I (Waxman & Strominger, 1983). 
The concentration of PBP and the affinity of the PBPs for beta lactams can play a role in 
beta lactam resistance in both Gram positive and Gram negative bacteria and are important 
considerations in the battle between bacterium and antibiotic. If the concentration of a 
given PBP is increased, more antibiotic may be required for bactericidal activity, and 
resistance may ensue (Richmond, 1978; Collatz et a!, 1984). Resistance may also be 
_ !?!()ught about by a decreased affinity of the PBP for the beta lactam compound - usually a 
result of a structural change in the PBP itself This is the primary mechanism of resistance 
of pneumococci to penicillin (Dever & Dermody, 1991). 
Despite the continued development of beta lactam compounds, resistance remams an 
important clinical problem. Resistance to the newer compounds, cephalosporins and 
carbapenems, is becoming a significant concern. 
1.3 BETA LACTAMASES 
- Bacterial resistance to the beta lactams can result from alteration of the PBPs, reduced 
access of the beta lactam to the target, or inactivation of the beta lactam, or from a 
combination of these mechanisms. Inactivation of the antibiotic is the commonest 
mechanism of resistance to beta lactams and is due to the action of beta lactamases. As 
this discussion focuses on beta lactamases, the other mechanisms will not be discussed. 
As early as 1940, the year that penicillin underwent its first clinical trials, the first beta 
lactamase was described (Abraham & Chain, 1940). By 1944 clinical isolates of 
Staphylococcus aureus with beta lactamase mediated penicillin resistance had been 
described (Moellering, 1993). Despite the development of the newer beta lactams 
-· described previously, resistance to this group of antibiotics continues to pose a problem, 
with beta lactamases being responsible for the majority of this resistance. 
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1.3.1.1 Beta Lactamases in Gram Positive Bacteria 
- Beta lactamases produced by Gram positive bacteria are released into the surrounding 
medium and act on the beta lactam before it reaches the bacterium. To be effective, the 
enzyme must be produced in large quantities. The greater the concentration of bacteria the 
greater the amount of enzyme produced, and hence the greater the resistance. This 
phenomenon is also known as the inoculum effect, and it plays an important role in clinical 
determination of sensitivity and resistance profiles (Sykes & Matthew, 1976). In effect, if 
an inoculum of 108 CFU/ml of an organism is used in sensitivity testing, as is used in 
clinical laboratories according to NCCLS (National Committee for Clinical Laboratory 
Satnadards) criteria (NCCLS, 1997), the organisms may appear sensitive to a particular 
beta lactam. However, if a larger inoculum of the same organism is used, it could appear 
·· fesi'stant to the same beta lactam by virtue of the greater amount of enzyme produced. 
1.3.1.2 Beta Lactamases in Gram Negative Bacteria 
In Gram negative organisms the enzyme is located primarily in the periplasmic space. 
Since it is located in a confined space, a smaller quantity of enzyme is required to attain an 
effective concentration. There is thus a relationship in Gram negative bacteria between the 
rate of influx of the antibiotic and the rate of inactivation. A faster rate of influx 
necessitates more beta lactamase in the peri plasmic space. If the rate of influx exceeds the 
rate of inactivation, beta lactam molecules will escape hydrolysis and be able to bind the 
PBPs (Sanders, 1992; Stratton, 1996a). Figure 1.4 illustrates the differences between 
Gram positive and Gram negative organisms with respect to the site of action of the beta 
lactamase. 
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Fig 1.4 Structure of the Gram positive and Gram negative cell walls. The beta lactarnase is concentrated in 
the periplasmic space of the Gram negative organisms while the enzyme is released extracellularly 
from Gram positive bacteria (Grieco, 1982). 
1.3.2 Beta Lactamase Inhibitors 
One ofthe strategies employed to combat beta lactamase mediated resistance has been the 
development of compounds that inhibit beta lactamases. To date, three compounds have 
been developed that are in use clinically - clavulanate, tazobactam and sulbactam 
(Livermore, 1993). The method of action of all three is similar in that they irreversibly bind 
to the beta lactamase, rendering it ineffective by means of suicide inactivation. The 
sequence of events starts with the binding of the inhibitor to the enzyme which then 
catalyses the fragmentation of the inhibitor. The resultant fragments contain active groups 
which react with additional residues on the enzyme to render it inactive (Bush & Sykes, 
1983). These three inhibitors have all been combined with beta lactam antibiotics and have 
been used to treat infections with beta lactamase producing organisms. 
Other substances are also able to inhibit beta lactamases, although they have not yet found 
a clinical niche in this capacity. Antibiotics such as cloxacillin, cefoxitin and aztreonam can 
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act as competitive substrates of certain beta lactamases. As the name implies, these 
compounds act as very poor substrates for the enzyme, and a long time is required for 
hydrolysis of the substrate. The compound·p-chloromercuribenzoate (pC.MB) acts as an 
amino acid modifier of enzymes such as lactic dehydrogenase as well as certain beta 
lactams (Bush & Sykes, 1983). 
1.3.3 Classification of Beta Lactamases 
Numerous beta lactamases have been described and much confusion exists in the literature 
over their classification. Over the years many schemes have been proposed, based on a 
variety of criteria, common being molecular structure or phenotypic properties of the beta 
lactamase. A drawback of many of these schemes is that as more and more beta lactamases 
are described, the Classifications become increasingly complex, and oftentimes unwieldy. 
Table 1.2 provides a summary of some of the more commonly used schemes and provides 
examples of representative enzymes. Not all classifications are represented, firstly to avoid 
. confusion and secondly because some, such as the Amyes/Payne scheme (1991), deal only 
with plasmid mediated extended spectrum beta lactamases (ESBLs) and do not readily fit 
into the more general schemes described . 
In 1973, Richmond and Sykes proposed a classification based on substrate and inhibitor 
profiles. This was extended in 1976 by Sykes and Matthew. The scheme proposed by the 
latter authors classifies the enzymes according to the location (chromosome or plasmid) of 
the beta lactamase . resistance genes. The enzymes encoded by chromosomally located 
genes are then subdivided into cephalosporinases, penicillinases and broad-spectrum beta 
lactamases. Similarly, three groups of plasmid mediated enzymes were proposed, based on 
the spectrum of substrates hydrolysed by the beta lactamase. The first group consists of 
enzymes that do not hydrolyse isoxazoyl beta lactam substrates, such as cloxacilliri. 
Enzymes with activity against methicillin and isoxazoyl beta lactam substrates comprise a 
second group, while miscellaneous beta lactamases constitute a third group. 
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The Ambler scheme, proposed in 1980, classified beta lactamases into four groups - A to 
D. The scheme is structurally based: groups A, C and D are evolutionary distinguishable 
groups of enzymes and contain a serine residue at the active site. Beta lactamases, 
including the penicillinases of some Gram positive bacteria (e.g. S. aureus) as well as 
various plasmid encoded enzymes (such as TEM-1 and -2) from Gram negative bacilli, are 
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included in Class A Enzymes which contain zinc at the active site are grouped in class B, 
and are referred to as metallo enzymes. One of the characteristics of these class B enzymes 
is the ability to hydrolyse carbapenems. In addition, these enzymes are not inhibited by 
beta lactamase inhibitors. Chromosomally encoded enzymes from Gram negative bacilli, 
which are not inhibited by beta lactamase inhibitors such as clavulanic acid, are located in 
class C while class D contains enzymes that preferentially hydrolyse cloxacillin as well as 
penicillin. 
Burgeoning data on beta lactamases ushered in further classifications. Based on rates of 
hydrolysis, preferred substrates and susceptibility of the enzyme to beta lactamase 
inhibitors, the Bush classification scheme of I989(b,c) placed beta lactamases into four 
groups. In this classification, group I type enzymes hydrolyse cephalosporins and are not 
inhibited by clavulanic acid, while enzymes in group 2 include most of those that are 
inhibited by clavulanate. In order to accommodate a large number of similar yet different 
enzymes, six subdivisions (2a, 2b, 2b', 2, 2d, 2e) were created within group 2. Group 3 
contains the previously mentioned metallo-enzymes, and penicillinases not inhibited by 
clavulanate are placed in group 4. 
Another proposal was made by Payne and Amyes in 199I. This classification was based on 
the differences in rates of hydrolysis of ceftazidime and cefotaxime by different 
transferable beta lactamases. Enzymes in group I hydrolyse both these beta lactams with 
poor efficiency whereas those in group 2 hydrolyse ceftazidime more readily than 
cefotaxime. Although group 3 contains three subgroups, a common feature of the enzymes 
within this group is that they all confer greater resistance to ceftazidime than to 
cefotaxime. Paradoxically the hydrolysis rates of cefotaxime are greater than for 
ceftazidime, and the greater susceptibility to cefotaxime is thought to be due to the fact 
that cefotaxime enters the periplasmic space more efficiently than ceftazidime [1.3.1.2]. 
· The group 4 enzymes confer resistance to all cephalosporins, and are resistant to inhibition 
by clavulanate. 
The most recent scheme, proposed by Bush et al. (1995) is probably the most 
comprehensive and is a modification of the previous classification proposed by Bush 
(I989b,c). While it retains the four classes of this scheme, two subdivisions were added to 
the existing six in group 2 to accommodate the increasing number of new TEM and SHV 
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related ESBLs. One of these subdivisions - 2br - was added to include enzymes with less 
affinity for beta lactamase inhibitors but still related to their counterparts in group 2. The 
other additional subdivision - 2bf - contains carbapenemases. While this is probably the 
most detailed classification to date, the numerous subdivisions in group 2 can cause 
confusion to both initiated and uninitiated alike. 
In this review, I will confine myself to the Ambler molecular classification. In addition, as 
this study is concerned with the detection of TEM and SHV related beta lactamases in 
- Gram negative bacilli, the remainder of the review will focus on these enzymes. 
1.4 TEM- AND SHV-RELATED BETA LACTAMASES 
In 1983 the first plasmid mediated beta lactamase able to hydrolyse extended spectrum 
cephalosporins (such as cefuroxime, cefotaxime, cetriaxone) as well as penicillins was 
reported (Knothe eta/., 1983). In the ensuing decade and a half, extended spectrum beta 
lactamases have flourished and are now a significant clinical problem, world-wide. The 
majority of ESBLs have been derived from the enzymes TEM-1, TEM -2, or SHV-1 
_ (Pl}ilippon et al., 1989). While these three may be progenitors of ESBLs they do not in 
themselves have the activity against the newer extended spectrum cephalosporins 
associated with ESBLs. 
1.4.1 Structure and Regulation of TEM- and SHY-Related Beta 
Lactamases 
TEM and SHV related beta lactamases consist of an alpha helical domain and beta pleated 
sheets. The active site containing a serine at amino acid position 70 (ser-70) is located in 
one of the alpha helices, and an oxyanion pocket is formed between this alpha helix and 
one of the beta pleated sheets. Ser-70 combined with a glutamine at position 166 (Glu-
166) are the prime catalytic amino acids. A beta lactam molecule is bound in the oxyanion 
pocket resulting in the formation of an acyl enzyme with the carbonyl of the beta lactam 
ring, followed shortly thereafter by deacylation and release of the inactive hydrolysed beta 
lactam (Bush & Sykes, 1983; Knox, 1995). 
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Point mutations at certain sites in the structural TEM and SHV resistance genes and the 
concomitant amino acid changes result in enzymes that hydrolyse some or all of the second 
and third generation cephalosporins. This can be illustrated by comparing MIC (minimum 
inhibitory concentration) profiles of some of the ~ephalosporins for various ESBL 
producing organisms (Table 1.3) (DuBois et al., 1995). 
Table 1.3 
MIC profiles (J..Lg/ml) of selected SHV and TEM derived beta lactamases 
(DuBois et al., 1995) 
Enzyme Ampicillin/Penicillin* Ceftazidime Cefotaxime 
SHV-1 1024 0,125 0,03 
SHV-2 >2048 4 4 
SHV-3 4096 2 4 
SHV-4 >2048 128 16 
SHV-5 >2048 64 8 
TEM-1 >128 0,25 0,03 
TEM-5 >128 128 4 
TEM-9 >128 128 2 
TEM-10 >128 32 0,25 
TEM-12 >128 2 0,03 
TEM-17 >128 0,03 0,25 
TEM-26 >128 64 0,25 
* All SHV MICs are for ampicillin and TEM MICs for penicillin 
As can be seen, the MICs can vary greatly depending on which ESBL is present. In some 
cases, such as TEM-17, the MICs may still be below the breakpoint required to label the 
organism resistant. However the MICs for the cephalosporin are in all cases higher than 
those obtained when testing organisms producing enzymes without extended spectrum 
activity, and the differences in activity are due to the different amino acid changes in the 
vanous enzymes. 
A's few as three amino acid changes in the TEM-1 structural protein are sufficient to 
increase its spectrum of activity to include many third generation cephalosporins. To date, 
twelve SHV and more than forty different TEM derivatives have been described world-
wide (Mabilat & Courvalin, 1990; Mercier & Levesque, 1990; Petit et al., 1990; Jacoby & 
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, Medeiros, 1991; Payne & Amyes, 1991; Moellering, 1993; Nuesch-Inderbinen et a!., 
1997) 
The point mutations and ammo acid changes found in ESBLs that enable them to 
hydrolyse the cephalosporins do not affect either of the two critical residues (serine and 
glutamine) or the less critical Lys-73, Ser-130 or Lys-234 residues. The amino acid 
changes that result in substrate changes have been reviewed before (Knox, 1995) and have 
been described both in the vicinity of and remote from the active site. Suffice it to say that 
the various changes induce either conformational changes in the oxyanion pocket, changes 
in thermodynamic factors, changes in electrostatic factors and in some cases the reason 
. l!Jlderlying the effect seen with a change in amino acid remains to be elucidated. The amino 
acid changes present in some extended spectrum beta lactamases are represented in Table 
1.4 (Sutcliffe, 1978; Mabilat & Courvalin, 1990; Mabilat et al., 1990; Ambler eta!., 1991; 
Jacoby & Medeiros, 1991; Naumovski et al., 1992; Palzkill & Botstein, 1992; Davies, 
1994; Jacoby, 1994; Palzkill et al., 1994; Knox, 1995; Bradford et al., 1996; Farzaneh et 
a!., 1996; Poyart et al., 1998; Yang et al., 1998). 
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Table 1.4 
Amino acid substitutions conferring extended spectrum activity 
in selected TEM- and SHY-related enzymes 
Amino acid Site 39 69 104 164 182 205 237 238 240 244 265 276 
Beta Iactamase 
TEM-1 Gin Met Glu Arg Met Gin Ala Gly Glu Arg Thr Asn 
TEM-2 Lys 
TEM-3 Lys Lys Ser 
TEM-4 Lys Ser Met 
TEM-5 Ser Thr Lys 
TEM-6 Lys His 
TEM-7 Lys Ser 
TEM-8 Lys Lys Ser Ser 
TEM-9 Lys Ser Met 
TEM-10 Ser Lys 
TEM-11 Lys His 
TEM-12 Ser 
TEM-13 Lys Met 
TEM-14 Lys Lys Ser Met 
TEM-15 Lys Ser 
TEM-16 Lys Lys His 
TEM-17 Lys 
TEM-18 Lys Lys 
TEM-19 Ser 
TEM-20 Tirr 
TEM-24 Lys Lys Ser Thr Lys 
TEM-26 Lys Ser 
TEM-27 His Lys Met 
TEM-30 Ser 
TEM-31 Cys 
TEM-32 lie Thr 
TEM-33 Leu 
TEM-34 Val 
TEM-35 Leu Asp 
TEM-36 Val Asp 
TEM-43 Lys His Thr 
TEM-52 Lys Thr Ser 
SHV-1 Gin Met Asp Arg Arg Ala Gly Glu Arg Leu Asn 
SHV-2 Ser 
SHV-3 Leu Ser 
SHV-4 Leu Ser Lys 
SHV-5 Ser Lys 
SHV-7 Ser Lys 
The amino acid abbreviations can be found on page xii 
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Despite the greater spectrum of activity conferred by the mutations, it has been shown that 
ESBLs have reduced catalytic activity compared to the parent TEM or SHV enzymes 
(Bush & Singer, 1989; Jacoby & Carreras, 1990). Purified TEM -3, -5, -9 and -10 
- • ...,..r.:.o. ·'• .· 
enzymes have between 0,4 and 2,2% ofthe catalytic activity against amoxycillin ofTEM-1 
(Jacoby, 1994). This can be partly countered by the fact that plasmid mediated beta 
lactamases are often produced in larger quantity. An important determinant of the 
resistance profile is also the level of expression of the beta lactamase, particularly in the 
case of the ESBLs, given the lower catalytic activity of these enzymes compared to the 
"parent" enzymes. Increased production of beta lactamases has been implicated in the 
emergence of ESBLs resistant to inhibition by beta lactamase inhibitors such as davulanic 
acid (Sanders et al., 1988; Roy et al., 1989; Thomson et al., 1990). Specific mutations in 
beta lactamase structural genes have also been linked to resistance to beta lactamase 
inhibitors (Henquell et al., 1994; Cormican et al., 1998) 
By and large, the level of expression of a resistance gene is determined by the number of 
copies of the gene and/or the regulation of transcription of the structural gene (Stratton, 
1988). The number of copies of a resistance gene can be increased if the gene is located on 
a high copy number plasmid. Although most ESBL genes to date have been described on 
large plasmids, which are usually low copy number, the presence of even a small number 
of these plasmids may allow for some increase in the expression of the particular beta 
lactamase. 
The regulation of transcription is a more complex issue, but mutations in some of the 
promoters of ESBL genes are thought to be responsible for increasing the level of 
expression of these genes. The gene encoding TEM-2 has a more efficient promoter that 
encoding TEM-1, which may explain why TEM-2 derivatives are more commonly 
encountered than their TEM-1 counterparts. Chen and Clowes (1987) showed a single 
base pair difference between the promoter regions ofthe TEM-1 and TEM-2 genes. This 
mutation results in two overlapping promoters for TEM-2. RNA studies showed that both 
promoters were recognised resulting in increased transcription of the gene and 
consequently up to ten times the ampicillin resistance in TEM-2 as compared to TEM-1. It 
has been shown subsequently that many of the enzymes derived from TEM-1 are regulated 
by two promoters which have presumably arisen by natural mutation (Mabilat et al., 
1990). 
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In TEM-6, an insertion sequence related to IS1, containing a -35 region, has inserted 
between the -10 and -3 5 regions of the prototype promoter. The insertion of this 116bp 
sequence results in a hybrid promoter consisting of the prototype -10 region of the TEM-
1 promoter P3, and the -3 5 sequence contained in the insertion sequence. This -3 5 region 
. -~· ,. 
shows perfect homology to the consensus -35 sequence for E. coli (TTGACA) (Hawley 
& McClure, 1983), resulting in a more efficient transcription of TEM-6 (Goussard et al., 
1991). Studies have shown that SHV related ESBLs are also regulated by different 
promoters. In 1991 Podbielski et al.(b) showed with RNA studies that the different 
promoters of SHV-2 and SHV-2a were responsible for different levels of cefotaxime 
resistance conferred by the two enzymes 
1.4.2 Location of TEM and SHV Related Beta Lactamase Resistance 
Genes 
Plasmid encoded beta lactamases of all classes have been described. The first plasmid 
mediated beta lactamases, TEM-1 and -2, SHY -1 and OXA-1, were described in the mid 
1960's (Bush, 1989d; Moellering, 1993) and the first plasmid mediated ESBL was 
described in 1983 (Knothe et al., 1983). This was shown to be a derivative of SHV-1, and 
was called SHV-2. Subsequently there has been a veritable deluge of reports on plasmid 
mediated extended spectrum beta lactamases (Kliebe et al., 1985; Bure et al., 1988; 
Gutmann et al., 1989; Petit at al., 1990; Payne & Amyes, 1991; Mugnier et al., 1996). 
Transposons, genetic elements capable of migrating from one site in the genome to 
another, are obviously important in the spread of resistance genes. Integrons, a component 
of one class of transposon, could also play an important role in resistance transfer. These 
elements have flanking regions and a central region which is capable of acquiring and 
rearranging so called "gene cassettes" which can code for a variety of genes, such as 
resistance genes (Hall & Collis, 1995). The fact that these cassettes are capable of moving 
around within the integron and thus within the transposon opens up frightening 
possibilities for antibiotic resistance transfer and dissemination. 
It is known that a number of plasmid mediated beta lactamases are transposon determined 
- TEM-1 and -2, SHV-1, OXA-1, and PSE-1 and -4, among others (Richmond et al., 
is 
1980; Medeiros, 1984). ESBLs have also been identified on transposable elements (Sirot 
et al., 1991; Heritage et al., 1992). Many chromosomally encoded enzymes are thought to 
be on transposons, especially in Klebsiella species (Frere, 1995), and this may well be one 
of the mechanisms of the escape of chromosomal genes to plasmids. Although no TEM-
or SHV -related ESBL genes have yet been described on integrons, other beta lactamase 
genes, particularly those related to the OXA "family" of beta lactamases, have been 
described on integrons (Danel et al., 1997; Vila et al., 1997; Naas et al., 1998). More 
recently, an integron located ESBL gene (VEB-1) was identified from a clinical isolate of 
Escherichia coli (Poirel et al., 1999). 
1.4.3 Incidence and Spread of Beta Lactamases 
Although there are a great number ofbeta lactamases as can be seen from Table 1.2, it is 
the ESBLs that are emerging as one of the more clinically important types (Jones, 1996). 
They are found almost exclusively in members of the family Enterobacteriaceae, including 
Klebsiella spp., Salmonella spp. and Escherichia spp. In a study of Gram negative 
infections in 396 Intensive Care Units (ICUs) in the USA, E. coli was shown to be the 
commonest pathogen (21,3%), followed by P. aeruginosa (19,7%), Enterobacter spp. 
(16,1%) and Klebsiella spp. (15,3%) (Itokazu et al., 1996). Respiratory tract infections 
accounted for 4 7% of the infections caused by these organisms, followed by urinary tract 
infections (UTis ), bacteraemias and wound infections. 
1.4.3.1 Incidence of Beta Lactamase Mediated Resistance 
Although beta lactamase resistance genes may be located on transposons, integrons, 
plasmids or in the chromosome of bacteria, all TEM and SHV related enzymes are plasmid 
mediated. A disturbing rise in ESBL mediated resistance in Gram negative pathogens has 
been documented over the last 5 - 10 years. The emergence and spread of these enzymes 
has been linked to the transfer of conjugative plasmids between bacterial strains. 
National Nosocomial Infection Surveillance (NNIS) data from the USA show that the 
resistance to extended spectrum beta lactams amongst K. pneumoniae has risen from 1,5% 
in 1986 to nearly 13% in 1993 (Archibald et al., 1997). This increase is not confined to 
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Klebsiella spp; ceftazidime resistant Enterobacter spp have increased from 30,8% in 1990 
to 38,3% in 1993 (Itokazu et al., 1996). Beta lactam resistance in E. coli rose from 8 - 28 
% from 1984 - 1987 (Sanders & Sanders, 1992). A study of ampicillin resistant E. coli 
isolates in 1990 showed that the majority of beta lactamases in these organisms were 
TEM-related (Cooksey et al., 1990). Beta lactam resistance in E. coli and K. pneumoniae 
isolates is usually due to the production of TEM- or SHY-related beta lactamases, 
whereas beta lactam resistance in Enterobacter spp. is more likely to be on the basis of 
chromosomal beta lactamase production - the so-called AmpC beta lactamase (Livermore, 
1995). 
In 1986, none of the isolates of K. pneumoniae from a hospital in Chicago (Rush-
Presbyterian-St Luke's) were ceftazidime resistant. By 1993, 27% of them displayed 
ceftazidime resistance (Schiappa et al., 1996). Similarly, at Mercy Hospital in Chicago, the 
p-ercentage of K. pneumoniae isolates resistant to ceftazidime increased from about 2% to 
15% between 1988 and 1990. This resistance was felt to be predominantly due to ESBL 
production by the isolates. It is interesting to note that the use of Ceftazidime in Mercy 
Hospital had increased nearly six-fold from 1987 to 1991 (1000g in 1987 and 5888g in 
1991) (Bradford et al., 1994). 
In 1990, a study in the United States showed approximately 3,6% of klebsiella isolates to 
be resistant to ceftazidime. This figure quadrupled to 14,4% in 3 years. While it is 
probable that the resistance rates will plateau and not rise at this rate indefinitely, it is still 
a cause for concern in clinical and microbiological circles (Itokazu et al., 1996). In 1994, 
60% of E. coli isolates in New York City were resistant to ceftazidime. Similar studies 
have shown similar increases in Europe: of 1000 Klebsiella spp. from ICU's throughout 
Europe, 23% were shown to be resistant to ceftazidime due to ESBL production 
(Livermore & Yuan, 1996). 
It can be seen that the problem is world-wide and while some countries may have slightly 
higher or lower incidences of ESBLs in Gram negative bacilli, no country would appear to 
be immune. No large scale studies of the problem have been carried out in South Africa, 
but it is thought that SHV-2 and -5, as well as TEM 26 are the commonest ESBLs in this 
country (Pitout, 1996). 
20 
Resistance rates have been found to be the highest in Intensive Care Units, and it is 
thought that resistance often emerges in an ICU, and spreads to the hospital and the 
community (De Champs et al., 1991; Sirot et al., 1992; Burwen et al., 1994). Risk factors 
for colonisation or infection by ESBL producing Gram negatives include length of stay in 
~ an 'ICU, recent surgery, instrumentation, prolonged stay in hospital and recent antibiotic 
exposure, particularly to extended spectrum beta lactam agents. 
There is a clear link between these factors and colonisation by resistant organisms. In 
terms of the focus of this dissertation, what deserves more consideration is the extent to 
which the use of the newer third generation cephalosporins has encouraged the emergence 
of resistance. 
A number of authors have linked the use of these agents to the emergence of resistance 
(Stratton 1988; Bush, 1989d; Neu, 1990b; Peiia et al., 1998). As previously mentioned, 
~ 75% of nursing home patients were found to be colonised by ceftazidime resistant Gram 
negative organisms soon after admission to a hospital. Ceftazidime was extensively used in 
these nursing homes (Quinn, 1994). It has been shown that use of a third generation 
cephalosporin within 2 weeks of an Enterobacter infection is associated with a 
significantly greater risk of subsequent infection by a cephalosporin resistant isolate. 
Infection by resistant Enterobacter organisms is also associated with a higher mortality 
rate - 32% vs 15% (Chow et al., 1991). Although this resistance may be due to 
chromosomal beta lactamases (AmpC) rather than ESBLs, the principle of a resistant 
organism being associated with higher morbidity and mortality would hold true for ESBL 
producing isolates as well . 
.. ~~···· 
1.4.3.2 Spread of Beta Lactamase Mediated Resistance 
The spread of antibiotic resistance is always cause for concern, particularly in the hospital 
setting. As detailed previously, since their first description in 1983 plasmid mediated 
ESBLs have been reported from many countries, and in many different species of 
Enterobacteriaceae (Tenover, 1991; Payne & Amyes, 1991; Jacoby & Medeiros, 1991). 
Plasmids encoding ESBLs have been transferred from strain to strain in vitro, and have 
also proven to be responsible for spread of beta lactam resistance within and between 
- 2t··-
wards. In 1990 a plasmid containing a gene encoding for TEM-3 was shown to be self 
transmissible, and was thought to have spread from an isolate of S. marcescens to seven 
different bacterial genera over 4 years in an area of France (Petit et al., 1990). In the early 
1990's, a study of multi-drug resistant K. pneumoniae isolates in a paediatric ward in 
France was undertaken. The result of ribotyping and plasmid profile studies showed 
genetically unrelated strains of the organism with the same plasmid content. Although 
these plasmids were not shown to contain the genes coding for the ESBL, all the isolates 
involved in the outbreak were ESBL producers and the possibility was raised that at least 
some of the plasmids contained ESBL genes (Bingen eta/., 1993). In 1995, a Tunisian 
isolate of Salmonella enteritidis was shown to have acquired a resistance plasmid 
encoding an ESBL in vivo following cefotaxime therapy. This resistance plasmid was 
thought to have originated in another intestinal organism (Barguellil eta/., 1995). 
In institutions such as nursing homes patients are in close contact with each other and may 
be exposed to antibiotics more frequently than other community members. In this setting 
development of resistance and subsequent transfer of resistance plasmids to other 
organisms can lead to clinical problems. The problem is compounded when patients from 
the nursing home require hospitalisation and thereby import resistant organisms to the 
hospital. In a Chicago hospital it was noted that up to 75% of ceftazidime resistant Gram 
negative isolates originated from patients who came from nursing homes. Most of this 
resistance appeared to be due to the production of the TEM-10 beta lactamase, suggesting 
transfer of a common resistance plasmid from organism to organism within the home 
(Quinn, 1994). 
Direct spread of organisms from patient to patient has also been demonstrated in similar 
situations. A study of ESBL producing Klebsiella pneumoniae strains in a geriatric ward 
showed that the outbreak was due to a single clone that had spread within the ward 
(Gouby et al., 1994). Another study in France showed spread of an ESBL producing K. 
pneumoniae strain from one hospital to another with subsequent spread within the 
respective hospitals. The organism was thought to have been carried by an infected patient 
who was transferred between the hospitals (Bure et al., 1988). Two other outbreaks of 
ESBL producing K. pneumoniae strains were also shown to be due to a single clone of the 
organism (Gazouli eta/., 1997; Pefia eta/., 1998). 
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Resistance spread within institutions is thus a complex and common problem, with both 
organism and plasmid transfer taking place. These data reinforce the need for strict 
infection control measures, particularly in cases where a multi-drug resistant organism is 
implicated in the infection. 
Spread of ESBLs by the expedient of international travel has been reported. Strains of K 
pneumoniae producing SHV type ESBLs (SHV -2 and -5) have been reportedly imported 
to the UK from Egypt and Greece (Shannon et al., 1990). Similar imported cases have 
been reported in France, Egypt and other European and African countries (Philippon et 
al., 1994). While the clinical importance of this mode of "transfer" is not known, it is 
unlikely to be as significant as plasmid transfer between organisms. 
It is not only pathogens that constitute a problem when considering the spread of ESBLs. 
Plasmids encoding resistance genes may remain cryptic in certain bacteria such as 
commensals in the gastro-intestinal tract (GIT). The introduction of an antibiotic into this 
environment would place selective pressure on organisms harbouring resistance genes, 
allowing them to flourish and increasing the relative proportions of resistant organisms 
within the GIT and possibly also within the general community. 
A study in Finland showed that 3 8% of Gram negative enteric bacilli from healthy people 
were resistant to ampicillin although no data was presented on transmissibility of this 
resistance (Leistevuo et al., 1996). A study in South Africa showed that amoxicillin 
resistance was present in 88% of the faecal flora of healthy people (adults and children) 
and 26% of this resistance was carried on self-transferable plasmids. While it was found 
that the majority of this resistance was mediated by TEM-1, which is not an ESBL, it still 
lends weight to the theory that faecal flora can act as a reservoir for resistance plasmids 
which may harbour ESBLs. Another concern is that many of these plasmids can carry 
. rrn.iitiple resistance genes, coding for resistance to commonly used antibiotics such as 
tetracycline and sulphonamides (Shanahan et al., 1995). With the increasing use of oral 
antibiotics it is easy to see how selective pressure could result in the proliferation of these 
commensals allowing them to act as a potential source of resistance determinants. 
Given the increasing spread and incidence of ESBL mediated resistance, detection of 
ESBLs is increasingly important. Reliable detection of these enzymes is however difficult. 
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Allied to this is the fact that an isolate harbouring an ESBL may appear sensitive in vitro 
despite being resistant in vivo. This can result in isolates being incorrectly reported as 
sensitive to cephalosporin antibiotics. Subsequent treatment failure, with its attendant 
higher morbidity and mortality, has been described both experimentally and in the clinical 
setting (Rice et al., 1991; Karas et al., 1996). 
1.4.4 Detection and Characterisation of Beta Lactamase Mediated 
Resistance 
The importance of detecting beta lactamases, especially ESBLs, was alluded to previously. 
For epidemiological purposes it is important to characterise ESBLs. This information may 
allow determination of whether a particular beta lactamase has arisen as a result of a new 
mutation or is a previously characterised enzyme in a hithertofore unsuspected organism 
or location. This section will deal firstly with some of the tests commonly used to 
characterise the enzymes and then address the problem of detection in more detail. 
A number of laboratory tests, including isoelectric focussing and determination of both 
.. §YQStrate and inhibition profiles, have been used for the detection and characterisation of 
beta lactamses (Sykes & Matthew, 1976; Bush, 1989a). Isoelectric focusing was first used 
in 197 5 (Mathew et a!., 197 5) for the detection and characterisation of beta lactamases. 
While this technique has proved to be useful in characterising these enzymes it has its 
drawbacks. It is a technically demanding test and suffers from the disadvantage that many 
related beta lactamases, especially ESBLs, cluster at the same pi. For example, most of the 
TEM related enzymes (of which there are more than forty) have pi's clustered around 5.5 
- 6.3 (Mabilat & Courvalin, 1990; Jacoby & Medeiros, 1991) making differentiation 
difficult. The information is often combined with the results of other investigations and 
may be useful as supportive or confirmatory evidence when investigating an outbreak of 
~~!.a lactamase producing organisms (Nouvellon et al., 1994). 
The rates at which different beta lactamases hydrolyse various antibiotics has also been 
used as a means of characterising enzymes. A number of antibiotics are used to determine 
the substrate profile of an enzyme. Benzylpenicillin, ampicillin, carbenicillin and cloxacillin 
are the penicillin compounds traditionally used. Of the cephalosporins, cephaloridine and 
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cephalothin were used initially. However, with the advent of the ESBLs, it was necessary 
to include the extended spectrum cephalosporins cefotaxime and ceftazidime in the 
substrate profile analysis. Other studies have also included antibiotics such as cefoxitin, 
ceftriaxone and imipenem (Bush, 1989c,d; Liu et al., 1992; Bauernfeind et al., 1996a). 
Both maximal hydrolysis rates (V max) and enzyme affinities (Km) should be included in the 
characterisation of a new beta lactamase, although in many instances only the V max is 
determined. 
Various substances, including beta lactamase inhibitors, are known to inhibit the action of 
- oefa lactamases by irreversibly inactivating the enzyme and different enzymes are affected 
to varying degrees by these inhibitors. Cephalosporinases are thought to be more strongly 
inhibited by aztreonam than by clavulanic acid, whereas the reverse is true for 
penicillinases, and this can be used as a means of distinguishing cephalosporinases from 
penicillinases (Bush, 1989a). 
Detection of the presence of an ESBL based on in vitro susceptibility tests has proven to 
be a problem (Meyer et al., 1993). In the laboratory many of the clinical strains that 
produce ESBLs do not appear resistant to cephalosporins, or at best they appear resistant 
to only some of the cephalosporins. Vercauteren et al. (1997) showed that the standard 
disc· diffusion test using ceftazidime detected only 48% of the ESBL producers. Allied to 
this problem is the consideration that with so many different cephalosporins available it is 
not practical to test every one of them. Representative antibiotics are often tested and 
different antibiotics chosen for testing depending on the suspected organism. The 
deduction of the resistance mechanism in the organism from these results has been called 
"interpretative reading" and allows prediction of the expected in vivo resistance phenotype 
(Courvalin, 1992). 
The presence of an ESBL in an organism may not lead to a high enough level of resistance 
to the antibiotic being tested to appear resistant on current criteria (either zone size or 
MIG). It has been reported that as few as 23% ofESBL producing K. pneumoniae isolates 
will be reported as resistant using NCCLS criteria on disc diffusion testing with 
cefotaxime (Jacoby & Han, 1996). This problem has also been noted for aztreonam, 
cefotaxime, ceftriaxone and ceftazidime in different studies (Bure et al., 1988; Katsanis et 
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~ al:;· 1994; Livermore & Yuan, 1996; Sanders et al., 1996), and incidences of treatment 
failure using a supposedly appropriate antibiotic have been reported (Karas et al., 1996). 
The above problem is related to the inoculum effect. If the inoculum tested in vitro is 
smaller than the inoculum in vivo, the MIC of the antibiotic for that organism may rise 
dramatically, with ensuing treatment failure (Rice et al., 1991; Katsanis et al., 1994). This 
is a result of the increased amount of beta lactamase produced by the larger number of 
organisms. This led to the recommendation by the NCCLS that any organism which is 
shown to produce an ESBL should be regarded as resistant to all cephalosporins, with the 
possible exception of cefepime (NCCLS, 1998). 
Since susceptibility testing on its own is often inadequate for determining the presence of 
ESBLs, and given the importance of detecting the enzymes, various strategies for 
overcoming the difficulties in detecting ESBL production have been devised. The 
following section will deal with some of the more promising methods. 
1. 4. 4.1 Phenotypic Methods 
i) Double Disc Diffusion Test 
ESBLs are inhibited (albeit sometimes to different degrees) by beta lactamase inhibitors 
(Glavulanate, sulbactam, tazobactam). A disc containing one of the cephalosporins (often 
ceftazidime) is placed proximal to a disc containing clavulanate on agar inoculated with an 
isolate. If an ESBL is produced by the isolate an increased zone of inhibition of growth 
will occur between the two antibiotic discs, often giving rise to a dumbbell shaped zone of 
inhibition (Fig 1.5). This occurs because the clavulanate inhibits the action of the ESBL 
and the cephalosporin can then act in the absence of the beta lactamase. 
Although some authors have reported great success with this method (Mabilat & 
Courvalin, 1990; Karas et al., 1996), others have found it to be unreliable and that inter-
laboratory variation may occur. This is due to the fact that the discs need to be placed an 
. appropriate distance apart (a distance that has not to date been reliably determined). The 
determination of whether this "zone of inhibition" is present is also subject to inter-
observer differences (Cormican et al., 1996; Jacoby & Han, 1996; Sanders et al., 1996). 
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Notwithstanding these problems, this test is still widely used because of the ease with 
which it can be incorporated into a laboratory's routine susceptibility testing. 
Figure 1.5 Double disc test on an ESBL producing isolate of K. pneumoniae, showing the characteristic 
zone of extension between the cefotaxime and clavulanic acid discs. Note the absence of such a 
zone between the ceftazidime and clavulanate discs. Left-hand disc contains cefotaxime, middle 
disc contains amoxicillin/clavulanic acid, lower right-hand disc contains ceftazidime. 
ii) Vitek ESBL Test 
This test also utilises clavulanic acid. Isolates are inoculated into 4 wells, two containing 
cefotaxime and ceftazidime (0,5 f!g/ml) alone and two wells containing each of the 
antibiotics plus clavulanic acid ( 4 f!g/ml). After incubation, a predetermined reduction in 
growth in the wells with antibiotic plus clavulanic acid as compared to the wells with 
antibiotic alone is taken to indicate the presence of an ESBL. A study conducted in 1996 
(Sanders et al.) compared this test with the double disc diffusion test, using organisms 
containing previously characterised beta lactamases, or by determining isoelectric points 
and substrate profiles on the beta lactamase. The organisms tested were K. pneumoniae 
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and E. coli, as well as a smaller number of Enterobacter species and miscellaneous Gram 
negative bacilli. 
The results showed that the Vitek ESBL test was 99,5% sensitive and 100% specific in 
detecting ESBLs, compared to 98% and 99,4% sensitivity and specificity respectively for 
the double disc test. The test was also shown to be better able to distinguish between an 
ESBL and the chromosomal beta lactamase of K. oxytoca. Whether this method will stand 
up to further testing and become widely used to detect ESBLs remains to be seen. 
iii) Etest ESBL Screen 
This is similar to the Vitek ESBL test although instead of inoculating the organism into 
. w.~lls containing antibiotic, plastic strips impregnated with the antibiotic are placed on agar 
inoculated with the organism. One side of the strip is impregnated with a gradient of 
ce:ftazidime (32 - 0, 12Jlg/ml) while the other side contains the same ce:ftazidime gradient 
plus a fixed concentration of clavulanate (2Jlg/ml). The strips are placed on agar 
inoculated with the strain to be tested, incubated, and the MICs for the antibiotic and the 
antibiotic plus inhibitor determined from where the zone of inhibition meets the plastic 
strip. The criteria for a positive result (i.e. ESBL present) are reduction of the ce:ftazidime 
:MIC by more than two log dilution steps when clavulanate is present. Using this criterion, 
the Etest has been shown to be more sensitive than the double disc test (100% vs 87% 
sensitivity) (Cormican et al., 1996). A major drawback to the Etest is the cost, a 
~9t:tsideration particularly important in South Africa. 
iv) Other Tests for Detection of ESBLs 
Apart from the above methods, a number of other strategies for the detection of ESBLs 
have been proposed. It has been reported that a disc with 5 Jlg of ce:ftazidime and a 
different breakpoint is more sensitive in detecting resistance than the usual 30Jlg 
ce:ftazidime disc (Jacoby & Han, 1996). Alternatively, results of disc diffusion tests using 
cefpodoxime have been shown to correlate very well with the presence of an ESBL 
(Coudron et al., 1997). Broth microdilution panels have also shown some promise in 
. d~tecting ESBL production (Moland et al., 1998). 
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Genes coding for ESBL production are often present on large plasmids which contain 
other antibiotic resistance genes. This may allow one to infer that an organism with 
phenotypic resistance to another class of antibiotic ( aminoglycosides for example) may 
also produce an ESBL despite this not being apparent on routine sensitivity testing . 
...... ... ~··· 
However this is very non-specific and resistance to non beta-lactam antibiotics is obviously 
not enough to unequivocally assume to presence of an ESBL (Katsanis et al., 1994). 
1.4.4.2 Molecular Techniques 
Molecular techniques have proved valuable tools for the characterisation and detection of 
beta lactamase resistance genes. DNA sequencing has allowed phylogenetic relationships 
to be explored, and has opened up the way for the use of DNA-DNA hybridisation in the 
detection and identification of beta lactamase genes. Amino acid sequences, whether 
deduced from DNA or determined primarily, also provide phylogenetic information and ... ..,...., ~ ,. 
facilitate the analysis of structure-function relationships (Mabilat & Courvalin, 1990; 
Knox, 1995; Bauernfeind et al., 1996a,b). 
i) DNA-DNA Hybridisation 
The use ofDNA probes for the detection and characterisation of beta lactamases has been 
well described. A number of studies have used this technique in epidemiological surveys of 
beta lactamases (Mabilat & Courvalin, 1990; Ling et al., 1994; Huovinen et al., 1988). In 
addition, it allows for more rapid analysis of samples than isoelectric focusing (Ouellette et 
al., 1988). The probes and techniques can be varied to either specifically identify an ESBL 
gene or to broadly categorise the gene into either TEM or SHV related groups. 'fhe use of 
DNA-DNA hybridisation techniques in the identification and characterisation of TEM and 
SHV related ESBLs will be discussed in subsequent chapters. 
ii) Polymerase Chain Reaction (PCR) 
Knowledge of DNA sequences of the beta lactamase resistance genes has allowed PCR to 
be used both for the detection and characterisation of beta lactamases. Using primers 
complementary to conserved sequences in, for example, TEM-related genes, the presence 
of a TEM related gene can be ascertained using PCR. Similarly, SHV related genes (or 
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any other beta lactamase gene) could be detected using appropriate primers (Leung et al., 
1997; Payne & Thomson, 1998). As with hybridisation, the use of PCR for detecting 
ESBL genes will also be discussed in more detail in subsequent chapters. 
1.5 AIM OF STUDY 
Beta lactamases are an ongoing and growing problem in clinical and laboratory circles. 
While the incidence of ESBLs in South Africa is not accurately known, SHV-2, SHV-5 
and TEM 26 are though to be prevalent in this country (Pitout, 1996). A study examining 
isolates from four major medical centres throughout South Africa (Cape Town, Durban, 
Johannesburg and Pretoria) found these ESBLs to be present in various isolates of 
Enterobacteriaceae (Pitout eta/., 1998b ). 
The incidence ofESBL activity may be underestimated because of the problems associated 
~ »dth detecting this activity. It is suggested that the ESBL incidence in some areas of the 
. . 
world may be as high as 74% (Sanders & Sanders, 1992). There is little information 
pertaining to large hospitals in the Western Cape - it is in large teaching hospitals that beta 
lactamases are known to proliferate - and none directly pertaining to Groote Schuur 
Hospital. 
The aims of this study were firstly to investigate the molecular epidemiology of TEM- and 
SHV -related beta lactamases at Groote Schuur Hospital, secondly to compare and 
contrast various methods of detecting ESBLs and ESBL activity, and thirdly to compare 
various molecular methods of detecting the presence ofTEM- or SHY-related genes. 
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CHAPTER TWO 
BACTERIAL ISOLATES AND ANTIBIOTIC 
SENSITIVITY TESTING 
. 
2.1-IDENTIFICATION OF BACTERIAL ISOLATES 
All media and solutions mentioned in this and subsequent chapters are to be found in 
Appendix A. The sample used in this study was selected from 209 clinical isolates of Gram 
negative bacilli collected between January 1991 and June 1995 by the clinical microbiology 
laboratory at Groote Schuur Hospital, Cape Town. Bacterial strains had been either freeze 
dried or stored on Dorset's egg agar. Following inoculation onto MacConkey agar and 
incubation aerobically at 37°C overnight, the organisms were identified using standard 
biochemical tests (CoHee & Miles, 1989) used in the Groote Schuur hospital clinical 
, l'aooratory. 
2.2 ANTIBIOTIC SENSITIVITY TESTING 
Antibiotic sensitivity tests were carried out using the Kirby Bauer disc diffusion test on 
Mueller Hinton agar incubated aerobically at 37°C for 18 hours as recommended by the 
NCCLS (NCCLS, 1997). A variety of beta lactam antibiotics and beta lactarnlbeta 
lactamase-inhibitor combinations were tested. Other antibiotic sensitivities were not 
determined since the focus of this research is on beta lactamase production. Discs 
_ ~5n1tained the following antibiotics - amoxicillin/clawlanic acid, ceftriaxone, ceftazidime, 
cefoxitin, cefuroxime, imipenem, piperacillin/tazobactam. All discs were supplied by Oxoid 
(Hampshire, UK) except piperacillin/tazobactam which was supplied by Mast diagnostics 
(Merseyside, UK). The zone size criteria (Table 2.1) used to determine sensitive, 




Zone size criteria (nun) recommended by the NCCLS for sensitivity testing 
(NCCLS, 1995) 
Amount (IJ.g) Resistant Intermediate Sensitive 
Amoxicillin/ Clavulanic acid 20/10 s; 13 14-17 ~18 
Piperacillin/ Tazobactam 100/10 s; 17 18-20 ~ 21 
Ceftazidime 30 s; 14 15- 17 ~ 18 
Ceftriaxone * 30 s; 14 15-17 ~ 18 
Cefoxitin 30 s; 14 15-17 ~ 18 
Cefuroxime 30 s; 14 15 -17 ~ 18 
Imipenem 10 S::l3 14-15 ~ 16 
*In the 1998 NCCLS Standards the criteria relating to ceftriaxone, ceftizoxime and cefotaxime have 
changed, with larger zones now required in order for an organism to be sensitive to these antibiotics. 
(NCCLS, 1998). 
Minimum inhibitory concentrations (MICs) of aztreonam, cefotaxime, ceftazidime and 
ceftazidime/clavulanic acid were determined using E-strips (AB Biodisk, Solna, Sweden). 
A single colony of the isolate was inoculated into 0,5ml Mueller Hinton broth to make a 
~· 0~ McFarland standard (NCCLS, 1997). A swab was dipped into the inoculum, excess 
medium was squeezed out against the side of the test tube and the inoculum spread onto 
Mueller Hinton agar in 150mm diameter Petri dishes using the method recommended by 
the manufacturer. The inoculum was allowed to dry for 15 minutes and the E-strips were 
placed on the inoculum and incubated at 37°C overnight. MICs were determined by 
assessing which concentration of antibiotic along the gradient had inhibited bacterial 
growth (Fig 2.1). 
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Fig 2.1 MIC determination using a ceftazidime - ceftazidime/clavulanate E-strip. The MIC is determined 
by visually assessing which antibiotic concentration along the gradient of the E-strip inhibits 
bacterial growth. Note also the presence of mutant colonies around the ceftazidime containing 
half, which may interfere with assessment of the MIC. TZL represents ceftazidime/clavulanate 
and TZ represents ceftazidime. MICs are read as J.Lg/ml . 
2.3 DETECTION OF ESBL PRODUCTION 
Two methods were used to detect the presence of ESBLs. Firstly, the double disc 
diffusion test [1.4.4.1] was used to detect the presence of these enzymes. An 
amoxicillin/clavulanic acid disc was placed between ceftazidime and ceftriaxone discs 
(20mm between adjacent edges ofthe discs) . Any dumb-bell shaped extension ofthe zone 
of inhibition around either of these discs towards the clavulanate disc was taken as 
indicative of the presence of ESBL activity. In certain cases, where the results were 
equivocal or negative, the test was repeated and the ceftazidime and ceftriaxone discs 
were placed 10 mm and 15 mm from the clavulanic acid containing disc and incubated 
overnight at 37°C. 
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E-strips were also used to test for ESBL production. Strips with a range of ceftazidime 
concentrations {0,5 - 32!J.g/ml) along one side and ceftazidime {0,125 - 8!J.g/ml) plus a 
fixed amount of clavulanate ( 4!J.g/ml) along the other side were used for this purpose. A 
ratio of the ceftazidime MIC to the ceftazidime plus clavulanate MIC of greater than four 
(i.e >2log dilutions) was taken to be indicative of the presence of an ESBL (Cormican et 
al., 1996). 
2.4RESULTS 
2.4.1 Identification and Antibiotic Susceptibility 
The identity of 160 of the 209 isolates was established although in some instances it was 
not possible to speciate an organism using the standard biochemical tests used in our 
laboratory. The remaining 49 isolates were either non-viable or yielded mixed growth on 
McConkey agar. Based on the identity and antibiotic susceptibility profiles of the 160 
isolates, 45 were chosen for further study. The 45 isolates selected represented a variety of 
organisms as well as a representative of each antibiotic susceptibility pattern. For example, 
all K. pneumoniae isolates with differing antibiograms were included. The identity and 
. a!ltibiotic susceptibility profile of these 45 isolates is shown in Table 2.2 and the MICs of 
aztreonam, cefotaxime, ceftazidime and ceftazidime/clavulanic acid for the isolates are 
detailed in Table 2.3. 
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Table 2.2 Identities and antibiotic resistance profiles of the 45 s~lected isolates. 
Isolate Identity Zone (Ame-Cro) Cro Arne Zone (Arne- Caz) Caz Fox Cxm Tzp 
K4 K. pneumoniae + 17 I 20 s + 20 s 24 s 15 I 24 s 
K8 K. pneumoniae +• NZR 15 I -· II R NZ R NZ R 17 R 
Kll K. pneumoniae + 16 I 16 I + 22 s 26 s 24 s 25 s 
K16 K. pneumoniae + 17 I 20 s + 19 s II R 9 R 20 I 
K17 K. pneumoniae - 12 R 17 I + 14 R 24 s 13 R 21 s 
K18 K. pneumoniae - 17 I 17 I + 20 s 22 s 15 I 21 s 
KZ9 K. pneumoniae + 15 I 19 s + 14 R 17 I 10 R 20 I 
K35 K. pneumoniae - 10 R 15 I + 15 I 25 s 10 R 18 I 
K36 K. pneumoniae + 14 R 11 I + 18 s 24 s 14 R 21 s 
K39 K. pneumoniae - 9 R 15 I + 13 R 25 s 9 R 15 R 
K42 K. pneumoniae - 19 s 16 I + 1 R 25 s 22 s 20 I 
K43 K. pneumoniae - 15 I 17 I + 19 s 25 s 13 R 19 I 
K46 K. pneumoniae +• II R 18 s +• NZ R 27 s 10 R 18 I 
KSO K. pneumoniae - 14 R 15 I + 20 s 25 s 15 I 18 I 
KS2 K. oxytoca - II R 12 R - 24 s 22 s NZ R NZ R 
KS4 K. pneumoniae +• NZ R 13 R +• NZ R 12 R NZ R NZ R 
KS8 K. pneumoniae + 1 R 15 I + 10 R 15 I NZ R 13 R 
K63 K. pneumoniae +· 15 I 16 I + NZ R 26 s 15 I 24 s 
K68 K. pneumoniae + 17 I 15 I + 20 s 24 s 15 I 19 I 
K69 K. pneumoniae + 13 R 14 I + 20 s 24 s 14 R 20 I 
M9 C.freundii - 10 R 10 R - NZ R NZ R NZ R 17 R 
MlO C. sp. - 8 R 10 R - 8 R NZ R NZ R 21 s 
M20 c. sp. - 8 R 8 R - 8 R NZ R NZ R 18 I 
M25 K. pneumoniae -· NZ R 10 R -· NZ R 15 I 1 R 13 R 
M26 K. pneumoniae + 20 s 20 s + 24 s 27 s 20 s 26 s 
M28 K. pneumoniae + 15 I 18 I + 16 I 26 s 14 I 21 s 
M30 K. pneumoniae -· 17 I 19 s -· 20 s 24 s 17 I 24 s 
M37 E. cloacae NZ R II R - 12 R NZ R NZ R 19 I 
M40 E. cloacae -· 16 I 18 s -· 10 R 24 s 13 R 22 I 
M43 P. agglamerans -· NZR 9 R -· 12 R NZ R NZ R 16 I 
M44-1 Salmonella sp. +• 15 I 21 s +• NZ R 28 s 13 R 22 I 
M44-2 Salmonella sp. +• 15 I 21 s +• NZ R 28 s 13 R 22 I 
M46 S. marscecens 12 R NZR - NZ R 16 I NZ R 16 R 
El E. cloacae - 9 R II R - II R 13 R NZ R 20 I 
ES E. cloacae - NZR 12 R - 1 R NZ R NZ R 18 I 
E7 E. cloacae - 8 R 10 R - 15 I NZ R NZ R 24 s 
E8 E.sp. - 17 I 15 I - 15 I NZ R NZ R 20 I 
ElO E. sp. - 15 I 14 I - 16 I NZ R NZ R 20 I 
E12 E. cloacae - 16 I 8 R - 15 I NZ R NZ R 20 I 
E13 E. cloacae - NZ R 10 R - II R NZ R NZ R 21 I 
E16 E. cloacae - 13 R 12 R - 1 R 1 R NZ R 22 s 
E17 E. cloacae 28 s 10 R - 29 s NZ R 24 s 27 s 
Ell E. sp. - 15 I 13 R - 15 I NZ R 1 R 19 I 
E37 E. sp. - 15 I 15 I - 13 R NZ R NZ R 18 I 
E49 E. cloacae + 20 s II R + 25 s 10 R 17 I 26 s 
.. . . . . 
Zone '+' represents a zone ofinhibttlon towards a BLI (beta lactarnase inhibttor) '-'represents no zone ofinhibttlon towards a BLI 
'*' organism tested twice for zone of inhibition. Zone sizes in mm. NZ =growth up to disc; S =sensitive, I= intermediate, 
R = resistant. Cro = Ceftriaxone, Arne = amoxicillinlclavulanic acid, Caz = ceftazidime, Fox = cefoxitin, Cxm = cefuroxime, Tzp = 
piperacillinltazobactam . Imipenem not listed - all isolates were sensitive to imipenem 
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Table 2.3 
MICs (J..lg/ml) ofthe 45 selected isolates 
ISOLATE IDENTITY CEFOTAXIME 
R264 Ss.8J..lglml 
AZTREONAM CEFTAZIDIME CEFTAZ!CLA V ESBL 
K4 K. pneumoniae 
K8 K. pneumoniae 
K11 K. pneumoniae 
K16 K. pneumoniae 
K17 K. pneumoniae 
K18 K. pneumoniae 
K29 K. pneumoniae 
K35 K. pneumoniae 
K36 K. pneumoniae 
K39 K. pneumoniae 
K42 K. pneumoniae 
K43 K. pneumoniae 
K46 K. pneumoniae 
K50 K. pneumoniae 
K52 K. oxytoca 
K54 K. pneumoniae 
K58 K. pneumoniae 
K63 K. pneumoniae 
K68 K. pneumoniae 
K69 K. pneumoniae 
M9 C. freundii 
M10 C.sp. 
M20 C. sp. 
M25 K. pneumoniae 
M26 K. pneumoniae 
M28 K. pneumoniae 
M30 K. pneumoniae 
M37 E. cloacae 
M40 E. cloacae 
M43 P. agglomerans 
M44-1 Salmonella sp. 
M44-2 Salmonella sp. 
M46 S. marscecens 
E1 E. cloacae 
E5 E. cloacae 
E7 E. cloacae 
E8 E. sp. 
E10 E. sp. 
E12 E. cloacae 
E13 E. cloacae 
E16 E. cloacae 












































































































































































































E21 E. sp. 4 4 >32 >8 N 
E37 E. sp. 4 >32 >8 N 
E49 E. cloacae 4 0,75 6-8 0,25 Y 
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Breakpoints for the antibiotics are given under the respective headings. None exist for 
ceftazidime/clavulanate. Under ESBL, Y = Yes, N = No, based on the ratio of ceftazidime MIC to 
ceftazidime/clavulanate MIC (see text). 
In instances where a significant difference between the ceftazidime MIC and ceftazidime 
disc diffusion result was present, both the disc diffusion test and ceftazidime MIC 
determination were repeated. A significant difference was taken as one where there was a 
sensitive/resistant discrepancy between the two results. Table 2.4 below shows the results 
of the repeat testing on the three isolates. It should be noted that interpretation of the 
second set of MIC results was made difficult due to the presence of mutant colonies 
growing alongside the E-strip. In these cases (K18 & K50) the MIC was taken as the 
highest concentration which inhibited the growth of mutant colonies. 
Table 2.4 
Results of repeat disc diffusion and E-test MICs on three isolates 
Isolate Ceftazidime z Ceftazidime Ceftazidime z Ceftazidime MI 
size - 1st test - t•t test size -2nd test 2nd test 
K18 20 s >32 R 17 I >32 R 
K50 20 s >32 R 18 s >32 R 
K69 20 s >32 R 18 s 8 s 
Zone size in mm, MIC in ~g/ml. S= sensitive, I= intermediate, R = resistant 
2.4.2 Detection of ESBL Activity 
ESBL activity was detected using the double disc diffusion test and the Etest ESBL test. 
Of the 45 isolates, 27 ( 60%) were shown to produce these enzymes by either one or both 
of the methods. The remaining 18 isolates showed no evidence of the presence of ESBL 
activity. It should be noted that the double disc test detected ESBL activity in five of the 
isolates (K8, K46, K54, M44-1 and M44-2) only when the test was performed using discs 
separated by both 10 and 15mm but not when the discs were 20mm apart. 
The double disc test detected 24 of the 27 ESBL producers and the Etest 26 of the 27. Of 
the 24 ESBL producers detected by the double disc test, 16 were identified using both the 
ceftriaxone/clavulanate discs and ceftazidime/clavulanate discs. Of the remaining eight, 
seven were detected only by the ceftazidime/clavulanate combination, and one (K8) was 
only detected usmg the ceftriaxone/clavulanate discs but not by the 
ceftazidime/ clavulanate combination. 
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Three additional isolates (M25, M30 and M40) were shown to have ESBL activity using 
the Etest but this activity was not demonstrated by the double disc test, even when the test 
" was repeated. Conversely, ESBL activity was demonstrated in isolate K8 by the double 
disc diffusion test but not by the Etest ESBL test. A comparison of the results of the 
double disc tests and Etests is shown in Table 2.5. 
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Table 2.5 
Results ofESBL detection tests comparing Etest to double disc test 
Isolate Identity Ceftriaxone/ Ceftriaxone/ Ceft<lZldime/ Ceftazidime/ E-tes 
Clanilanate Clanilanate Clani!anate Clanilanate 
20nun apart 10/lSmm apar 20nun apart IO/l5mm apar 
K. pneumoniae Pos Pos Pos 
K. pneumoniae Neg Pos Neg Neg Neg 
K. pneumoniae Pos Pos Pos 
K. pneumoniae Pos Pos Pos 
K pneumoniae Neg Pos Pos 
K. pneumoniae Neg Pos Pos 
K pneumoniae Pos Pos Pos 
K. pneumoniae Neg Pos Pos 
K. pneumoniae Pos Pos Pos 
K. pneumoniae Neg Pos Pos 
K. pneumoniae Neg Pos Pos 
K. pneumoniae Neg Pos Pos 
K. pneumoniae Neg Pos Neg Pos Pos 
K. pneumoniae Neg Pos Pos 
K. pneumoniae Neg Pos Neg Pos Pos 
K. pneumoniae Pos Pos Pos 
K pneumoniae Pos Pos Pos 
K. pneumoniae Pos Pos Pos 
K. pneumoniae Pos Pos Pos 
K. pneumoniae Neg Neg Neg Neg Pos 
K. pneumoniae Pos Pos Pos 
K. pneumoniae Pos Pos Pos 
K. pneumoniae Neg Neg Neg Neg Pos 
E. cloacae Neg Neg Neg Neg Pos 
Salmonella sp. Neg Pos Neg Pos Pos 
Salmonella sp. Neg Pos Neg Pos Pos 
E. cloacae Pos Pos Pos 
Neg = No ESBL detected Pos = ESBL detected 
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2.5 DISCUSSION 
The antibiotic susceptibilities of 45 isolates of Gram negative bacilli to ceftriaxone, 
ceftazidime, cefuroxime, cefoxitin, urupenem, amoxicillin/clavulanate and 
piperacillin/clavulanate were determined using disc diffusion tests, while the MICs of 
· cefotaxime, ceftazidime and aztreonam of the isolates were determined using Etests. The 
45 isolates comprised 24 Klebsiella spp., 14 Enterobacter spp., 3 Citrobacter spp., 1 
Serratia marcescens, 2 Salmonella spp. and 1 Pantoea agglomerans. The presence of 
ESBL activity was determined using both the double disc diffusion test and Etest MICs. 
For 11 of the isolates there were differences in the results of the Etest MICs and the disc 
diffusion tests for ceftazidime. These consisted of sensitive/intermediate or 
intermediate/resistant discrepancies and were not considered to be significant. A number 
of factors could account for these inconsistencies such as inoculum effect and visual error. 
Standardisation of the inoculum is done visually and differences in inoculum size can lead 
· ttnhe above-mentioned discrepancies. The disc diffusion tests and Etests were carried out 
at different times and the inoculum size used for each test may subsequently have differed. 
The difference between an "intermediate" reading and either "sensitive" or "resistant" can 
be a matter of one or two millimetres and inaccuracies in visual measurement may also 
account for the discrepancies. 
The discrepancies between the MICs and the disc diffusion results for the three isolates 
K18, K50 and K69 were more disturbing given the significant differences between the two 
sets of results. All three isolates initially produced zones 20mm in diameter on the disc 
diffusion test, a result compatible with susceptibility to ceftazidime. The MICs of 
ceftazidime for all three isolates were >32!J.g/ml, above the resistance breakpoint for this 
antibiotic. These discrepancies could not be easily disregarded or explained and 
consequently the tests were repeated. 
While the results after repeating the tests did not eliminate the discrepancies, they did go 
some way to explaining them. Firstly, it should be noted that the two sets of ceftazidime · 
zone sizes differed by 2-3mm. This may not appear significant but it does lend weight to 
part of the explanation of the "insignificant" discrepancies described earlier. The 
40 
ceftazidime MIC of isolate K69 was 8jlg/ml on repeated testing, compatible with both of 
the disc diffusion results for this isolate. Although the ceftazidime MICs of the other two 
isolates remained >32jlg/ml, these MICs were determined on the basis of mutant colonies, 
such as those shown in Fig 2.1, which may not have been detected by the disc diffusion 
test, and this is one possible explanation for the discrepancies in the results. 
ESBL activity was demonstrated in 27 of the 45 isolates using one or both of the tests. Of 
the 27 ESBL producing organisms, the majority (23) were Klebsiella pneumoniae, two 
were Salmonella species and two were Enterobacter cloacae. This is in agreement with 
previous work (De Champs eta/., 1989; Liu et al., 1992) where K. pneumoniae isolates 
have been frequently shown to produce ESBLs. The presence ofESBLs in E. cloacae and 
Salmonella spp. has been described but this activity in these organisms is unusual 
(Barguellil et al., 1995; Pitout eta/., 1997). 
The Etest failed to detect ESBL activity in only one isolate (K8). This isolate had a 
ceftazidime MIC of >32ug/ml and a ceftazidime/clavulanate MIC of >8ug/ml. Both of 
these figures represent the upper limits of the MIC determination for these antibiotics 
using Estrips. The actual MICs are thus unknown and if they were determined (using broth 
dilution techniques for example) the ratio may in fact indicate the presence of an ESBL. 
Eight of the 27 ESBL producing isolates (K8, K46, K54, M25, M30, M40, M44-1 and 
M44-2) did not initially show ESBL activity using the double disc diffusion tests. In five of 
these isolates ESBL activity was detected only by when the discs were placed closer 
together (either 10 or 15mm). Since the double disc test relies on clavulanate diffusing 
through agar sufficiently to inhibit the organism's beta lactamase in an area where the 
cephalosporin will still be active, it is perhaps not surprising that placing the discs closer 
together would increase the sensitivity of this test. The problem is that the zones created 
by doing this sometimes overlap, which could make interpretation equally difficult for 
isolates which have a "positive" double disc test using discs 20mm apart. Assuming that a 
clinical laboratory would neither repeat sensitivity testing, nor vary the distance at which 
the discs are placed on routine isolates, undetected ESBL activity may be present in nearly 
30% of Gram negative bacilli. This figure corresponds with previous work in which the 
false negative rate of the double disc test has been estimated to be 20% (Cormican et al., 
1996). 
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What is also interesting is that despite testing these eight isolates twice by the double disc 
test, ESBL activity could still only be demonstrated in three isolates using the Etest. This 
again highlights the difficulties in detecting extended spectrum beta lactamase activity in a 
clinical laboratory. To date no satisfactory alternative to the double disc test has been 
widely accepted, although a number of other strategies have been tested [ 1. 4. 4]. 
As mentioned previously, 7 of the 24 ESBL producers, detected using the double disc test, 
only showed ESBL activity between ceftazidime and clavulanate. The significance of this 
finding is that in a clinical laboratory ESBL production may be missed in up to 3 0% of 
isolates if a ceftazidime disc is not placed adjacent to a clavulanate containing disc. This 
correlates with the recommendation that ceftazidime should be used alongside a 
clavulanate disc in the double disc diffusion test (Jacoby & Han, 1996). Contrast this, 
however, with the finding that the ESBL of one isolate was .only detected between 
ceftriaxone and clavulanate. This suggests that the clavulanate disc should probably be 
placed between two extended spectrum cephalosporins to maximise the efficiency of 
ESBL detection, a practice that is routinely carried out in the Groote Schuur Hospital 




DNA- DNA HYBRIDISATION STUDIES 
3.1 - INTRODUCTION 
A number of antibiotic resistance gene probes, including probes specific for TEM or SHV 
genes, have been used in hybridisation experiments to detect the presence of the 
corresponding gene in DNA prepared from resistant bacterial strains. Both oligoprobes 
and longer probes have been used to identify and characterise beta lactamase genes from 
clinical isolates (Seetulsingh et al., 1991; Liu et al., 1992, Ling et al., 1994; Hibbert-
Rogers et al., 1995; Huovinen et al., 1988; Ouellette et al., 1988). A similar approach was 
adopted in this study. Since TEM- and SHY-related enzymes are the most commonly 
identified enzymes in clinical isolates (Jacoby & Medeiros, 1991), probes specific for SHV 
and TEM related genes were used in hybridisation experiments to detect their counterparts 
in the isolates selected in chapter 2. 
0ligoprobes have also been used to accurately type beta lactamases [1.4.4.2]. Mabilat and 
Courvalin {1990) described a technique whereby oligoprobes were used to determine the 
"subtype" of the TEM beta lactamase gene present in the organism. The technique relies 
on the fact that a limited number of areas in the progenitor TEM gene contain "hotspots" 
where point mutations occur, resulting in the altered spectrum of activity of the enzyme. 
Oligoprobes were designed around the areas containing point mutations, with the 
potentially mutated nucleotide centred in the oligoprobe. If the isolate under investigation 
contained a structural gene with the same point mutation, the probe would anneal and a 
hybridisation signal would be obtained. However, if the mutation was not present, the 
probe would not anneal and no signal would be obtained. Using combinations of 
·· oligoprobes, the various point mutations present in the gene were identified and the 
identity of the TEM-related beta lactamase could consequently be deduced from this 
information. However, the increased number of TEM-related enzymes described since 
1990 would make this technique far more difficult to apply at present. 
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. A .factor complicating hybridisations for the detection of SHV -related genes is the 
presence of chromosomal genes (such as LEN-I) with a high degree of homology to the 
plasmid mediated SHV -1 in isolates of K. pneumoniae. It is believed that SHV -1 was 
derived from LEN-1 and they share approximately 89% homology (Garbarg-Chenon et 
al., 1990). Some authors have suggested that other chromosomal beta lactamase genes in 
strains of K. pneumoniae may be more closely related to the plasmid mediated SHV -1 
(Hregmann et al., 1997; Leung et al., 1997). To date, however, LEN-1 is the only 
chromosomal beta lactamase gene inK. pneumoniae that has been sequenced (Arakawa et 
al., 1986). 
~ During the course of this study a number of hybridisation experiments were carried out to 
detect the presence of TEM or SHV related genes. Probes specific for these genes were 
hybridised either to DNA prepared from colonies on a nylon membrane (colony blot) or to 
DNA that had been transferred to a nylon membrane using a slot blot apparatus. 
3.2 MATERIALS AND METHODS 
3.2.1 Bacterial Isolates and Plasmids 
Control strains of E. coli containing plasmids encoding SHV-1 and -2 beta lactamases 
,"'. .... _........... ... 
were kindly donated by Dr C. Thomson, University of Edinburgh. The plasmid vector 
pUC19, containing the TEM-1 gene (Yanisch-Perron et al., 1985), was introduced into E. 
coli DH5a. by transformation and used as a TEM positive control strain. 
3. 2.1.1 Preparation of Competent Cells 
Competent cells, capable of taking up DNA, were prepared as follows (Chung & Miller, 
1988). An aliquot (0,5ml) of an overnight broth culture of E. coli DH5a. was inoculated 
into 50mls of fresh YT (Yeast Tryptone) broth and cultured aerobically at 3 7°C until early 
log phase (OD6oo between 0,2 and 0,4). The cells were harvested by centrifugation at 5 
OOOxg for five minutes in a Beckman GS-6 centrifuge (Beckman Instruments, California) 
and resuspended in one tenth the volume of ice cold TSB broth. 
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3.2.1.2 Transformation 
50- 100pg of DNA was added to 100Jll of competent cells, which were left on ice for 10 
minutes to allow the DNA to adhere to the cells. The cells were heat shocked at 42°C for 
2 minutes to facilitate uptake of the DNA. After addition of YT broth (0,9ml) the cells 
were incubated at 37°C for 30 - 60 minutes to allow for antibiotic resistance gene 
expression. An aliquot (100- 200Jll) of the transformation mix was then inoculated onto 
YT agar containing ampicillin (lOO!J.g/ml) and incubated at 37°C for 18 hrs. 
3.2.1.3 Extraction of Genomic DNA 
Genomic DNA of the isolates and controls was extracted as follows (Ausubel et al., 
1987). Organisms were cultured overnight at 37°C in 3- 4ml oftryptone water. The cells 
were harvested by centrifugation in a microfuge (Eppendorf5415C) at 12 000 rpm for one 
to two minutes and the cell pellet resuspended in 10% SDS (30Jll) to lyse the cells and 
proteinase K (3Jll of 20 mg/ml) (Boehringer Mannheim, Germany). The mixture was 
incubated at 37°C for one hour to allow the proteinase K to break down proteinaceous 
products after which 1001J.l of 5M NaCl and 80Jll of CTAB/NaCl were added. Cell wall 
debris, denatured protein and polysaccharides are complexed to the CT AB while the 
presence of NaCl at concentrations greater than 0,5M prevents similar complexing of 
nucleic acids. The mixture was incubated at 65°C for ten minutes. An equal volume of 
chloroform was added to remove CT AB/protein/polysaccharide complexes, the mixture 
was centrifuged at 14 000 rpm in a microfuge and the aqueous phase extracted to a clean 
eppendorf tube. The DNA was purified further by at least three extractions with 
phenoVchloroform until the white proteinaceous interface had disappeared. The use of 
tryptone water, a relatively nutritionally poor culture medium (compared to YT broth), 
produced cells with less capsular material and thus reduced the number of 
phenoVchloroform extractions required. The DNA was precipitated by adding 0,6 volumes 
of isopropanol, standing the mixture at room temperature for ten minutes and then 
centrifuging it at room temperature at 12 000 rpm for 10 minutes. The DNA pellet was 
washed with 70% ethanol, centrifuged briefly in a microfuge and any remaining liquid 
removed with a pipette. The dry pellet was then suspended in TE buffer. An aliquot of the 
DNA was subjected to agarose gel electrophoresis alongside standards of known 
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concentration (Boehringer Mannheim molecular weight marker X), and the concentration 
of DNA estimated visually. 
3.2.2 Transfer of DNA to a Stable Matrix 
3. 2. 2.1 Slot Blots 
Genomic DNA [3.2.1.3] was transferred to nylon membranes (Hybond N', Amersham, 
England) using a slot - blot apparatus (Shleicher and Sheuell, West Germany). 
Approximately one microgram of DNA in 501J.l of distilled water was heated in a water 
bath at 95°C for five minutes to separate the DNA strands after which they were 
immediately placed on ice to prevent reannealing of the DNA In order to increase the 
ionic content of the mixture and facilitate binding of the DNA to the membrane, 501J.l of 
20xSSC was added to each sample. An appropriately sized sheet of nylon membrane was 
soaked in lOxSSC, placed on two sheets of filter paper (Whatman) also saturated with 
lOxSSC and all three sheets then placed in the slot-blot apparatus. The samples were 
loaded into the wells in the slot blot apparatus and transferred to the membrane by a 
vacuum, which was applied until the samples had been transferred from the wells to the 
membrane. The membrane was removed and placed on filter paper soaked in a solution of 
1,5M NaCI, 0,5M NaOH for five minutes to denature the DNA Neutralisation was 
achieved by placing the membrane onto filter paper soaked in a solution of 1,5M NaCl, 
0,5M Tris at pH 7,4 for at least five minutes. After air drying, the DNA was cross linked 
to the membrane by exposing it to UV light (254nm) in a UV Crosslinker (Hoefer 
Scientific, San Francisco). 
3.2.2.2 Colony Blots 
A number of procedures were used to transfer colonies to the membrane prior to lysis and 
transfer of DNA First, bacteria were inoculated onto YT agar and incubated at 37°C for 
approximately six hours - ideally until colonies were about 2 mm in diameter. A nylon 
membrane was then placed onto the colonies on the agar and peeled off after 1 minute 
with the colonies adhering to the membrane. Alternatively, bacteria were inoculated 
directly onto the nylon membrane on YT agar and incubated at 37°C until the colonies on 
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the membrane had reached a size of approximately 2mm in diameter. The membrane was 
· then removed from the agar. A third procedure involved inoculating isolates into 200111 of 
YT broth in a microtitre plate and incubating them overnight at 37°C. These were then 
transferred by means of a multi-pronged "hedgehog" device to either plain YT agar or 
onto a membrane that had been placed on YT agar, which were then incubated as before. 
DNA was released from the bacterial colonies by placing the membrane onto filter paper 
saturated with O,SM NaOH for five minutes. Bacterial cell wall debris was removed by 
vigorously washing the membrane in 5xSSC for one minute. After two such washes the 
membrane was air dried on clean filter paper. 
3'.2.3 Methods Used in the Preparation of the TEM Probe 
3.2.3.1 PCRAssay 
The probe used for the detection of TEM genes was obtained by amplifying a portion of 
the pUC19located TEM-1 gene by the polymerase chain reaction (PCR). PCR consists of 
cyclical replications of DNA using a thermostable DNA polymerase enzyme in the 
presence of dNTPs and primers. Primers are annealed to denatured sample DNA and 
synthesis of a complementary strand of DNA is initiated from these primers by the 
polymerase enzyme (Taq) in the presence of dNTPs. The newly synthesised strands are 
once again denatured by heat and when the temperature drops the primers anneal and 
another cycle of synthesis commences. 
With each cycle, the amount of dsDNA produced increases exponentially, since each new 
fragment of dsDNA synthesised serves as a template in subsequent cycles. If sufficient 
nucleotides and primers are provided in the reaction mixture the process can be repeated 
30 - 40 times and a large quantity of a specific DNA sequence can be synthesised. This 
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Fig 3.1 PCR consists of repeated cycles of denaturation, primer annealing and extension as illustrated above. In tl1e first round, heterogenous sized products are formed, but witll 
subsequent rounds, tlle segment of DNA tllat lies between the two primers (tl1e open and closed arrmvs) is amplified preferentially, and becomes t11e major product of tlle 
reaction. The original template in this diagram is shown by a solid line, and newly syntllesised DNA shown by a wavy line. Iftl1e original template is double stmnded, both 
strands, once denatured in tlle initial denaturation step, would undergo tlle same process (Sambrook eta!., 1989). 
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The primers (TEM-A 5' -CCC CGA AGA ACG TTT TC and TEM-B 5' -ATC AGC 
AAT AAA CCA GC) described by Mabilat and Courvalin (1990) were used in a PCR 
assay to amplify a 517bp fragment of the TEM-1 gene on pUC19 (Fig 3.2). Boehringer 
Mannheim Taq polymerase, PCR buffer and dNTP's were used with primers synthesised 
by the Department of Medical Biochemistry at UCT. PCR assays were carried out in a 
Perkin Elmer Thermocycler (Perkin Elmer GeneAmp 2400) under the following 
conditions. Initial denaturing was at 94°C for 5 minutes, followed by cycles of94°C for 30 
seconds, 60°C for 50 seconds and 72°C for 60 seconds. After 40 cycles final extension 
was carried out at 72°C for seven minutes. 
ATGCTTCAAT AATATTGAAA AAGGAAGAGT ATGAGTATTC AACATTTCCG TGTCGCCCTT 60 _... 
ATTCCCTTTT TTGCGGCATT TTGCCTTCCT GTTTTTGCTC ACCCAGAAAC GCTGGTGAAA 120 
GTAAAAGATG CTGAAGATCA GTTGGGTGCA CGAGTGGGTT ACATCGAACT GGATCTCAAC 180 
AGCGGTAAGA TCCTTGAGAG TTTTCGCCCC GAAGAACGTT TTCCAATGAT GAGCACTTTT 240 
TEM-A 
AAAGTTCTGC TATGTGGCGC GGTATTATCC CGTATTGACG CCGGGCAAGA GCAACTCGGT 300 
CGCCGCATAC ACTATTCTCA GAATGACTTG GTTGAGTACT CACCAGTCAC AGAAAAGCAT 360 
CTTACGGATG GCATGACAGT AAGAGAATTA TGCAGTGCTG CCATAACCAT GAGTGATAAC 420 
ACTGCGGCCA ACTTACTTCT GACAACGATC GGAGGACCGA AGGAGCTAAC CGCTTTTTTG 480 
CACAACATGG GGGATCATGT AACTCGCCTT GATCGTTGGG AACCGGAGCT GAATGAAGCC 540 
ATACCAAACG ACGAGCGTGA CACCACGATG CCTGTAGCAA TGGCAACAAC GTTGCGCAAA 600 
CTATTAACTG GCGAACTACT TACTCTAGCT TCCCGGCAAC AATTAATAGA CTGGATGGAG 660 
GCGGATAAAG TTGCAGGACC ACTTCTGCGC TCGGCCCTTC CGGCTGGCTG GTTTATTGCT 720 
TEM-B 
~~TCTG GAGCCGGTGA GCGTGGGTCT CGCGGTATCA TTGCAGCACT GGGGCCAGAT 760 
GGTAAGCCCT CCCGTATCGT AGTTATCTAC ACGACGGGGA GTCAGGCAAC TATGGATGAA 820 
CGAAATAGAC AGATCGCTGA GATAGGTGCC TCACTGATTA AGCATTGGTA ACTGTCAGAC 880 ._ 
CAAGTTTACT CATATATACT TTAGATTGAT TTAAAACTTC 921 
Fig 3.2 DNA sequence of the TEM-1 gene in pUC19 (Yanisch Perron eta/, 1985) with the intragenic 
sequence amplified by PCR and used as a probe underlined. The primer sequences are 
highlighted in italics. TEM-1 coding sequence starts at base 31. Start and stop codons are 
highlighted with arrowheads. 
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3.2.3.2 Agarose Gel Electrophoresis 
The PCR product was purified by electrophoresis at 90V for 50 - 60 minutes on 1% 
~garose gels. Negatively charged DNA migrates through agarose towards a positive 
electrode when a current is applied across it. The rate of migration is proportional to the 
voltage being applied, the concentration of the agarose and the size of the DNA. 
Agarose was dissolved in TAE buffer (Tris-Acetate-EDTA) by heating in a microwave 
oven, allowed to cool to about 55°C and poured into horizontal moulds. A comb was 
placed into the molten agarose approximately 1 em from one end of the mould. Once the 
agarose had set the comb was removed leaving wells into which samples could be loaded. 
The gel was submerged in 1xTAE buffer in an electrophoresis apparatus. The samples of 
. RNA were mixed with 2 - 3 J.ll of tracking dye containing bromophenol blue, sucrose and 
EDT A. The high molecular weight of the sucrose maintains the sample in the well while 
the dye allows monitoring of the progress of the sample during electrophoresis. After 
loading the samples a constant voltage (5 - 20 volts/em gel) was applied until the dye had 
migrated about 60 - 70% of the length of the gel. 
DNA in the gels was visualised using ethidium bromide (EtBr), which intercalates in the 
DNA molecules and fluoresces under ultraviolet light. Ethidium bromide (1 0 mg/ml) was 
usually added to the molten agarose ( 1 111 per 1 OOml agarose) prior to pouring. However, 
since it intercalates into the DNA, it affects the electrophoretic mobility of DNA. When 
a~curate size determinations were required, no EtBr was added to the agarose prior to 
electrophoresis. Instead, the agarose gels were immersed in a solution of T AE containing 
the same proportions of EtBr (1J.1l per 100ml of TAE) after electrophoresis. DNA was 
visualised at 302nm on a Mighty Bright UV transilluminator (Hoefer Scientific, San 
Francisco) and photographed using a Polaroid Gel cam (Polaroid corporation, Cambridge, 
Massachusetts). 
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3.2.3.3 DNA Extraction from Agarose Gels 
DNA extraction from agarose gels (Seth, 1984) was carried out by slicing the fragment of 
agarose containing DNA out of the gel, cutting this gel slice into fragments and placing it 
iq. an Eppendorf tube. After weighing these fragments, an equal volume of phenol was 
added to the agarose to solubilise it. This was incubated at -70°C for 10 minutes and then 
centrifuged at 14 000 rpm at room temperature for 1 0 minutes. The aqueous phase was 
transferred to a clean Eppendorf tube and the DNA was further purified by two 
phenol/chloroform extractions. To precipitate the DNA, 1/10 volume of 4M LiCl was 
added followed by 3 volumes of 100% ethanol. One micro litre of glycogen (Boeringer 
Mannheim, Germany) was added to the mixture to aid in precipitation, which was carried 
out at -70°C for ten minutes. The DNA was pelleted by centrifugation at 14 000 rpm in a 
microfuge for ten minutes, washed with 70% ethanol, centrifuged, dried and suspended in 
TE buffer as before [3.2.1.3]. 
3.2.3.4 Cloning 
i) Preparation of Insert 
Since Taq polymerase adds one or more gratuitous 'A' residues to the ends of PCR 
products, it was necessary to remove these residues before the PCR product could be 
cloned into an appropriately digested vector. The 'A' residues were removed and the PCR 
product blunted using a blunting kit supplied by Amersham International (England). In this 
reaction the ends ofthe PCR product were blunted by T4 DNA polymerase which has both 
polymerase and exonuclease activity enabling the enzyme to add bases to a 5' protruding 
.. e!l4 and remove bases from a 3' protruding end. In the case of PCR products, the 'A' 
residues are removed by the exonuclease activity. The reaction was carried out according 
to the manufacturer's instructions and the blunted PCR product was then ligated to 
prepared vector. 
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ii) Preparation of Vector 
Six micrograms of the plasmid vector pUC19 was digested with the restriction enzyme 
Smai (10 units) (Boehringer Mannheim) at 25°C for one hour. The enzyme was 
inactivated and removed by carrying out a phenoVchloroform extraction. After adding 3 
volumes of 100% ethanol to precipitate the DNA, it was pelleted, washed, dried and 
suspended in 50!11 TE buffer. [3.2.1.3] 
iii) Ligation 
Approximately 1 OOng of digested vector was ligated to the blunted PCR product 
(approximately 1 OOng) using the Amersham ligation kit and following the manufacturer's 
instructions. 
iv) Transformation 
The ligation mixture (25!11) was introduced into 100111 of competent E.coli DH5a cells 
[3 .2.1.2]. All transformation experiments included the following controls. In order to 
calculate the competency of the cells, 50pg and 500pg of undigested pUC19 were 
introduced into the cells. Since only circular DNA can be taken up by the competent cells, 
1 OOng of Smai digested vector was transformed to assess the efficiency of the digestion of 
the vector. During ligation 1 OOng of digested vector was self-ligated and 25!11 of this 
reaction mix was introduced into the cells to assess the efficiency of the ligation reaction 
itself To ensure that the cells were not contaminated by pUC19, competent cells were 
plated onto selective media containing ampicillin (lOO!lg/ml). 
v) Isolation and Characterisation of Recombinants 
After transformation, the cells were spread onto YT agar containing ampicillin 
(10011g/ml), X-gal (10011g/ml) and IPTG (1001lg/ml). The alpha terminal of the beta 
galactosidase gene (approximately 150 amino acids) is located in the region of the multiple 
cloning site ofpUC19 while the carboxy terminal ofthis gene is present in the genome of 
E. coli DH5a. If these two portions of the gene are expressed in the same cell they form 
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an active enzyme by a process called alpha complementation. IPTG in the agar serves as 
an inducer of the expression of beta galatosidase, which in tum cleaves the X-gal, thereby 
imparting a blue colour to colonies of organisms producing the enzyme. 
If DNA is ligated into the multiple cloning site, the alpha terminal of the f3-galactosidase 
gene is disrupted, alpha complementation will not occur and recombinants will be white in 
colour, rather than blue (Sambrook et al., 1989). The entire transformation mixture (1ml) 
was plated onto selective media in Petri dishes (150mm). With respect to the controls, 
200J.1l of the transformation mix was plated onto the selective media. The tests and 
controls were incubated at 3 7°C for 18 hours. 
vi) Plasmid DNA Extraction 
Plasmid DNA was isolated from the putative recombinants using the modified alkaline 
lysis method of Bimboim and Doly (Sambrook et al., 1989). White colonies were 
inoculated into YT broth (5-50ml) containing ampicillin (100J.1g/ml) and incubated at 37°C 
for four to six hours. The cells were pelleted by centrifugation in a microfuge at 14 000 
rpm for 30 seconds. The supernatant was poured off and the bacterial pellet resuspended 
in 0,2ml of solution 1 (0,025M Tris, 0,05M EDT A, 1% glucose w/v). To lyse the cells and 
release the DNA twice the volume (0,4ml) of solution 2 (0,2M NaOH, 1% SDS w/v) was 
added and the solution placed on ice for five minutes. Selective renaturation of the plasmid 
DNA was achieved by the addition of 0,3ml of solution 3 (3M potassium acetate, 11,5% 
glacial acetic acid v/v) and the mixture was again kept on ice for five minutes. Cell wall 
debris was pelleted by centrifugation in a microfuge at 14 000 rpm for ten minutes. 
Isopropanol (0,6 volumes) was added to the lysate and left at room temperature for at 
least ten minutes to precipitate the nucleic acids. After centrifugation to pellet the nucleic 
acids, the DNA was washed, dried and suspended in TE buffer [3.2.1.3]. 
When large amounts of purified pDNA were required, the plasmids were extracted from 
50ml volume cultures using the Nucleobond kit (Machery Nagel, Germany). This is based 
on the same principle as the alkaline lysis method with some modification of the solutions. 
Purification was performed through cartridges containing ion exchange silica. 
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After extraction ofDNA, following the manufacturer's instructions, the lysate was filtered 
through gauze to trap any solid particles that may interfere with the subsequent column 
purification process. The ion exchange silica was equilibrated with 2ml of buffer N2 (0, 1M 
Tris/H3P04, 0,9M KCl, 15% ethanol, pH 6,3) and the lysate was loaded into the columns· 
and allowed to drip through. Plasmid DNA remained bound to the silica. After washing 
the columns twice with 4 ml each time of buffer N3 (O,IM Tris/H3P04, I, 15M KCl, 15% 
ethanol, pH 6,3), the DNA was eluted with 2 ml of buffer N5 (O,lM Tris/H3P04, 1M KCl, 
15% ethanol, pH 8,5). Plasmid DNA was then precipitated by adding 0, 7 volumes of 
isopropanol, allowed to stand for ten minutes and then pelleted, dried and suspended in 
TE buffer [3.2.1.3]. 
vii) Restriction Endonuclease Digestion 
The presence of an insert in a plasmid was ascertained by digesting putative recombinant 
plasmids with a restriction endonuclease. Since the insertion of the blunted PCR product 
into the vector eliminated the Smal site, an alternative enzyme, Hindlll, (Boehringer 
Mannheim) with a site in the multiple cloning site (MCS) was used to digest the 
recombinanats. The resulting DNA fragments were separated by electrophoresis on 0,8% 
agarose gels and photographed as before [3.2.3.2]. Recombinants were identified on the 
basis of size, being approximately 500bp larger than the vector. 
3.2.3.5 DNA Sequencing 
DNA sequences were determined by Sanger's dideoxy chain termination method 
(Sambrook et al., 1989) using the T7 Sequencing kit (Pharmacia, USA) and e5S]dATP. 
Approximately 2-31J.g of DNA in 321J.l of sterile water was used in the sequencing 
reaction. DNA was denatured by the addition of81J.l of 2M NaOH followed by incubation 
at room temperature for 10 minutes. 3M Sodium acetate pH4.8 {71J.l) and 41J.l of water 
were then added to neutralise the alkali, and 3 volumes (1201J.l) of 100% ethanol was 
added to the mixture and left at -70°C for 15 minutes to precipitate the denatured DNA. 
The DNA was pelleted by centrifuging at 14 000 rpm for 15 minutes in a microfuge, 
washed with ice cold 70% ethanol, dried, and resuspended in 1 O!J.l of sterile water. 
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The templates prepared above were annealed to the universal forward and reverse primers 
as follows. In separate reactions, 2f.ll of forward and reverse primers (5f.!M) were added to 
the denatured DNA template (10f.ll). After the addition of2f.ll ofthe annealing buffer (T7 
Sequenase kit), the primers were annealed to the DNA to be sequenced by incubation at 
65°C for 5 minutes, 37°C for 10 minutes and room temperature for 5 minutes. 
After annealing of the primers, DNA synthesis was commenced by the addition of 3f.ll of 
dNTPs (dCTP, dTTP, dGTP), 1f.ll ofe5S]dATP and 2f.ll ofT7 polymerase. DNA synthesis 
was allowed to continue for five minutes at room temperature. After this incubation, 4,5f.ll 
aliquots of the reaction mixture were transferred to each of 4 separate Eppendorf tubes 
containing dNTPs with either ddATP, ddCTP, ddGTP or ddTTP. When dideoxy 
nucleotides are incorporated into the extending complementary strand, chain elongation is 
terminated because the dideoxy nucleotides lack the 3' hydroxyl group necessary for the 
formation of the next phosphodiester bond. By using limiting amounts of each of the 
ddNTPs, DNA fragments are generated that terminate at positions occupied by any A, C, 
G or T in the template strand. The termination reactions were incubated for 5 minutes at 
37°C and then 5f.ll of a stop solution containing formamide, EDTA and a tracking dye was 
added to each tube. 
The sequencing reaction products were separated by electrophoresis on denaturing 
polyacrylamide gels prepared as follows. Two glass plates separated by spacers (0,25 -
1mm thick) along their long axes and by a strip of filter paper at the bottom end were 
assembled by clamping them together with bulldog clips. A 6% acrylamide, 8M urea gel 
was prepared by mixing 6 ml of a 50% acrylamide 2,5% biscrylamide solution with 24g 
urea and 5ml of 10xNNB. The urea was dissolved by warming the solution prior to adding 
distilled water to make a volume of 50ml. Polymerisation of the acrylamide was initiated 
by the addition of20f.ll ofTEMED (NNN'N' - tetramethylethylene-diamine) and 125f.ll of 
10% ammonium persulphate. The mixture was poured slowly between the two glass plates 
using a 25ml pipette and running the mixture slowly between the plates while holding them 
at an angle of about 70° to the vertical. This was done to avoid the formation of bubbles in 
the acrylamide gel. Once poured, the plates were rested horizontally and a sharks-tooth 
comb inserted into the open end of the glass plates with the flat side inwards. The top was 
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then covered with filter paper and soaked with the remaining acrylamide solution. The 
glass plates were sealed with clingwrap and left to polymerise overnight. 
The clingwrap and the comb were removed and the latter replaced with the teeth just 
touching the flat interface of the polyacrylamide gel created by the flat end of the shark's 
tooth comb. The plates were placed on vertical supports with the lower end resting in a 
buffer tank connected to the positive electrode. The upper end was in contact with another 
buffer tank connected to the negative electrode. The buffer tanks were filled with 1xNNB 
and a current of 40W passed through the gel for about 30 minutes to preheat the gel to aid 
in denaturation of the DNA samples. The sequencing reactions were heated to 85°C for 2 
minutes to denature the dsDNA and 3 Ill of the sample loaded into the wells at the top end 
of the gel in the order 'A', 'C', 'G' and 'T' for each primer/template combination. 
Electrophoresis was performed at 40W for approximately 150 minutes. 
After electrophoresis the glass plates were carefully separated and a sheet of filter paper 
applied to the gel. This was peeled off with the gel adhering to the filter paper. The gel 
was wrapped in clingwrap, placed in a drying apparatus (Slab Gel Dryer SE1150, Hoefer 
Scientific Instruments, San Francisco) and dried under vacuum at 80°C for 2 hours. The 
dried gel, after removal of the clingwrap, was exposed to X-Ray film (Curix RPI, Agfa) in 
a light proof X-ray box for 3 days and the film developed. 
3.2.4 Methods Used in the Preparation of the SHV Probes 
Two probes for the detection of SHV type genes were prepared. The first probe consisted 
of a 34 nucleotide oligoprobe designed to anneal to conserved sequences in SHV -related 
genes but not to the chromosomal gene (LEN-1) encoding a beta lactamase enzyme inK. 
pneumoniae (Fig 3.3). This probe was synthesised by Whitehead Scientific. The DNA 
sequence of the probe, 5' CTG ACC AGC CAG CGT CTG AGC GCC CGT TCG CAA 
C, anneals to nucleotides 570 to 604 ofthe SHV-1 gene and has 85% homology to the 
LEN-1 gene. 
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Len-1 CTTTGCTCGC CCTTATCGGC CCTCACTCAA GGAAGTATTG CGGTTATGCG TTATGTTCGC 60 
***** **** ***** 
SHV-1 ATGCG TTATATTCGC 15 
Len-1 CTGTGTGTTA TCTCCCTGTT AGCCACCCTG CCACTGGTGG TATACGCCGG TCCACAGCCG 120 
****** *** ********** ********** ** **** ** ** ***** * ** ****** 
SHV-1 CTGTGTATTA TCTCCCTGTT AGCCACCCTG CCGCTGGCGG TACACGCCAG CCCGCAGCCG 75 
Len-1 CTTGAGCAGA TTAAACAAAG CGAAAGCCAG CTGTCGGGCC GCGTGGGGAT GGTGGAAATG 180 
******** * ****** *** ********** ********** **** ** ** * * ****** 
SHV-1 CTTGAGCAAA TTAAACTAAG CGAAAGCCAG CTGTCGGGCC GCGTAGGCAT GATAGAAATG 135 
Len-1 GATCTGGCCA ACGGCCGCAC GCTGGCCGCC TGGCGCGCCG ATGAACGCTT TCCCATGGTG 240 
********** ********* **** ***** ********** ********** ******* ** 
SHV-1 GATCTGGCCA GCGGCCGCAC GCTGACCGCC TGGCGCGCCG ATGAACGCTT TCCCATGATG 195 
Len-1 AGCACCTTTA AAGTGCTGCT GTGCGGCGCG GTGCTGGCGC GGGTGGATGC CGGGCTCGAA 300 
********** **** **** ******** ********** ********** *** **** 
SHV-1 AGCACCTTTA AAGTAGTGCT CTGCGGCGCA GTGCTGGCGC GGGTGGATGC CGGTGACGAA 255 
Len-1 CAACTGGATC GGCGGATCCA CTACCGCCAG CAGGATCTGG TGGACTACTC CCCGGTCAGC 360 
** ***** * * ****** *** ****** ********** ********** ********* 
SHV-1 CAGCTGGAGC GAAAGATCCA CTATCGCCAG CAGGATCTGG TGGACTACTC GCCGGTCAGC 315 
Len-1 GAAAAACACC TTGTCGACGG GATGACGATC GGCGAACTCT GCGCCGCCGC CATCACCCTG 420 
********** *** ***** ****** ** ********** ********** *** *** ** 
SHV-1 GAAAAACACC TTGCCGACGC AATGACGGTC GGCGAACTCT GCGCCGCCGC CATTACCATG 375 
Len-1 AGCGATAACA GCGCTGGCAA TCTGCTGCTG GCCACCGTCG GCGGCCCCGC GGGATTAACT 480 
********** **** * *** ****** *** ********** ********** ***** *** 
SHV-1 AGCGATAACA GCGCCGCCAA TCTGCTACTG GCCACCGTCG GCGGCCCCGC AGGATTGACT 435 
Len-1 GCCTTTCTGC GCCAGATCGG TGACAACGTC ACCCGTCTTG ACCGCTGGGA AACGGCACTG 540 
****** *** ********** ********* ***** **** ********** ***** **** 
SHV-1 GCCTTTTTGC GCCAGATCGG CGACAACGTC ACCCGCCTTG ACCGCTGGGA AACGGAACTG 495 
Len-1 AATGAGGCGC TTCCCGGCGA CGCGCGCGAC ACCACCACCC CGGCCAGCAT GGCCGCCACG 600 
********** ********** *** ****** ***** **** ********** ****** ** 
SHV-1 AATGAGGCGC TTCCCGGCGA CGCCCGCGAC ACCACTACCC CGGCCAGCAT GGCCGCGACC 555 
Len-1 CTGCGCAAAC TA---CTGAC CGCGCAGCAT CTGAGCGCCC GTTCGCAACA GCAACTCCTG 657 
******** * ***** * **** * ********** ********* *** ** *** 
SHV-1 CTGCGCAACG TTGGCCTGAC CAGCCAGCGT CTGAGCGCCC GTTCGCAACG GCAGCTGCTG 615 
Len-1 CAGTGGATGG TGGACGATCG GGTTGCCGGC CCGCTGATCC GCGCCGTGCT GCCGCCGGGC 717 
********** ********** *** ***** *** ****** ** ******* **** ***** 
SHV-1 CAGTGGATGG TGGACGATCG GGTCGCCGGA CCGTTGATCC GCTCCGTGCT GCCGGCGGGC 675 
Len-1 TGGTTTATCG CCGACAAAAC CGGGGCTGGC GAACGGGGTG CGCGCGGCAT TGTCGCCCTG 777 
********** **** ** ** *** ****** ** ******* ******* ** ********** 
SHV-1 TGGTTTATCG CCGATAAGAC CGGAGCTGGC GAGCGGGGTG CGCGCGGGAT TGTCGCCCTG 735 
Len-1 CTCGGCCCGG ACGGCAAACC GGAGCGCATT GTGGTGATCT ATCTGCGGGA TACCCCGGCG 837 
** ****** * **** * ********* ******** * ********** ********** 
SHV-1 CTTGGCCCGA ATAACAAAGC AGAGCGCATT GTGGTGATTT ATCTGCGGGA TACCCCGGCG 795 
Len-1 AGTATGGCCG AGCGTAATCA ACATATCGCC GGGATCGGCC A-GCGCTGAT CGAGCACTGG 896 
** ******* **** ***** ** ****** ********* * ****** ********** 
SHV-1 AGCATGGCCG AGCGAAATCA GCAAATCGCC GGGATCGGCA AGGCGCTGTA CGAGCACTGG 855 
Len-1 CAACGCTAAC CCGGCGGTAC CGTGCGTTAG CGCGGCCCGC AGCACCTGGC AGGCGTGCCG 956 
********* 
SHV-1 CAACGCTAA 864 
Fig 3.3 -Alignment of the DNA sequences of the LEN-1 (Arakawa et a/., 1986) and SHV-1 genes (Mercier & 
Levesque, 1990), showing the position of the 35-base SHV oligoprobe (underlined in italics). Asterisks 
represent identical nucleotides in the sequences. Sequence alignment performed with BLAST software 
(Altschul et al., 1990). 
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A second probe for the detection of SHV -related genes was prepared by amplifying a 
portion of the SHV-1 gene in a PCR assay. Primers were designed which annealed to 
conserved areas of the SHV related genes but not t9 LEN-1. However, since this probe 
was 714bp long, and given the fact that there is 89% homology between LEN-1 and the 
probe over this region, it would be less specific than the oligoprobe for the detection of 
SHV -related genes. 
PCR was carried out in a similar fashion to that described earlier for the TEM probe 
[3.2.2] using plasmid DNA extracted from the SHV-1 producing control strain as a 
template. The parameters of the PCR assay were identical to those described for the 
preparation of the TEM probe. The primers SHV-A (5' CTG GCG GTA CAC GCC 
AGC) and SHV-B (5' TGC GCT CTG CTT TGT TA) which anneal to positions 48- 66 
and 769 - 743 respectively on the SHV-1 gene (Fig 3.4) yield a product of 714 bp in 
length. 
GTTATGCGTT ATATTCGCCT GTGTATTATC TCCCTGTTAG CCACCCTGCC GCTGGCGGTA 60 _. 
SHV-A 
CACGCCAGCC CGCAGCCGCT TGAGCAAATT AAACTAAGCG AAAGCCAGCT GTCGGGCCGC 120 
GTAGGCATGA TAGAAATGGA TCTGGCCAGC GGCCGCACGC TGACCGCCTG GCGCGCCGAT 180 
GAACGCTTTC CCATGATGAG CACCTTTAAA GTAGTGCTCT GCGGCGCAGT GCTGGCGCGG 240 
GTGGATGCCG GTGACGAACA GCTGGAGCGA AAGATCCACT ATCGCCAGCA GGATCTGGTG 300 
GACTACTCGC CGGTCAGCGA AAAACACCTT GCCGACGGCA TGACGGTCGG CGAACTCTGC 360 
GCCGCCGCCA TTACCATGAG CGATAACAGC GCCGCCAATC TGCTACTGGC CACCGTCGGC 420 
GGCCCCGCAG GATTGACTGC CTTTTTGCGC CAGATCGGCG ACAACGTCAC CCGCCTTGAC 480 
CGCTGGGAAA CGGAACTGAA TGAGGCGCTT CCCGGCGACG CCCGCGACAC CACTACCCCG 540 
GCCAGCATGG CCGCGACCCT GCGCAAGCTG CTGACCAGCC AGCGTCTGAG CGCCCGTTCG 600 
CAACGGCAGC TGCTGCAGTG GATGGTGGAC GATCGGGTCG CCGGACCGTT GATCCGCTCC 660 
GTGCTGCCGG CGGGCTGGTT TATCGCCGAT AAGACCGGAG CTGGCGAGCG GGGTGCGCGC 720 
GGGATTGTCG CCCTGCTTGG CCCGAATAAC AAAGCAGAGC GCATTGTGGT GATTTATCTG 780 
SHV-B 
CGGGATACGC CGGCGAGCAT GGCCGAGCGA AATCAGCAAA TCGCCGGGAT CGGCGCGGCG 840 
CTGATCGAGC ACTGGCAACG CTAA 864 .__ 
Fig 3.4- DNA sequence ofSHY-1 gene (Mercier & Levesque, 1990) with the rumealing position of the two primers 
(SHY-A and SHY-B) illustrated. Coding sequence for SHY-1 starts at base 3. Start and stop codons are 
highlighted with arrowheads. 
After performing PCR, the amplified DNA was purified by agarose gel electrophoresis and 
extracted from the agarose as described for the TEM probe [3.2.3.1- 3.2.3.3]. 
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3.2.5 Preparation of Probes 
3. 2. 5.1 ECL Chemiluminescent Labelling 
Probes were labelled with a non-radioactive chemiluminescent label, horseradish 
peroxidase, provided in the ECL hybridisation, labelling and detection kit (Amersham, 
UK). Probe DNA (10~1 at 10ng/ml) was denatured by placing it in boiling water for five 
minutes after which it was kept on ice to prevent re-annealing of the DNA. Equal volumes 
of the manufacturer's labelling solution and glutaraldehyde were added and the mixture 
incubated at 37°C for ten minutes. The initial binding of the enzyme to the denatured DNA 
probe takes place due to charge attraction and subsequently covalent chemical cross-links 
are formed when glutaraldehyde is added. The labelling reaction was performed 
immediately prior to hybridisation. 
The presence of labelled DNA was detected using the two reagents provided by the 
manufacturers. The first detection reagent decays to hydrogen peroxide which is the 
substrate for horseradish peroxidase, and the hydrogen peroxide is degraded to water and 
oxygen radicals as described in the following equation: 
2H202 ----> 2H20 + 02-
The second reagent contains luminol which when oxidised by the radicals produces a blue 
light which can be detected by exposing the membrane to an X-Ray film. The production 
of the blue light is increased in intensity and duration by an enhancer present in the second 
reagent. The presence of the labelled probe was assessed by exposing the membrane to X-
Ray film (Curix) for 15 minutes to 18 hours. 
3.2.5.2 P 2 Radioloabelling of Probe 
The oligoprobe for the detection of SHV genes was also labelled with [a.-32P]dCTP using 
Ready-To-GoTM DNA labelling beads (Pharmacia, USA). Briefly, 50ng of the oligoprobe 
was dissolved in 45~1 TE buffer in the reaction tube containing he DNA labelling beads. 
After the addition of 5~1 of [a.-32P]dCTP, the mixture was incubated at 37°C for 15 
minutes, and the labelled probe was then used in a hybridisation reaction. 
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3.2.6 - DNA-DNA Hybridisation Using TEM and SHV Probes 
3.2. 6.1 ECL Labelled Probes 
The probes were hybridised to DNA that had been transferred to nylon membranes. 
Hybridisation was carried out using the ECL hybridisation and detection kit and were 
performed in hybridisation buffer provided by the manufacturers. This buffer contains 6M 
urea which lowers the Tm of the hybridisation and a blocking agent (5% w/v) which 
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prevents the probe binding to areas of the membrane that contain no sample DNA. The 
recommended concentration ofO,SM NaCl was added to the hybridisation buffer. 
The membranes containing the transferred DNA were prehybridised in the hybridisation 
buffer at 42°C for at least two hours. Freshly labelled probe (lOOng) was then added and 
hybridisation took place at 42°C overnight. The membranes were removed the following 
day and washed using varying stringency conditions. For the TEM probe, the wash buffer 
contained 6M urea, 0,4% SDS and 0,2x or 0, 1xSSC. Two washes for ten minutes each at 
55°C were carried out. The low concentration of SSC and consequently low ionic strength 
of the wash buffer increases the stringency of the washing procedure. Urea, which acts as 
a denaturing agent, also increases the stringency of the washing stage. Under these high 
stringency conditions, only a probe with a high degree of homology (approximately 90% 
or greater) to the sample DNA will remain annealed to the sample. 
When the PCR generated SHV probe was used in hybridisation experiments, the 
membranes were washed under conditions of high stringency because of the high degree of 
homology between SHV-1 and the chromosomal LEN-1 of K. pneumoniae. These post 
hybridisation washes consisted of two washes for ten minutes each at 55°C using a buffer 
containing 6M urea, 0, 1xSSC and 0,4% SDS. When the oligoprobe was used, however, 
the stringency was lowered: the wash buffer contained O,SxSSC and the washes were 
performed at 42°C. After the washes, the membranes were sealed in clear plastic and 
exposed to X-Ray film (Curix RPI, Agfa) for a variable time before being developed. The 
chemiluminescent signal used in the ECL kit decays after approximately 72 hours, and the 
probes were thus not stripped from the membranes prior to being used in further 
hybridisation experiments. 
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3. 2. 6. 2 ( 1 P]Labelled Probe 
The membranes were prehybridised at 68°C in a prehybridisation solution containing 
6xSSC, 5x Denhardt's reagent, 0,5% SDS and fragmented salmon sperm DNA 
(100!-lg/ml). Denhardt's reagent, salmon sperm DNA and SDS are all used to decrease 
non-specific binding of the probe to the membrane (Sambrook et al. , 1989). 
After prehybridisation for an hour at 68°C, the freshly labelled probe was added to the 
solution, and hybridisation occurred overnight at 68°C. The following day the 
hybridisation solution was discarded and the membrane was washed in 6xSSC and 0,1% 
SDS four times at 68°C (ten minutes each wash). Following this, four washes of ten 
minutes each at 71 °C were performed, and a single wash of two minutes at 74°C (Brown, 
1991a). The membrane was then exposed to X-ray film (Hyperfilm, Amersham) for 72 
hours at -70°C and developed. This hybridisation was only performed once, and the 
probes were not stripped off the membrane. 
3.3 RESULTS 
3.3.1 Preparation of TEM Probe 
An internal fragment of the TEM-1 gene was amplified in a PCR assay. After extraction of 
the PCR product from agarose gel, it was cloned into pUC19 and introduced into 
competent cells. 
Plasmid DNA was extracted from 18 ofthe putative transformants. Digestion of the DNA 
with the restriction enzyme Hindiii confirmed the presence of recombinants in 12 of these 
18. A partial DNA sequence was obtained of one ofthese [3 .2.3.5], which showed 100% 
homology to the TEM-1 gene (Fig 3.5). The PCR product was then used as a probe for 
the detection of TEM related genes. 
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Clone ATGAGCACTT TTAAAGTTCT GCTATGTGGC GCGGTATTAT CCCGTATTGA CGCCGGGCAA 60 
********** ********** ********** ********** ********** ********** 
TEM-1 229 ATGAGCACTT TTAAAGTTCT GCTATGTGGC GCGGTATTAT CCCGTATTGA CGCCGGGCAA 288 
Fig 3.5 Alignment of the sequence obtained from the recombinants with that of TEM-1 (numbering of TEM-1 
corresponds to that in Fig 3.2). Asterisks indicate identical nucleotides in the sequence. Sequences aligned 
using BLAST software (Altschul eta/., 1990). 
3.3.2 Results of Hybridisation with the TEM Probe 
3. 3. 2.1 Slot Blots 
DNA transferred to a nylon membrane was hybridised with the TEM probe [3 .2.6]. A 
signal was obtained from the DNA extracted from E. coli DH5a(pUC19) as well as 
pUC19 plasmid DNA, while no signal was obtained with the DNA of E. coli DH5a (Fig 
3.6). 
Of the 45 isolates, a strong signal was obtained with the DNA of 11, indicating the 
presence of a TEM related gene in these 11 isolates (Fig 3.6). A weak signal was obtained 
with the DNA of one isolate, M43. DNA from this isolate (approximately 21J.g) was re-
transferred to a nylon membrane along with appropriate controls. Hybridisation with the 
TEM probe was repeated and the membrane washed under the same stringency conditions 
and a strong signal was obtained from the isolate (Fig 3.6). The 12 isolates finally shown 
to contain a TEM related gene or genes consisted of 8 strains of K. pneumoniae, 2 
Salmonella spp., 1 S. marcescens and 1 P. agglomerans (Table 3.1 ). 
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Fig 3.6 Hybridisation of the TEM probe to genomic DNA The membrane was exposed to X-ray film (Curix RPI, 
Agfa) for I hour. 
K4 - K50, K. pneumoniae 
K52, K. oxytoca 
K54- K69, K. pneumoniae 
M9, C. freundii 
MIO & M20, Citrobacter spp. 
M25 - M30, K. pneumoniae 
M37 & M40, E. cloacae 
M43, P. agglomerans 
M44-I, M44-2, Salmonella spp 
M46, S. marscecens 
EI - E7, E. cloacae 
63 
E8, EIO, Enterobacter spp. 
El2- El7, E. cloacae 
E2I & E37, Enterobacter spp. 
E49, E. cloacae 
C I, E. coli DH5a 
C2, E. coli DH5a(pUCI9) 
C3, distilled H20 
C4, pUCI9 
SHV-I , E. coli KI2(SHV-I) 
SHV-2, E. coli KI2(SHV-2) 
Table3 .1 
Summary of results obtained after hybridisation with the TEM probe 
1\oltlte ltleutity Remit J~o/Cite ltleutity Remit /so/Cite Jtleutity Remit 
K. pneumoniae N N Salmonella sp. p 
K. pneumoniae N N Salmonella sp. p 
K. pneumoniae p p S. marscecens p 
K. pneumoniae N p N 
K. pneumoniae N p N 
: K. pneumoniae N N N 
· K. pneumoniae p N N 
. K. pneumoniae N N N 
: K. pneumoniae N N N 
: K. pneumoniae N N N 
K. pneumoniae p N N 
: K. pneumoniae p N N 
: K. pneumoniae N N N 
: K. pneumoniae p N N 
: K. oxytoca N 
P = Positive 
N= Negative 
3.3.2.2 Colony Blots 
The TEM probe was hybridised to two colony blots and the membranes were washed 
under conditions of high stringency [3.2.6]. A strong signal was obtained with the DNA 
from the positive control, E. coli DH5a(pUC19), but signals, although of less intensity, 
were also obtained from the DNA of the negative control, E. coli DH5a. 
With respect to the blot prepared by lysing cells which were initially cultured on agar 
[3 .2.2.2], a signal was obtained from 21 ofthe isolates, including those with a weak signal 
(Fig 3. 7) Of these 21 , only one was a K. pneumoniae isolate. The other 20 consisted of 14 
Enterobacter spp., 3 Citrobacter spp., 2 Salmonellae and 1 S. marcescens. As can be seen 
from the blot (Fig 3. 7), the intensity of the signal obtained from the DNA of the positive 
controls is not consistent and a signal was also obtained from the DNA of the negative 
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control, albeit weaker than the signal from the positive controls. The signal obtained from 
the DNA of 9 of the 21 isolates is of a similar intensity to the signal obtained from the 
negative control. 
K4 KB K11 K16 K17 K 18 
K29 K35 K36 K39 K42 K43 K46 KSO 
K52 K54 . KSB K 63 K68 K69 M9 M10 
M20 M25 M26 M28 M30 M37 M40 M43 .. .. 
M44
1 
M44 2 M46 E1 ES E7 EB E10 • • • • 
E12 E13 E16 E17 E21 E37 
• • • 
E 49 p N p 
• 
Fig 3. 7 Hybridisation of TEM probe to colony blot prepared by culturing colonies of the test isolates on 
agar, transferring the colonies to a nylon membrane and lysing the cells with NaOH. Exposed to 
X-ray film (Curix RPI, Agfa) for 30 minutes. 
K4 - K50 = K. pneumoniae 
K52 = K. oxytoca 
K54 - K69 = K. pneumoniae 
M9 = C. freundii 
M l 0 & M20 = Citrobacter spp. 
M25 - M30 = K. pneumoniae 
M37 & M40 =E. cloacae 
M43 = P. agglomerans 
M44-l, M44-2 =Salmonella spp 
65 
M46 = S. marscecens 
El- E7 =E. cloacae 
E8, E l 0 = Enterobacter spp. 
El2- El7 =E. cloacae 
E2l & E37 = Enterobacter spp. 
E49 =E. cloacae 
P = E. coli DH5cx.(pUC 19) 
N = E. coli DH5cx. 
With respect to the blot prepared by inoculating the cells directly onto the nylon 
membrane, a signal was obtained from the DNA of 18 of the 45 isolates. Of the 18 
positive signals, 13 were from Enterobacter spp., 2 from Citrobacter spp., 2 from 
Salmonella spp. and one from S. marcescens. In this blot, however, the difference 
between the intensity of the signals obtained from the positive and negative controls was 
less distinct than in the first blot. Three negative controls were included in this blot and a 
signal obtained from all of them. The signals obtained from some of the negative controls 
were stronger than the signal obtained from the positive control. Once again, the 
differentiation of positive signals from negative signals produced by the isolates was 
difficult, with the signals obtained from 10 of the isolates being of a similar intensity to the 
signal generated by the negative control. 
Comparison of the results of the colony blot with the results of the slot blots shows no 
significant correlation. For example, only one isolate of K. pneumoniae was shown to 
contain a TEM-related gene in these hybridisations, while 8 K. pneumoniae isolates were 
shown to contain a TEM-related gene by hybridisation of the same probe to genomic 
DNA. Given the inconsistent nature of the signals obtained from both the controls and the 
test isolates as well as the discrepancies with the slot blot hybridisations, meaningful 
analysis of the results of these colony blots is not feasible. 
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3.3.3 Results of Hybridisation with the SHV Probes 
3.3.3.1 Slot Blots 
The oligoprobe (labelled with the chemiluminescent label) was hybridised to genomtc 
DNA of all the isolates and washed under conditions of low stringency. The same 
membranes were used as were used for the hybridisation with the TEM probe and the 
SHV positive controls are on a separate membrane. These two membranes were 
hybridised and washed at the same time under the same stringency conditions, and for 
clarity will be referred to jointly as one membrane. As mentioned in section 3 .2.6.1, low 
stringency conditions were used with the oligoprobe, since no signal could be obtained 
under conditions of higher stringency. 
After hybridisation of the oligoprobe to the membrane, positive signals were obtained from 
the DNA of the positive controls, E. coli K-12 (SHV-1) and E. coli K12 (SHV-2). No 
signal was obtained from the negative controls. A signal was obtained with DNA of 24 of 
the 45 isolates. Of these 24, 20 were K. pneumoniae isolates, 2 were E. cloacae and 2 
were Salmonella spp. A faint signal was obtained from the DNA of isolate K63 (K. 
pneumoniae) (Fig 3.8-i). 
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Fig 3.8- i Hybridisation of the SHY oligoprobe (ECL chemiluminescent label) to genomic DNA The membrane was 
washed under low stringency conditions and exposed overnight to X-ray film (Curix RPI, Agfa). 
K4- K50, K. pneumoniae 
K52 , K. oxytoca 
K54- K69, K. pneumoniae 
M9, C. freundii 
MlO & M20, Citrobacter spp. 
M25- M30, K. pneumoniae 
M37 & M40, E. cloacae 
M43, P. agglomerans 
M44-l, M44-2, Salmonella spp 
M46, S. marscecens 
E 1 - E7, E. cloacae 
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E8, ElO, Enterobacter spp 
El2- El7, E. cloacae 
E2 1 & E37, Enterobacter spp. 
E49, E. cloacae 
Cl , E. coli DH5a 
C2, E. coli DH5a(pUC 19) 
C3, distilled H20 
C4, pUC19 
SHV-1 , E. coli Kl2(SHV-l) 
SHV-2, E. coli Kl2(SHV-2) 
In order to increase the sensitivity and specificity of the hybridisation with the oligoprobe, 
the oligoprobe was labelled with [a-32P]dCTP and washed under conditions of higher 
stringency [3 .2.6.2]. Under these conditions the probe hybridised to the DNA from the 
positive control E. coli K12(SHV-1) but not to DNA from E. coli DH5a or to the plasmid 
pUC19 (containing the TEM-1 gene). A signal was obtained with the DNA of 27 of the 
isolates. These isolates consisted of 23 K. pneumoniae, 2 E. cloacae and 2 Salmonella 
spp. The signal obtained from 7 (6 K. pneumoniae and 1 E. cloacae) of these 27 isolates 
was weaker than the signal from the positive control (Fig 3.8-ii). Despite these signals 
being weak, they were assessed as being positive results in light of the absence of any 
signal from the negative controls. The strains to which the radiolabelled probe hybridised 
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Fig 3.8 - ii Hybridisation of SHV oligoprobe ([32P] labelled) to genomic DNA of isolates. Overnight exposure to X-ray 
film (Hyperfi.lm, Amersham). The signals obtained from hybridisation to DNA of isolates K4, K63 and 
M26 are not readily visible in the photograph, but are discernible (albeit weakly) in the original 
autoradiograph. 
K4 - K50, K. pneumoniae 
K52 , K. oxytoca 
K54- K69, K. pneumoniae 
M9, C.freundii 
MlO & M20, Citrobacter spp. 
M25 - M30, K. pneumoniae 
M37 & M40, E. cloacae 
M43, P. agglomerans 
M44-l, M44-2, Salmonella spp 
M46, S. marscecens 
El- E7, E. cloacae 
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E8, EIO, Enterobacter spp 
El2-El7,E. cloacae 
E21 & E37, Enterobacter spp. 
E49, E. cloacae 
Cl , E. coli DH5a. 
C2, E. coli DH5a.(pUC 19) 
C3, distilled H20 
C4, pUC19 
SHV-l,E. co/iK12(SHV-l) 
The second SHV probe was designed to assess whether any differences would arise in the 
results of hybridisation with an oligoprobe or a longer probe. This probe was obtained 
using primers specific for the SHV genes in a PCR assay and purifying the product. 
Hybridisation with this probe was carried out under highly stringent conditions given the 
high degree of homology between SHV -1 and the chromosomal gene of K. pneumoniae 
(90%). The washes were performed at 55°C with the wash buffer containing 0, lxSSC. 
The same membranes were used as were used for the hybridisation with the 
chemiluminescent labelled SHV oligoprobe. 
Under high stringency conditions a signal was obtained from the DNA of the positive 
controls. No signal was obtained from genomic DNA extracted from E. coli 
DH5a(pUC19) on the larger membrane. A faint signal was seen from the area in which 
pUC19 had been transferred to the membrane (position C4 in Fig 3.8-iii), but a similar 
signal was obtained from a blank area in the smaller membrane (between SHV- and SHV-
2, Fig 3.8-iii). This is interpreted as possibly representing some form of binding of the 
probe to the membrane itself The difference between these weaker signals and the positive 
controls is easily distinguishable, and amongst the test isolates no signals of a similarly low 
intensity were obtained. All 23 of the K. pneumoniae isolates yielded a positive signal, but 
the single K. oxytoca did not show any signal. Of the other isolates, 2 E. cloacae and 2 
Salmonella spp. also showed a positive signal (Fig 3.8-iii). The results ofthe hybridisation 
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Fig 3.8- iii Hybridisation ofPCR generated SHV probe (ECL chemiluminescent label) to genomic DNA One hour 
exposure to X-ray film (Curix RPI, Agfa). 
K4 - K50, K. pneumoniae 
K52 , K. oxytoca 
K54- K69, K. pneumoniae 
M9, C.freundii 
MlO & M20, Citrobacter spp. 
M25 - M30, K. pneumoniae 
M37 & M40, E. cloacae 
M43, P. agglomerans 
M44-l & M44-2, Salmonella spp 
M46, S. marscecens 
El- E7, E. cloacae 
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E8 & E!O, Enterobacter spp 
El2- El7, E. cloacae 
E21 & E37, Enterobacter spp. 
E49, E. cloacae 
Cl , E. coli DH5a 
C2, E. coli DH5a(pUC!9) 
C3, distilled H20 
C4, pUC!9 
SHV-l , E. coliK12(SHV-l) 
SHV-2, E. coli Kl2(SHV-2) 
The results of the three hybridisations are shown in Table 3 .2. The results that do not 
correlate among all three hybridisations are highlighted. 
Table 3.2 
Results of the hybridisations using the various SHY probes 
N J> p M25 K p11eumo11iae N p p 
p p p K. pneumoniae p p p 
p p p K. pneumoniae p p p 
p p p K. pneumoniae p p p 
p p p E. cloacae N N N 
p p p E. cloacae p p p 
p p p P. agglomerans N N N 
p p p Salmonella sp. p p p 
p p p Salmonella sp. p p p 
p p p S. marscecens N N N 
p p p E. cloacae N N N 
p p p E. cloacae N N N 
p p p E. cloacae N N N 
p p p E. sp. N N N 
N N N E. sp. N N N 
p p p E. cloacae N N N 
p p p E. cloacae N N N 
N p p E. cloacae N N N 
p p p E. cloacae N N N 
p p p E. sp. N N N 
N N N E. sp. N N N 
N N N E. cloacae p p p 
N N 
[ffiiiffr i*t~% : rmm N 
1 - SHY oligoprobe, ECL labell ed, low stringency 
2 - SHY oligoprobe, radiolabell ed, high stringency 
3 - SHY PCR Product, high stringency 
P = Positive 
N= Negative 
3.3.3.2 Colony Blot 
The SHY probe obtained by PCR was hybridised to a blot where the isolates had been 
initially inoculated onto agar, incubated and then a nylon membrane placed on the agar and 
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peeled off The hybridisation was done under high stringency conditions at 55°C with 
0, lxSSC in the wash buffer. 
K11 ~16 • . 
K17 K18 K29 K35 K36 K 39 
K 42 · K43 K46 K50 K52 K54 K58 K61 
K68 . K69 M9 M 10 M20 M25 M26 
M28 MJO M37 M¢0 M43 M44 1 M442 M46 
E1 • E7 E8 E12 . E5 E10 E13 
E17 E 21 · E37 •E4 9 
N P1 
P2 
Fig 3.9 Hybridisation of PCR generated SHV probe to colony blot prepared by culturing colonies of the test isolates 
on agar, transferring the colonies to a nylon membrane and lysing the cells with NaOH. The membrane was 
exposed to X-ray film (Curix RPI, Agfa) for I hour. 
K4 - K50, K. pneumoniae 
K52 , K. oxytoca 
K54- K69, K. pneumoniae 
M9, C. freundii 
MIO & M20, Citrobacter spp. 
M25 - M30, K. pneumoniae 
M37 & M40, E. cloacae 
M43, P. agglomerans 
M44-l, M44-2, Salmonella spp 
M46, S. marscecens 
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El - E7, E. cloacae 
E8, EIO, Enterobacter spp 
El2- El7, E. cloacae 
E21 & E37, Enterobacter spp. 
E49, E. cloacae 
N, E. coli DH5a 
PI, E. coli Kl2(SHV-l) 
P2, E. coli Kl2(SHV-2) 
A weak signal was obtained from the positive controls, and a similarly weak signal 
obtained from the negative control E. coli DH5a, making differentiation of positive from 
negative in the isolates difficult. Looking at the blot (Fig 3.9), a weak signal can be seen 
with all the isolates. However, 18 of the isolates, compdsing 9 K. pneumoniae, 5 
Enterobacter spp., 2 Salmonella spp., 1 Citrobacter spp. and 1 S. marcescens, show a 
strongly positive signal. Of these 18 isolates, 11 also gave positive results in the three slot 
blots. However, 5 of the isolates that produced "positive" results on the colony blot were 
negative on all three slot blots, while 13 of the isolates with "negative" results from this 
colony blot were positive on all three slot blots. Given the considerable inconsistencies 
between the results of the colony blots and the slot blots, the results of these colony blots 
(as with the TEM hybridised colony blots) were considered to be unreliable and were 
disregarded. 
3.4 DISCUSSION 
TEM-related genes were detected in 12 of the 45 isolates studied. Of these, 8 were K. 
pneumoniae, 2 Salmonella spp., 1 P. agglomerans and 1 S. marcescens. Thus, of a total 
of 23 K. pneumoniae isolates in the study, 8 were shown to contain TEM related genes. 
Studies from around the world have found differing proportions of TEM related genes in 
isolates of K. pneumoniae. In 1988, Jarlier et al. demonstrated the presence of TEM 
related genes in 5 of 16 K. pneumoniae isolates from Paris with a decreased susceptibility 
to cefotaxime. These 5 comprised 2 TEM-1 and 3 CTX-1/TEM-3 beta lactamases. It is 
interesting to note that the isolates in this study that produced TEM-1 beta lactamases also 
produced SHV-2 beta lactamase. 
In another study, 5 out of 11 K. pneumoniae isolates from Poland were shown to contain 
TEM-related ESBLs and 3 of the isolates contained SHY-related ESBLs (Gniadkowski et 
al., 1998). In South Africa, a study of faecal isolates of E. coli and K. pneumoniae 
showed TEM-1 and TEM-2 to be present in over 95% of the isolates. Unfortunately, this 
study did not discriminate between the incidence in E. coli and K. pneumoniae (Shanahan 
et al., 1995). While TEM-1 is by far the most common beta lactamase produced by the 
Enterobacteriaceae, comprising about 80% of all plasmid encoded beta lactamases in 
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these organisms (Du Bois et al., 1995), TEM-related ESBLs are not necessarily more 
common than their SHV related counterparts. This is also interesting in view of the fact 
that there are a larger number of different TEM-related enzymes than SHV -related 
enzymes. Our finding of TEM-related genes in 8 out of 24 K. pneumoniae isolates is in 
keeping with findings in other areas of the world. 
The finding of TEM-related genes in other members of the Enterobacteriaceae, such as. 
species of Serratia and Salmonella, has also been described. (Gutmann et al., 1988; 
Kariuki et al., 1996; Morosini et a!., 1996; Perilli et a!., 1997; Luzarro et al., 1998; 
Shanahan eta!., 1998}. Similar information on Pantoea agglomerans is lacking, although 
this may be due to Enterobacter agglomerans having been reclassified as P. agglomerans 
(Holt et a!., 1994). What is interesting, is that both Serratia and Pantoea species are 
known to harbour a chromosomal beta lactamase (AmpC) (Livermore, 1995), which 
makes it unlikely that the acquisition of another beta lactamase encoding gene would 
confer any survival advantage. However, plasmids conferring antibiotic resistance often 
contain more than one resistance gene, and the presence of the other resistance genes may 
confer the survival advantage that allows the strain with the plasmid to predominate 
(Pitout eta!., 1998b). The TEM-related gene (whether encoding an ESBL or not) in this 
case is something of an "innocent bystander". 
The initial results using the oligoprobe for detection of SHV -related genes in isolates of K. 
pneumoniae were promising. This probe did not hybridise to some of the isolates, 
suggesting that hybridisation to non-specific, SHV -like chromosomal beta lactamase genes 
did not occur. However, in subsequent hybridisation studies using the same oligoprobe 
with a radioactive label, as well as the longer SHV probe, signals were obtained with DNA 
from all the K. pneumoniae isolates. As it is unlikely that all the K. pneumoniae isolates 
contain a plasmid mediated SHV related gene, these results were disregarded. 
While some studies have found a predominance of SHV -related ESBLs in K. pneumoniae 
isolates, no studies have demonstrated SHV -related ESBLs in all the K. pneumoniae 
isolates studied. In 1996, Jacoby and Han characterised the beta lactamases produced by 
117 transconjugants from crosses involving clinical isolates of E. coli and K. pneumoniae 
by iso-electric focussing. Their findings indicated that SHV -related ESBLs (especially 
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SHV -4 and SHV -5) were the commonest ESBLs produced by the transconjugants, 
although TEM-related enzymes were also found. Unfortunately, the study did not specify 
which organisms contained which beta lactamases. 
Jarlier et al. (1988) conducted a similar study, and found that all the K. pneumoniae donor 
strains produced an enzyme with an isoelectric point of 7. 7, identified as SHV -1, and 
presumed it to be chromosomal. Unfortunately this gene was not sequenced and any 
similarity with LEN-1 is unknown. However, since LEN-1 has a pi of 7,0 - 7,1 
(Hreggman eta/., 1997) it is probable that the chromosomal beta lactamase gene with a pi 
of 7.7 differs in some respects from LEN-1. Hreggman eta/. (1997) also found that the 
majority of chromosomal beta lactamases from isolates of K. pneumoniae had a pi of 
either 7.6 (SHV-llike) or 7.1 (LEN-I like). Similarly, Leung eta/. (1997) found that non-
transferable beta lactamases from 77 isolates of K. pneumoniae had pis ranging from 6,7-
8,0 with the majority (~80%) ranging from 7,1 -7,6. It therefore appears that while LEN-
I is the only chromosomal beta lactamase from K. pneumoniae that has been sequenced to 
date, there are probably other SHV -like chromosomal genes in K. pneumoniae with even 
greater homology to the plasmid mediated SHV -1. 
Since both probes hybridised to DNA from all of the K. pneumoniae isolates, it is assumed 
that both probes hybridised to a chromosomal beta lactamase gene similar to SHV -1 or 
LEN-1, as well as to any plasmid mediated SHY-related gene/sin the organisms. Workers 
who have demonstrated plasmid mediated SHV -related genes in K. pneumoniae isolates 
have relied on analysis of E. coli transconjugants following conjugation experiments. A 
similar approach was adopted in this study and conjugation experiments were carried out 
[chapter 5]. 
Hybridisations using the SHV probes proved useful for detecting SHV -related genes in 
genera other than Klebsiella. Since any chromosomal beta lactamase genes in these 
organisms should not cross hybridise with a SHV probe, interpretation of the results is 
possible. Of the 22 non-K. pneumoniae isolates (including members of the genera 
Citrobacter, Enterobacter, Pantoea, Serratia and Salmonella), a positive signal was 
obtained from 2 isolates of E. cloacae and 2 isolates of Salmonella sp. 
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The finding of SHV -related genes in Enterobacter species is unusual, although it has been 
described (Pitout eta!., 1997; Pitout eta!., 1998a,b). What is possibly more interesting is 
the demonstration of SHV genes in the Salmonella isolates in addition to the TEM genes 
[3 .3 .2.1]. Although Salmonella species are usually sensitive to extended spectrum 
cephalosporins, instances of Salmonella species harbouring either SHV or TEM related 
beta lactamases have been reported (Barguellil et a!., 1995). Although there is no reason 
why both types of beta lactamase may not be present in a single isolate, it is unusual. It 
may be that one of the enzymes has extended spectrum activity, conferring a survival 
advantage, which is absent in the other enzyme. It should be mentioned here that the 
Salmonella isolates examined in this study were obtained from the same patient, albeit 4 or 
5 days apart and are probably the same strain. 
Some other considerations should also be mentioned pertaining to the use of hybridisation 
for detection ofbeta lactamases. Whether an oligoprobe or longer probe is used, it should 
b.e designed to anneal to the intragenic portion of a beta lactamase gene rather than 
upstream or downstream regions, since the latter can lead to false positive results (Payne 
& Thomson, 1998). With respect to the use of hybridisations in a routine diagnostic 
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CHAPTER4 
DETECTION OF TEM AND SHV RELATED GENES 
USING THE POLYMERASE CHAIN REACTION 
(PCR) 
4.1 INTRODUCTION 
One of the many applications of the polymerase chain reaction (PCR) is the detection of 
resistance genes, including the detection of TEM and SHV related genes in Gram negative 
bacilli (Leung et al, 1997; Payne & Thomson, 1998; Van Belkum et al, 1998). This 
chapter will describe PCR assays performed to detect TEM- and SHY-related genes in the 
45 clinical isolates selected in chapter 2, and the use of PCR will be evaluated and 
compared to the hybridisation techniques described in chapter 3. 
4.2 MATERIALS AND METHODS 
A variety of methods were used to prepare DNA for use as a template in the PCR assays, 
particularly during optimisation. This was done to ascertain a method of DNA preparation 
that would both yield a suitable template and be feasible in a clinical laboratory. The 
different methods used to isolate DNA are described below, followed by the details of the 
PCR assays. All PCR assays were performed in a Perkin Elmer GeneAmp 2400 PCR 
system. 
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4.2.1 Isolation of DNA 
4.2.1.1 Plasmid DNA 
P!a.smid DNA was extracted using the alkaline lysis method and purified further either by 
centrifugation in a CsCl density gradient or by using a commercial kit (Nucleobond, 
Machery Nagel, Germany) according to the manufacturer's instructions [3.2.3.4.vi]. 
Plasmid DNA was purified by centrifugation in a CsCl gradient (Sambrook eta/., 1989) by 
adding of lg CsCl per ml of solution to the cleared lysate. Ethidium bromide (EtBr) was 
then added at 0,1 ml per ml of solution. The refractive index of the solution was adjusted 
by adding either CsCl or sterile water until the refractive index was 1,391, equivalent to a 
density of 1,55g/ml. The solution was then transferred to Beckman quickseal tubes and 
centrifuged overnight at 50 000 rpm (Beckman L 70 Ultracentrifuge with V -ti 65-2 rotor). 
After centrifugation plasmid DNA was recovered in an Eppendorftube. 
Ethidium bromide was removed from the solution by repeated extractions with salt 
saturated isopropanol until the solution was colourless (usually 4 - 5 extractions). Two 
volumes of TE buffer were added, followed by isopropanol equal to the new volume. 
After standing at room temperature for ten minutes the solution was centrifuged in a 
microfuge at 12 000 rpm for ten minutes to pellet the DNA which was then washed, dried 
and resuspended in TE buffer [3.2.1.3]. 
4.2.1.2 Genomic DNA from Broth Cultures 
Genomic DNA was extracted [3.2.1.3] and resuspended in TE buffer. Aliquots of the 
DNA solution were subjected to agarose gel electrophoresis alongside known standards in 
order to estimate the concentration of DNA 
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4.2.1.3 Genomic DNA from Colonies 
Three methods were used to extract DNA from colonies of bacteria cultured on YT agar. 
a) Two or three bacterial colonies were transferred from YT agar plates into 50j.!l 
of sterile water in an Eppendorf tube. These were then placed in a bath of 
boiling water for five to fifteen minutes to lyse the cells and release the DNA. 
The samples were then centrifuged in a microfuge at 14 OOOrpm at room 
temperature for 2 minutes to pellet bacterial cell wall debris and the tubes were 
placed on ice. A Sj.!l aliquot ofthe supernatant fluid was used as the template in 
a PCR reaction. 
b) Two or three colonies were emulsified in 50j.!l of sterile water, placed in a bath 
of boiling water for five to fifteen minutes and then placed on ice. These 
samples were not centrifuged and Sj.!l of the mixture was used in the PCR 
reaction. 
c) Two or three colonies were emulsified in 50j.!l of sterile water and Sj.!l used as 
the template without prior boiling or centrifugation. 
4. 2.1. 4 Control Strains 
The positive control strains were those used in the hybridisation experiments [3.2.1]. 
Negative controls consisted of DNA extracted from broth cultures or colonies of E. coli 
LK111 or DHSa. Sterile water was also used as a negative control. 
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, ~-~~.2 PCR Assay for the Detection of TEM Related Genes 
4.2. 2.1 Primers 
The same primers used to amplify an intragenic portion of the pUC19 TEM-1 gene 
[3.2.3.1] were used in the PCR assays. The primers anneal to conserved sequences in the 
intragenic portion of TEM-related genes and when used in PCR assays an amplification 
product 517bp long is obtained. The primers (TEM-A 5' -CCC CGA AGA ACG TTT 
TC and TEM-B 5' -ATC AGC AAT AAA CCA GC), which anneal to bases 177-194 and 
677-693 of the TEM-1 gene, respectively, were synthesised in the Department of Medical 
, Biochemistry, University of Cape Town [3.2.3.1- Fig 3.2]. 
4.2.2.2 PCR Assay: Parameters 
i) Primer concentration 
Aliquots of concentrated primer solutions were stored at -20°C and diluted to working 
stocks of IO~M which were used in the PCR assays at concentrations ranging from 0,2~M 
to 0,6~M. 
ii) dNTPs 
dNTPs were used at a final concentration of200~M of each dNTP. 
iii) Annealing Temperature and Time 
The melting temperature of the primers was determined by applying the following 
equation. 
TM = 22 + 1,46 (2x ~ G&C + ~ A&T) (Wu et al., 1991) 
1fl G&C and 1fl A&T represents the number of each of these bases in the primer sequence. 
Using this formula the melting temperatures for TEM-A and TEM-B were 60°C and 
- 5't6C, respectively. The recommended annealing temperature is approximately soc below 
the melting temperature (Innis & Gelfand, 1990). The anneaiing temperatures used in the 
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PCR assays ranged from 55°C- 62 °C and the duration of annealing was from 30 to 50 
seconds. 
iv) Denaturation and Extension 
An initial denaturation step at 94°C for five minutes was performed. This was followed by 
cycles of denaturation, annealing and extension. Denaturation was carried out at 94 °C and 
extension at 72°C. The duration of each stage varied slightly and denaturation time was 
increased from an initial 20 seconds to 30 seconds. Extension took place for 60 seconds 
with one exception, where the time was decreased to 30 seconds. A final extension step at 
72°C for seven minutes occurred once the cycles had finished. 
1U Mmtber qf Amplification Cycles 
To increase the number of amplicons produced, the number of cycles was increased from 
25 to 35 and then to 40. 
4. 2. 2. 3 Predigestion with Avail 
Contamination ofPCR mixtures resulting in false positives is a well recognised hazard of 
this technique (Vaneechoutte & Van Eldere, 1997). To minimise this problem, digestion of 
the reaction mix with the restriction enzyme Avail prior to the addition of template was 
carried out. AvaiT recognises the restriction site, G/GWCC (W = NT). This site occurs 
twice between the two primer sites in the TEM -1 gene but is not present in either of the 
primers. By pre-digesting the PCR mixture with AvaiT, any contaminating DNA containing 
a TEM related gene would be digested into fragments too small to serve as a template. 
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4.2.3 PCR Assay for the Detection of SHV Related Genes 
4.2.3.1 Primers 
A set of primers was designed to anneal to conserved sequences of all the SHV -related 
genes but not to the chromosomal LEN-1 gene of K. pneumoniae. The primers were 
designed to render the 3' ends incompatible with the corresponding regions of the LEN-1 
gene, while still being compatible with all SHV related genes. The primers, SHV-A (5' 
CTG GCG GTA CAC GCC AGC) and SHV-B (5' TGC GCT CTG CTT TGT TA) 
anneal to bases 154-171 and 852-868, respectively, ofthe SHV-1 gene. SHV-A contains 4 
mismatches with LEN-1, of which 2 (CIT and NG) are in the last 3 nucleotides at the 3' 
end. Similarly, SHV-B contains 5 mismatches: 3 at the 3' end, in addition to two 
mismatches which are 8 and 10 base pairs from the 3' end. The mismatches are highlighted 
in Fig 4 .1. The primers were synthesised by an oligonucleotide synthesiser at the 
University of Cape Town Department of Medical Biochemistry. 
LEN-1 CCACTGGTGGTATACGCCGGTCCA LEN-1 TGCCGTTTGGCCTCGCGTAA 
** **** **** ***** * ** * **** * ********* 
SHV-1 CCGCTGGCGGTACACGCCAGCCCG SHV-1 TATTGTTTCGTCTCGCGTAA 
SHV-A 3' 3' SHV-B 
Fig 4.1- Annealing positions of the primers SHV-A and SHV-B, showing the mismatches with LEN-1 
A second set of SHV primers, SHV-C and SHV-D, described by Nuesch-Inderbinen eta/ 
(1996), were also synthesised. Products amplified by these primers contain a site 
recognised by the restriction enzyme Nhel. This site is present only in SHV related ESBL 
genes and not in the SHV -1 or LEN-1 genes. The presence of an SHV related ESBL gene 
can thus be detected by digesting the amplicon with the enzyme Nhel. The primers, SHV-
C and SHV-D (5' GCC CGG GTT ATT CTT ATT TGT CGC and 5' TCT TTC CGA 
TGC CGC CGC CAG TCA respectively), which anneal to sequences flanking the 
structural SHY-related genes (Nuesch-lnderbinen et al., 1996) (Fig 4.2), were obtained 
from Boehringer Mannheim, Germany. 
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SHV-1 TGAAGGAAAA AAGAGGAATT GTGAATCAGC AAAACGCCGG GTTATTCTTA TTTGTCGCTT 60 
SHV-C 
LEN-1CTTTGCTCGC CCTTATCGGC CCTCACTCAA GGAAGTATTG CGGTTATGCG TTATGTTCGC 60 
***** **** ***** 
SHV-1 CTTTACTCGC CTTTATCGGC CCTCACTCAA GGATGTATTG TGGTTATGCG TTATATTCGC 120 
..... 
LEN-1 CTGTGTGTTA TCTCCCTGTT AGCCACCCTG CCACTGGTGG TATACGCCGG TCCACAGCCG 120 
****** *** ********** ********** ** **** ** ** ***** * ** ****** 
SHV-1 CTGTGTATTA TCTCCCTGTT AGCCACCCTG CCGCTGGCGG TACACGCCAG CCCGCAGCCG 180 
SHV-A 
LEN-1 CTTGAGCAGA TTAAACAAAG CGAAAGCCAG CTGTCGGGCC GCGTGGGGAT GGTGGAAATG 180 
******** * ****** *** ********** ********** **** ** ** * * ****** 
SHV-1 CTTGAGCAAA TTAAACTAAG CGAAAGCCAG CTGTCGGGCC GCGTAGGCAT GATAGAAATG 135 
II 
LEN-1 TGGTTTATCG CCGACAAAAC CGGGGCTGGC GAACGGGGTG CGCGCGGCAT TGTCGCCCTG 777 
********** **** ** ** *** ****** ** ******* ******* ** ********** 
SHV-1 TGGTTTATCG CCGATAAGAC CGGAGCTGGC GAGCGGGGTG CGCGCGGGAT TGTCGCCCTG 840 
LEN-1 CTCGGCCCGG ACGGCAAACC GGAGCGCATT GTGGTGATCT ATCTGCGGGA TACCCCGGCG 837 
** ****** * **** * ********* ******** * ********** ********** 
SHV-1 CTTGGCCCGA ATAACAAAGC AGAGCGCATT GTGGTGATTT ATCTGCGGGA TACCCCGGCG 900 
SHV-B 
LEN-1 AGTATGGCCG AGCGTAATCA ACATATCGCC GGGATCGGCC A-GCGCTGAT CGAGCACTGG 896 
** ******* **** ***** ** ****** ********* * ****** ********** 
SHV-1 AGCATGGCCG AGCGAAATCA GCAAATCGCC GGGATCGGCA AGGCGCTGTA CGAGCACTGG 960 
LEN-1 CAACGCTAAC CCGGCGGTAC CGTGCGTTAG CGCGGCCCGC AGCACCTGGC AGGCGTGCCG 956 
********** *** * * ** ****** * ******** ******* ** ** ******* 
SHV-1 CAACGCTAAC CCGCGTGGCC GC-GCGTTAT C-CGGCCCGC AGCACCTCGC AG-CGTGCCG 1020 ._ 
SHV-1 GGCGATATGA CTGGCGGCGG CATCGGAAAG ATGCCGGTCG GTAATGATGG TGGTGAACCG 1080 
SHV-D 
SHV-1 GGTCAAAGGT AACGCCATAA ACGTGGCCAC CTGATTGTAT TTCGAACTGT CGCACGACGG 1140 
Fig 4.2 Sequence of the SHV-1 gene and flanking areas showing the sites of the primers used in PCR 
assays for detection of SHV -related genes. The start and stop codons are highlighted with 
arrowheads. Asterisks indicate identical nucleotides in the sequences of SHV-1 (Mercier & 
Levesque, 1990) and LEN-1 (Arakawa et al., 1986). Sequences aligned using BLAST software 
(Altschul et al., 1990). It should be noted that the first two 5' nucleotides of the SHV-C primer 
[4.2.3.1] do not correspond to the published sequence of the SHV-1 gene. The SHV-C sequence 
detailed in 4.2.3.1 is as described by Nuesch-Inderbinen et al. (1996). 
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4.2.3.2 PCR Assays: Parameters 
The same parameters as those investigated for the TEM-PCR assays were used to 
optimise the SHV-PCR assays, and the calculations for annealing temperature of the 
primers were done in the same manner. The ranges of the various parameters altered while 




Primer concentration 0,2-0,6~ 
dNTP concentration 100-400~ 
Melting temperature (calculated) SHV-A67°C 
SHV-B 59°C 







94°C or 95°C for 30s 
Annealing temp and time 48°C - 60°C for 30 - 50s 45°C - 60°C for 30 - 50s 
Extension temp and time 72°C for 30- 50s 72°C for 50s 
Number of cycles 35-40 40 
4.3 RESULTS AND DISCUSSION 
4.3.1 Results of Optimisation of PCR Assay to Detect TEM-Related 
Genes 
Purified pUC19 or genomic DNA extracted from either broth cultures [3.2.1.3] or 
colonies [4.2.1.3] of E. coli DH5a.(pUC19) were used as templates in optimisation of the 
PCR assays with the primers specific for TEM-related genes. Negative controls were as 
described earlier [ 4.2.1.4]. 
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4.3.1.1 Parameters 
A summary of the results of optimisation experiments showing the variations in primer 
concentration, template and thermal cycle is presented in Table 4.2. 
Table 4.2 
Template Primer Dena tu ration Annealing Extension Number of 
concentration Cycles 
' 
0,2J1M 94°C 20 s 55°C 30 s 72°C 60s 25 
0,4J1M 94°C 20 s 55°C 30 s 72°C 60s 25 
pUC19 0,6J1M 94°C 20 s 55°C 30 s 72°C 60s 25 
0,4J1M 94°C 20 s 60°C 30 s 72°C 60s 25,35,40 
0,4J1M 94°C 20 s 62°C 30 s 72°C60 s 25 
Genomic DNA of 0,4J1M 94°C 20 s 55°C 30 s 72°C 60s 25 
· EY:oli 0,4J1M 94°C 30 s 60°C 30 s 72°C 30 s 25 
DH5cx.(pUC19) 
0,4J1M 94°C 20 s 55°C 30 s 72°C 60s 25,35 
Boiled and spun 
E. coli 0,4J1M 94°C 30 s 60°C 50s 72°C60 s 25,35, 40 
DH5cx.(pUC19) 
0,4J1M 94°C 30 s 62°C 30 s 72°C 30 s 25 
An initial denaturing step at 94 'C for 5 minutes and a final extension at 72 'C for seven minutes was 












Yes (with both 
cycles) 
Yes (with al13 
cycles) 
Yes 
i) Primer Concentration 
The appropriate sized amplicon was produced using primer concentrations of both 0,4J.1M 
and 0,6J.1M. No product was obtained using a primer concentration of 0,2J.1M. All 
subsequent reactions were carried out using a primer concentration of0,4uM. 
ii) Annealing Temperature 
t.Jsing an initial annealing temperature of55°C, an amplification product of the correct size 
was obtained from the positive controls. The same size product however, was also 
obtained from the DNA of the negative controls using the same annealing temperature. To 
eliminate what was thought to be non-specific annealing of the primers, the annealing 
temperature was raised to 60°C and then to 62°C. At these annealing temperatures the 
false positive reactions were initially eliminated, but reappeared sporadically in subsequent 
experiments. It was at this stage that contamination of one of the stock solutions of 
primer, buffer or dNTP was suspected, with the primer solution thought to be the most 
likely source of contaminating DNA. Predigestion of the PCR mixtures with Avail was 
initiated, and using an annealing temperature of 60°C no further false positive results were 
e-ncountered. The results of assays performed on both test isolates and controls before 
digestion with Avail was initiated are shown in Fig 4.3. The faint bands of DNA resulting 
from contamination of the PCR mixture, clearly distinguishable from the intense bands 
representing true positive results, can be seen (E7, E8, E12, E13 in Fig 4.3). The results of 
subsequent assays on the test isolates, after digestion with Avail, will be shown later. 
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Fig 4.3 PCR assay performed on test isolates and controls prior to predigestion with Avam, showing faint bands of DNA amplified from some of the test isolates. Agarose gel elctriophoresis 
(AGE) performed on 1,2% gel at IOV/cm for 90 minutes. 
89 
M44-1, Salmonella sp. 
M44-2, Salmonella sp 
M46, S. marcescens 
El, E. cloacae 
ES, E. cloacae 
E7, E. cloacae 
E8, E. sp 
ElO, E sp. 
E12, E. cloacae 
E13, E. cloacae 
El6, E. cloacae 
E17, E. cloacae 
E21, E. sp 
E37, E. sp 
E49, E. cloacae 
Nl, E. coli DH5a 
P, E coli DH5a(pUC 19) 
N2, Distilled H20 
N3, No template 
E, Empty lanes 
MW, Molecular weight marker VI, 
with the size of one of the fragments 
highlighted 
iii) Denaturation and Extension 
None of the changes in the duration of any of the cycles could be seen to make a 
difference to the amount of PCR product obtained. A final time cycle of 30 seconds, 50 
seconds and 60 seconds for the denaturation, annealing and extension steps, respectively, 
was chosen. 
iv) Number of Cycles 
No visually discernible difference could be found in the intensity of the band of PCR 
product on the agarose gel using different numbers of cycles. The final assays were 
performed with 40 cycles of the thermal profile. 
4.3.1.2 Templates 
i) Plasmid DNA 
Of the vanous templates used, purified pUC19 was used in the majority of the 
optimisation assays and produced consistent results (lane 14 in Fig 4.4). 
ii) Genomic DNA 
The results using genomic DNA were disappointing, with inconsistent results, and often 
fainter bands of DNA, obtained from the positive controls (lane 12 in Fig 4.4). For this 
reason as well as the laborious nature of the DNA extraction, little work was done using 
genomic DNA as a template. 
iii) Colonies 
Using colonies after boiling and centrifugation provided good results. The correct sized 
amplicon was consistently obtained from the positive control (E. coli DH5a(pUC19)). 
The PCR product was readily discernible on agarose gels (lane 9 in Fig 4.4), and the ease 
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of sample preparation made it suitable for use in a diagnostic laboratory, m marked 
contrast to the previous two templates. 
To conclude optimisation, it was shown that an amplicon of the correct size was produced 
from DNA extracted directly from colonies (Fig 4.4). The conditions consisted of an initial 
denaturing step of 94°C for five minutes followed by 40 cycles of 94°C for 30 seconds 
(denaturation), 60°C for 50 seconds (annealing) and 72°C for 60 seconds (extension). A 
final extension step of 72°C for 7 minutes was performed. Primers were used at a 
concentration of 0,4flM and dNTPs at 200flM, and all PCR mixtures were digested with 
the restriction enzyme Avail prior to addition of the template. 
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2 3 4 5 6 7 8 9 MW 
517bp 
10 11 12 13 14 15 16 17 MW 
._517bp 
Fig 4.4 - PCR assay under the conditions described in the text, showing the nature of amplification product obtained 
from the 3 different template preparations. 
Lanes 1 - 6, Miscellaneous test isolates 
Lane 7, E. coli DH5a 
Lane 8, Empty 
Lane 9, E. coli DH5a(pUC19) 
Lane 10, Distilled H20 
Lane 11, Empty 
Lane 12, Genomic DNA of E. coli 
DH5a(pUC19) 
Lane 13, Empty 
Lane 14, pUC19 
Lane 15, Empty 
Lane 16, No template 
MW, Molecular weight marker VI 
4.3.2 Detection of TEM- Related Genes in the Clinical Isolates 
PCR assays to detect TEM-related genes were carried out on all 45 clinical isolates 
described in chapter 2 using the conditions described above. The PCR products were 
stored at 4°C prior to detection by electrophoresis. DNA was extracted from all the 
isolates by emulsifying colonies in water, boiling for five minutes followed by 
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centrifugation at 14 000 rpm in a microfuge for 20- 30 seconds. The supernatant (5J.ll) 
was used as the template. 
The assays were carried out in triplicate and the results are shown in Table 4.3 and Figs 
4.5-i to 4.5-iii. An amplicon was obtained from colonies of E.coli DH5a(pUC19) in all the 
assays. No product was detected using the DNA from colonies of E. coli DH5a. Similarly, 
amplicons were not detected when distilled water was used as a template nor were they 
detected when no template was added to the PCR mixture. Amplicons were obtained from 
11 of the 45 isolates in all three assays, indicating the presence of a TEM related gene in 
these isolates. In two isolates (K35 and K39), an amplicon was detected in only one ofthe 
assays (Fig 4.6-i) . When the assay was repeated on these isolates no amplicons were 
detected (Fig 4.6-ii), and these two isolates were assumed not to contain a TEM-related 
gene. Amplicons were detected in 2 out of 3 assays containing template from isolate M46, 
one of which is shown in Fig 4.5-iii. A negative result was obtained in a repeat assay (Fig 
4.7). Nevertheless, this isolate was assumed to contain a TEM-related gene as a positive 
signal was obtained with the TEM probe in the hybridisation experiments [3. 3 .2 .1]. 
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MW K4 K8 K11 K16 K17 K18 K29 K35 K36 K39 K42 K43 K46 
517bp_. 
51 
Fig 4.5-i PCR assays perfonned on test isolates and controls. AGE performed at 10V/cm for 90 minutes. 
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K4, K. pneumoniae 
K8, K. pneumoniae 
Kll , K. pneumoniae 
K16, K. pneumoniae 
K17, K. pneumoniae 
K18, K. pneumoniae 
K29, K. pneumoniae 
K35, K. pneumoniae 
K36, K. pneumoniae 
K39, K. pneumoniae 
K42, K. pneumoniae 
K43, K. pneumoniae 
MW K50 K52 E N1 E P E N2 E N3 
K46, K. pneumoniae 
KSO, K. pneumoniae 
K52, K. oxytoca 
Nl, E. coli DH5a 
P, E coli DH5a(pUC19) 
N2, Distilled H20 
N3, No template 
E, Empty lanes 
MW, Molecular weight marker VI 
·-
MW K54 K58 K63 K68 K69 M9 MlO M20 M25 M26 M28 M30 M37 
Fig 4.5-ii PCR assay performed on test isolates and controls. AGE performed at lOV/cm for 90 minutes. 
95 
K54, K. pneumoniae 
K58, K. pneumoniae 
K63, K. pneumoniae 
K68, K. pneumoniae 
K69, K. pneumoniae 
M9, C. freundii 
MlO, C. sp. 
M20, C. sp. 
M25, K. pneumoniae 
M26, K. pneumoniae 
M28, K. pneumoniae 
M30, K. pneumoniae 
MW M40 M43 E 
517bp 
M37, E. cloacae 
M40, E. cloacae 
M43, P. agglomerans 
Nl , E. coli DH5a 
Nl E p 
P, E coli DH5a(pUC19) 
N2, Distilled H20 
N3, No template 
E, Empty lanes 
E N2 
MW, Molecular weight marker Vl 
E N 
MW M44 1 M442 M46 El E5 E7 E8 ElO El2 E13 E16 El7 E21 E37 E49 MW MW E Nl E p E N2 E N3 
517bp 
Fig 4.5-iii PCR assay perfonned on test isolates and controls. AGE performed at lOV!cm for 90 minutes. 
P, E coli DH5a.(pUC19) 
M44-1, Salmonella sp. ES, E. cloacae E12, E. cloacae E21, E. sp N2, distilled H20 
M44-2, Salmonella sp E7, E. cloacae E13, E. cloacae E37,E. sp N3, no template 
M46, S. marcescens E8, E. sp E16, E. cloacae E49, E. cloacae E, Empty lanes 
El, E. cloacae ElO, E sp. E17, E. cloacae Nl, E. coli DH5a. MW, Molecular weight marker v 
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517bp _. 
MW K4 K8 Kll Kl6 Kl7 Kl8 K29 K35 K36 K39 K42 K43 K46 
17bp __.. 
MW K50 K52 E Nl E p E 
Fig 4.6-i PCR assay performed on test isolates K4- K52 and controls, showing the presence of amplification product from the templates of isolates K35 and K39. 
K4, K. pneumoniae Kl7, K. pneumoniae K36, K. pneumoniae K46, K. pneumoniae P, E coli DH5a(pUCI9) 
K8, K. pneumoniae Kl8, K. pneumoniae K39, K. pneumoniae KSO, K. pneumoniae N2, Distilled H20 
Kll , K. pneumoniae K29, K. pneumoniae K42, K. pneumoniae K52, K. oxytoca E, Empty lanes 




MW K29 K35 K36 K39 E Nl E p E N2 E N3 
Fig 4.6-ii Repeat PCR assay perfonned on isolates K29, K35 , K36 and K39 after the results seen in Fig 4.6-i 
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K29 , K. pneumoniae 
K35, K. pneumoniae 
K36, K. pneumoniae 
K39, K. pneumoniae 
Nl, E. coli DH5a 
P, E. coliDH5a(pUC19) 
N2, Distilled H20 
N3, No template 
E, Empty 
MW, Molecular weight marker VI 
___. 
517bp 
MW M44 1 M442 M46 El ES E7 E8 ElO El2 El3 E16 E17 E21 MW E37 E49 E Nl E p E N2 E N3 
Fig 4.7 PCR assay performed on test isolates M44-1 to E49, showing the absence of an amplicon from isolate M46, compared to the amplicon detected previously (Fig 4.5-iii). 
P, E coli DHSa(pUC19) 
M44-1 , Salmonella sp. ES, E. cloacae El2, E. cloacae E21, E. sp N2, distilled H20 
M44-2, Salmonella sp E7, E. cloacae E13, E. cloacae E37, E. sp N3, no template 
M46, S. marcescens E8, E. sp El6, E. cloacae E49, E. cloacae E, Empty lanes 




Summary of results ofPCR assays for detection ofTEM-related genes 
Isolate Itlentit~ Assay Assa~ Assay Isolate Itlentit~ Assay Assay Assay 
1 2 3 1 2 3 
K. pneumoniae N N N K. pneumoniae N N N 
N N N K. pneumoniae N N N 
K. pneumoniae p p p K. pneumoniae N N N 
N N N K. pneumoniae N N N 
N N N E. cloacae N N N 
N N N E. cloacae N N N 
p p p P. agglomerans p p p 
N N P::::>N Salmonella sp. p p p 
N N N Salmonella sp. p p p 
K. pneumoniae N N P=>N S. marcescens p p N=>N 
p p p E. cloacae N N N 
p p p E. cloacae N N N 
N N N E. cloacae N N N 
p p p E. sp. N N N 
N N N E. sp. N N N 
N N N E. cloacae N N N 
K. pneumoniae N N N E. cloacae N N N 
p p p E. cloacae N N N 
p p p E. cloacae N N N 
p p p E. sp. N N N 
N N N E. sp. N N N 
N N N E. cloacae N N N 
N N N 
p p p N N N 
Those results in boldface are those for which a discrepancy between the first two and third sets ofPCR 
results was noted (see text). 
N = No amplicon detected P = amplicon detected 
Assay 1,2 and 3 are the 1•\ 2nd and 3rd sets ofPCR assays performed on the isolates. 
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TEM related genes were detected in 11 of the 45 isolates using the PCR assay- Kll, 
K29, K42, K43, K50, K63, K68, K69, M43, M44-1 and M44-2. These results 
correlate almost perfectly with the results of the slot-blot hyb~disation experiments 
using the TEM probe. The only discrepancy arises when the PCR and hybridisation 
results on isolate M46 are compared. A TEM-related gene was detected by 
hybridisation in this isolate, but PCR assays detected the gene inconsistently. The 
reason for the failure of the PCR assays to consistently detect the gene is unknown. 
Two of the isolates (M43 and M46) that were shown to contain TEM-related genes 
were not shown to be ESBL producers by either the double disc diffusion test or the 
Etest ESBL screen. [2.3]. This suggests that the TEM-related genes in these isolates 
are TEM-1 or TEM-2. However, it is noteworthy that the ceftazidime and 
ceftazidime/clavulanate MICs of M43 (P. agglomerans) were >32~g/ml and >8~g/ml 
respectively. This is analogous to the MIC results of isolate K8 [2.4] where the 
presence of an ESBL cannot be excluded since the MICs of both antibiotics for that 
isolate are higher than the upper limit that can be determined by the Estrip, and a ratio 
cannot be calculated. In the case of isolate M46 (S. marscecens) the MICs of the two 
agents were 12~g/ml and >8~g/ml respectively, which is certainly not indicative of the 
presence of an ESBL. 
The ease of sample preparation makes the PCR assay eminently suitable for use in a 
clinical laboratory. The cost of the equipment is not expensive, and the total time 
involved in carrying out the assay, from sample preparation to detection, is 
approximately 3,5 to 4 hours. It could quite easily be used to determine the number of 
TEM and non-TEM related enzymes in a hospital setting. 
During the course of this study, contamination was a problem, and this is probably the 
largest drawback to the use of PCR. The primers in this study were thought to have 
been contaminated by pUC19 (or a similar TEM-1 containing plasmid vector). These 
plasmids are widely used in molecular biology laboratories and it is easy to envisage 
the accidental introduction of such a plasmid into the primer stock solution. The 
problem was overcome by pre-digestion of the PCR mixture with A vall, and 
underscores the need for adequate controls and dedicated areas and equipment for the 
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setting up and performing ofPCR. Nevertheless, the PCR assays as described detected 
TEM-related genes in clinical isolates with a high degree of reliability, and a minimum 
of difficulty. 
4.3.3 Results of Optimisation of PCR to Detect SHV Related Genes 
First Set of Primers (SHV-A and SHV-B) 
As with the optimisation of the PCR assays usmg the TEM specific pnmes, 
optimisation with both sets of SHV specific primers was carried out using templates 
consisting of purified plasmid DNA extracted from E. coli Kl2 (SHV-1), E. coli Kl2 
(SHV -2) and DNA extracted from colonies of the same organisms by boiling and 
centrifuging the colonies. Negative controls were included in all assays and these were 
similar to those used in the TEM-related PCR assays, although the TEM producing 
control (E. coli DH5a(puc19)) was used as a negative control. The results of the 
optimisation assays with both sets of primers are discussed below. 
4.3.3.1 Parameters Using SHV-A and SHV-B 
Conditions for a PCR assay with the primers SHV-A and -B using DNA from the 
control strains were determined relatively quickly, and the results of these optimisation 
assays are presented below in Table 4.4. 
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Table 4.4 
Primer Denaturing Annealing dNTPs Product from 
(J.lM) Temperature ("C) Temperature (OC) (J.lM each) Plasmid Colonies 
0,2 94 60 200 + 
0,4 94 60 200 + (2) . (2) 
0,6 94 60 200 + (2) 
0,8 94 60 200 + 
0,4 95 55 200 + 
0,4 95 60 200 + 
Numbers in paren1heses indicate 1he number of occasions on which the assay was performed 
+ = presence of an amplicon 
- = no amplicon detected 
i) Primer Concentration 
The correct sized amplicon was obtained from plasmid DNA template when pnmer 
concentrations of 0,4; 0,6 and 0,811M were used, and significantly less (lane 1, Fig 4.8) 
obtained using a primer concentration of 0,2uM. Using the same parameters (Table 
4.4) and a primer concentration of 0,4!lM no product was obtained with DNA 
prepared from colonies of E. coli K12 (SHV-1), on two occasions. However, when the 
denaturing temperature was raised to 95°C, amplicons were obtained from colony 
preparations using a primer concentration of 0,4!lM (Fig 4.9). 
653bp 
_____. 
MW 2 3 4 
Fig 4.8- PCR assay using plasmid DNA prepared from E. coli Kl2(SHV-l) as a template. The thennal profile 
consisted of 40 cycles of denaturation at 94°C, annealing at 60°C and extension at 72°C. dNTPs were 
used at 2001-!M each and primer concentrations varied. 
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MW, Molecular weight marker VI, with the position of one of the fragments illustrated. 
Lane 1, Primer concentration 0,2uM 
Lane 2, Primer concentration 0,4uM 
Lane 3, Primer concentration 0,6uM 
Lane 4, Primer concentration 0,8uM 
653bp 
_____. 
MW 2 3 4 5 6 7 
Fig 4.9 - PCR assay using template prepared by boiling SHY-containing control strains, and increasing the 
denaturation temperature to 95°C, with mmealing at 55°C and extension at 72°C. Primer concentration 
0,41.lm, dNTP concentration 2001.1M 
MW, Molecular weight marker VI 
Lane 1, E. coli RI010-6(SHV-l ) 
Lane 2, E. coli K l2(SHV-l) 
Lane 3, E.coli Kl2(SHV-2) 
ii) Annealing Temperature 
Lane 4, E. coli DH5a 
Lane 5, E. coli DH5a(pUC19) 
Lane 6, Distilled water 
Lane 7, No template 
Arnplicons were produced at an annealing temperature of 60°C usmg a variety of 
primer concentrations, different denaturing temperatures and different template 
preparations. 
iii) Denaturing Temperature 
As mentioned previously, ra1smg the annealing temperature from 94°C to 95°C 
resulted in successful amplification of DNA from templates prepared from colonies 
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(Figs 4.8 and 4.9). It is interesting that the denaturing temperature of 94°C resulted in 
amplification using plasmid DNA as the template. 
In summary, the following conditions were initially found to result in the production of 
the correct sized amplicon from templates prepared by boiling and centrifugation of 
colonies (Fig 4.10) and using primer and dNTP concentrations of 0,4JlM and 200J.!M, 
respectively. An initial denaturing step of 5 minutes at 95°C was followed by 40 cycles 
of 95°C (30s), 60°C (45s) and 72°C (50s) (denaturing, annealing and extension 
respectively) followed by final extension at 72°C for 7 minutes. Storage and detection 
were carried out as before [ 4.3 .2]. 
MW 2 3 4 5 6 
653bp _____. 
Fig 4.10- PCR assay using SHY primers. Denaturation performed at 95C for 5 minutes, followed by 40 cycles of 
denaturation (95°C for 30s), mmealing (60°C for 45s) and extension (72°C for 50s), and a fmal 
extension at noc for 7 minutes. Primers used at 0,2JlM each and dNTPs at 200JlM each. 
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MW, Molecular weight marker VI 
Lane l, E. coliRl010-6(SHV-l) 
Lane 2, E. coli Kl2(SHV-l) 
Lane 3, E. coli Kl2(SHV-2) 
Lane 4, E. coli DH5a(pUC19) 
Lane 5, Distilled water 
Lane 6, No template 
The assay as described above was performed on the 45 test isolates. The appropriate 
sized amplicons were obtained from colonies of one of the positive controls and no 
amplicons were detected from the negative controls. However, the amount of amplicon 
produced, judged by the intensity of the band on the agarose gel, varied from assay to 
assay (Fig 4.11-i to 4.11-iii). Similarly, the results of the assays on the 45 isolates were 
not consistent from one assay to the next (Fig 4.11-i to 4.11-iii; Table 4.5). 
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Table 4.5 
Summary of results ofPCR assays for detection of SHV -related Genes 
Isnlntc Identity Assny Assay Assny Isolate Identity Assny Assny Assay 
I 2 3 1 2 3 
p p N K. pneumoniae p N NR 
p p Weak K. pneumoniae p Weak NR 
p p p K. pnewnoniae p Weak NR 
N p p K. pneumoniae p p NR 
N p p E. cloacae N N NR 
N p p E. cloacae p p NR 
p p p P. agglomerans N N NR 
N p p Salmonella sp. p p NR 
p N N Salmonella sp. p p NR 
p N N S. marcescens N N NR 
p N N E. cloacae N N NR 
N p N E. cloacae N N NR 
p p p E. cloacae N N NR 
p p N E. sp. N N NR 
N N N E. sp. N N NR 
p p NR E. cloacae N N NR 
p p NR E. cloacae N N NR 
p p NR E. cloacae N N NR 
p p NR E. cloacae N N NR 
p p NR E. sp. N N NR 
N N NR E. sp. N N NR 
N N NR E. cloacae p N NR 
N N NR 
p p P*/NR p p 
N N N N N NR 
N =No amplicon detected 
P*INR = Amplicons detected from positive control of assays involving isolates K4 - K52, and no amplicons 
detected from positive controls of assays involving isolates K54- E49. 
NR = No amp !icon obtained from controls or test isolates 
Weak= A faint band ofDNA (of the correct size) was visible on the EtBr stained gel. 
Positive control= E. coli Kl2 (SHV-1) or E. coli Kl2(SHV2) 
Negative control =E. coli DH5a (pUC19) 
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653bp ___. 
MW K4 K8 Kll Kl6 Kl7 Kl8 K29 K35 K36 K39 K42 K43 K46 
653bp ___. 
MW KSO K52 E Nl E Pl P2 E N2 E N3 
Fig 4.11 -i 2 sets of PCR assays (A this page and B overleaf) performed on isolates K4 - K52 . Note the different intensities of the DNA bands in the two sets of results, as well as the 
differences in which isolates produced an amplicon. AGE performed at 1 OV /em for 90 minutes. 
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K4 , K. pneumoniae 
KS, K. pneumoniae 
Kll, K. pneumoniae 
K16, K. pneumoniae 
Kl7, K. pneumoniae 
K18, K. pneumoniae 
K29, K. pneumoniae 
K35, K. pneumoniae 
K36, K. pneumoniae 
K39, K. pneumoniae 
K42, K. pneumoniae 
K43, K. pneumoniae 
K46, K. pneumoniae 
KSO, K. pneumoniae 
K52, K. oxytoca 
Nl, E coli DH5a(pUC19) 
Pl , E coli Kl2(SHV-1) 
P2, E. coli Kl2(SHV-2) 
N2, Distilled H20 
N3, No template 
E, Empty lanes 
MW, Molecular weight marker Vl 
MW K4 K8 K11 K16 K17 K18 K29 K35 K36 K39 K42 K43 K46 
653bp 
Fig 4. 11-i 2"d set ofPCR assays (B) perfonned on isolates K4- K52. 
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K4, K. pneumoniae 
K8 , K. pneumoniae 
Kll , K. pneumoniae 
K16, K. pneumoniae 
K17, K. pneumoniae 
K18, K. pneumoniae 
K29, K. pneumoniae 
K35, K. pneumoniae 
K36, K. pneumoniae 
K39, K. pneumoniae 
K42, K. pneumoniae 
K43 , K. pneumoniae 
MWKSO K52 E Nl E 
K46 , K. pneumoniae 
KSO, K. pneumoniae 
K52, K. oxytoca 
1, E coli DH5a(pUC19) 
Pl , E coli K12(SHV-I) 
Pl P2 E N2 E N3 
P2, E. coli K12(SHV-2) 
N2, Distilled H20 
N3, No template 
E, Empty lanes 
MW, Molecular weight marker VI 
635bp ______. 
MW K54 K58 K63 K68 K69 M9 M1 0 M20 M25 M26 M28 M30 M37 
635bp --. 
MW M40 M43 E N1 E P1 P2 E N2 E N3 
Fig 4.11-ii 2 sets of PCR assays (A this page and and B overleaf) performed on isolates K54- M43 . Note the different intensities of the DNA bands in the two sets of results, as well as the 
differences in which isolates produced an amplicon. AGE performed at 1 OV/cm for 90 minutes 
M37, E. cloacae P2, E. coli K12(SHV-2) 
K54 , K pneumoniae K69, K pneumoniae M25, K pneumoniae M40, E. cloacae N2, Distilled H20 
K58, K pneumoniae M9, C.freundii M26, K pneumoniae M43, P. agglomerans N3, No template 
K63 , K pneumoniae MlO, C. sp. M28, K pneumoniae Nl, E coli DH5a(pUC19) E, Empty lanes 
K68, K pneumoniae M20, C. sp. M30, K pneumoniae Pl, E coli K12(SHV-1) MW, Molecular weight marker VI 
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MW K54 K58 K63 K68 K69 M9 M10 M20 M25 M26 M28 M30 M37 MW M40 M43 E N1 E P1 P2 E N2 E N3 
653bp 
653bp---+ 
Fig 4.11-ii 2ND set ofPCR assays (B) performed on isolates K54- M43. 
M37, E. cloacae P2, E. coli K12(SHV-2) 
KS4, K. pneumoniae K69, K. pneumoniae M25, K. pneumoniae M40, E. cloacae N2, Distilled H20 
KS8, K. pneumoniae M9, C. freundi i M26, K. pneumoniae M43, P. agglomerans N3, No template 
K63, K. pneumoniae MlO, C. sp. M28, K. pneumoniae Nl, E coli DHSa(pUC19) E, Empty lanes 
K68, K. pneumoniae M20, C. sp. M30, K. pneumoniae Pl, E coli K12(SHV-1) MW, Molecular weight marker VI 
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MW M441 M442 M46 El ES E7 E8 ElO E12 E13 E16 E17 E21 MW E37 E49 E Nl E Pl P2 E N2 E N3 
653~ 
Fig 4.11-iii PCR assay performed on test isolates M44-1- E49. AGE performed at lOV/cm for 90 minutes. 
E21, E. sp P2, E. coli K12(SHV-2) 
M44-l , Salmonella sp. ES, E. cloacae E12, E. cloacae E37, E. sp N2, distilled H20 
M44-2, Salmonella sp E7, E. cloacae E13, E. cloacae E49, E. cloacae N3, no template 
M46, S. marcescens E8,E. sp E16, E. cloacae Nl , E. coli DH5a(Puc19) E, Empty lanes 
El, E. cloacae ElO, E sp. El7, E. cloacae Pl, E coli K12(SHV-1) MW, Molecular weight marker Vl 
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On repeating some of the assays for the third time, no amplicon was obtained from 
either the positive controls or the test isolates. These assays were repeated and once 
again no amplicon was obtained. Given the inconsistency of the results, a further round 
of more extensive optimisation assays was carried out. The results of the further 
optimisation assays are shown in Table 4.6 followed by a discussion of the results of 
the changes in the various parameters. The table shows the effects of variation in 
primer and dNTP concentration as well as annealing and denaturing temperatures. The 
results ofthe initial optimisation assays (Table 4.4) have been included in this table to 
allow for better comparison of various conditions. 
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Table 4.6 
Primers Denaturing Annealing dNTPs 
(f!M) temperature temperature (f!M each) Product obtained from 
(DC) ec) 
Plasmid DNA Colonies 
0,2 94 50 100 Yes Yes 
200 No No 
300 No No 
400 No No 
57 100 Faint No 
200 No 
400 No 
60 100 No 
200 No 
200 Faint Faint 
300 No 
95 55 200 Yes 
60 200 Yes 
0,4 94 48 200 Yes 
50 100 Yes Yes 
200 No No 
300 No No 
400 No No 
57 100 Yes 
200 No 
400 No 
60 100 No (3) No (1) 
Yes (1) 
200 No (7) No (4) 
Yes (2) Yes (1) 
300 No (2) 
400 No ~32 No ~22 
95 55 200 Faint Yes (2) 
55 400 No 
55,5 200 Yes Faint 
56 200 No No 
57 200 No 
60 200 No (4) No (2) 
Yes 3 
0,6 94 50 100 Yes Yes 
200 No No 
300 No No 
400 No No 
57 100 Faint 
200 Yes 
400 No 
60 100 No (2) No (3) 
Yes (3) Yes (1) 
200 No (3) No (5) 
Faint (4) Yes (2) 
300 No (2) No (2) 
400 No (3) No (3) 
Numbers in parentheses indicate the number of assays performed that gave a particular result 
Faint= A faint band of the correct sized DNA was visualised on EtBr stained agarose gels. 
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iv) Primers, Annealing Temperature and dNTP Concentration 
The use of primers at a concentration of 0,2).l.M resulted in amplification of the 
expected fragment of DNA at annealing temperatures of 55°C and 60°C and a 
denaturing temperature of 95°C. However, these results were not reproducible. 
Despite utilising a range of annealing temperatures (50°C - 60°C) and dNTP 
concentrations (100 - 400).l.M), a reliable amplification could not be achieved with a 
primer concentration of 0,2).l.M. 
Increasing the primer concentration to 0,4).l.M resulted in the expected amplicon at an 
annealing temperature of 57°C and a dNTP concentration of 100).l.M. Increasing the 
annealing temperature to 60°C also resulted in amplification of DNA from both 
plasmid DNA and colonies, this time with a dNTP concentration of 200).l.M. 
Unfortunately this too was not reproducible, the amplification product being produced 
in only two out of nine assays using plasmid DNA and one out of five assays using 
DNA extracted from colonies (Table 4.6). 
The denaturing temperature was again increased to 95°C, with primer concentrations 
of 0,4).l.M. Assays using annealing temperatures from 55°C - 57°C, with dNTPs at 
200).l.M and 400).l.M were carried out, but these conditions resulted in either additional 
non-specific amplicons (TA 55°C), only small amounts of amplification products or no 
product at all. When the annealing temperature was increased to 60°C (dNTP 200).l.M), 
no product was obtained from purified pDNA. However, amplicons of the expected 
size were obtained from boiled and centrifuged colonies in three out of five assays. In 
the assays using purified plasmid DNA a fresh stock of Taq polymerase and dNTPs 
was used after the initial negative assays. This did not result in successful amplification 
of the expected fragment. 
No amplification of the expected fragment was achieved using primer concentrations 
of 0,6).l.M at an annealing temperature of 50°C (dNTPs ranging from 100- 400).l.M). 
Raising the annealing temperature to 57°C resulted in a variable amount of product 
with dNTPs at lOO).l.M or 200).l.M, but with the formation of additional products at 
both dNTP concentrations. At an annealing temperature of 60°C, inconsistent results 
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were attained with dNTP concentrations of 1001JM and 2001JM, and no amplification 
achieved with either 3001JM or 4001JM. At 1001JM dNTP, three out of five assays 
using plasmid DNA and one out of four assays using DNA from colonies yielded 
amplicons. In a similar vein, four of seven assays using plasmid DNA and two of seven 
assays using boiled colonies were successful with a dNTP concentration of2001JM. 
The duration of the annealing step was initially 30 seconds, but was subsequently 
increased to 45 and then 50 seconds. Although it is difficult to comment on the value 
of increasing the annealing time given the inconsistencies of the results, the changes did 
not appear to have any long-lasting effects on the reliability ofthe assay. 
v) Denaturation and Extension 
Raising the denaturating temperature to 95°C did appear to improve the consistency of 
the yield of PCR product, particularly at a higher annealing temperature (60°C). 
However these results were again not reliable in the long term. Denaturation was 
carried out for 30 seconds at both 94°C and 95°C. Extension was initially performed 
for 50 seconds, and was increased to 60 seconds. The theory behind this change is 
based on the fact that the shorter time may not have allowed extension to continue to 
completion, with the formation of only partially synthesised amplicons. However, this 
alteration had no noticeable effect on the assay. 
vi) Number C?f Cycles 
In the initial experiments the number of cycles ranged from 3 0 to 3 5 with no noticeable 
effect. Subsequent experiments were performed using 40 amplification cycles in an 
attempt to increase the yield of product, with little success. 
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4.3.3.2 Template 
Both purified plasmid DNA extracted from the positive controls and DNA extracted 
from colonies of the positive controls were used in some of the optimisation 
experiments. This was done since the chance of impurities affecting the PCR reaction 
would be less with plasmid DNA, while the colony DNA extractions are easier to 
prepare and it was hoped that the assays on the clinical isolates would be carried out 
using this form of template. 
The initial results ofPCR assays using both plasmid DNA and colonies as the template 
were promising, with good yield obtained from both. (Figs 4.8- 4.1 0). As described in 
section 4.3 .3 .1 (iv) the further results using plasmid DNA were not consistent. The use 
of plasmid DNA as the template did yield positive results when the colony preparations 
were negative but this situation was reversed on occasion. This lack of consistency 
proved to be the most troublesome factor in these experiments. 
Although it is difficult to ascribe the inconsistencies usmg plasmid DNA to the 
template alone, there was a possibility that templates prepared from the colonies may 
have been insufficient and contain inhibitory substances. For this reason, assays using 
colony suspensions boiled for fifteen minutes were attempted, on the basis that boiling 
for longer may have released more DNA and also eliminated any potential inhibitory 
substances. Plasmid and genomic DNA from the controls were used in these assays, 
which were carried out with primer concentrations of 0,4f.!M, dNTP concentrations of 
200f.!M and denaturing and annealing temperatures of95°C and 60°C, respectively. 
The results showed the production of the expected amplicon usmg the colony 
preparations, although less product was amplified from both plasmid and genomic 
DNA templates. This result using genomic DNA was not entirely surprising given the 
similar lack of success with this template i_n the TEM series of experiments. The lack of 
results with the plasmid DNA was unexpected and no explanation could be found for 
this. Although boiling colonies for 15 minutes initially seemed to be a useful strategy, 
further assays using this method once again proved unreliable. 
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Despite extensive optimisation experiments, conditions that would result in reliable 
amplification of SHY-related genes using primers SHV-A and SHV-B could not be 
determined. 
4.3.4 Results of Optimisation of PCR to Detect SHV Related Genes 
Second Set of Primers (SHV-C and SHV-D) 
The same controls were used in these optimisation assays as were used with the first 
set of SHV primers [4.3.3], with templates consisting of both plasmid DNA and 
colonies prepared by boiling and centrifugation. 
4.3.4.1 Parameters Using the Second Set of Primers 
The results of the optimisation assays using the primers SHV-C and SHV-D are 
presented in Table 4.7. No product of the correct size was obtained at any of the 
parameters using primers SHV-C and SHV-D. 
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Table 4.7 
Optimisation ofPCR assay using SHV-C and SHV-D 
Template PrimerptM dNTP ptM Denaturing Annealing Amplicon 
Plasmid' 0,2 100 95°C 50°C Nil 
200 
300 
Plasmid' 0,4 100 95°C 50°C Nil 
200 
300 
Plasmid' 0,6 100 95°C 50°C Nil 
200 
300 
Plasmid 0,4 200 94°C 55°C Nil 
Colonies 0,4 200 94°C 45°C Wrong size 
Colonies 0,2 100 94°C 50°C Nil 
200 
300 
Colonies 0,4 100 94°C 50°C Nil 
200 
300 
Colonies 0,6 100 94°C 50°C Nil 
200 
300 
Colonies 0,4 200 94°C 53°C Wrong size 
Colonies 0,2 100 94°C 55°C Nil 
200 
300 
Colonies' 0,4 100 94°C 55°C Nil 
200 
300 
Colonies 0,6 100 94°C 55°C Nil 
200 
300 
Colonies 0,4 100 95°C 55°C Nil 
200 
300 
Colonies 0,4 200 94°C 60°C Wrong size 
a- These assays were repeated with negative results 
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4.3.5 Detection of SHV - Related Genes in the Clinical Isolates 
The results of the PCR assays for the detection of SHV related genes were 
disappointing. The first set of primers were designed to anneal to SHV related genes in 
areas where there was as little homology as possible with LEN-1, and the 3' ends of 
both primers contained mismatches with the LEN-1 gene. Certain primer/template 
mismatches (C-C, G-A, A-G) have been shown to reduce the product yield from the 
primer-template pairing to less than 1%, while an A-A mismatch reduces the product 
approximately 20-fold (Kwok et al., 1990). SHV-A and SHV-B each contain one A-G 
mismatched nucleotide pair at the 3' end. While there are also two T -C mismatches at 
the 3' end of SHV -B, these mismatches are not thought to be as critical in preventing 
annealing and extension in PCR assays. 
Despite the mismatches, the data suggest that the primers annealed to the LEN-1 gene 
as well as SHY-related genes. The results ofthe initial assay (Table 4.5) showed that 
an amplicon was produced from all of the K. pneumoniae isolates on at least one 
occasion, a situation similar to that seen with the results of hybridisation using the 
SHV probes [3. 3. 3 .1]. One method of proving that the primers were also annealing to 
LEN-1 would have been to extract plasmid DNA from the clinical isolates and 
compare PCR assays on the plasmid DNA to assays on genomic DNA extracted from 
the colonies. Since the assay using purified plasmid DNA from the controls yielded 
equivocal results, this experiment was not carried out. 
Importantly, the results obtained from the isolates other than K. pneumoniae do 
correlate with the hybridisation results on the same isolates. Specifically, amplicons 
were obtained from the 2 Salmonella isolates (M44-1 & M44-2) and 2 strains of E. 
cloacae (M40 & E49). It is noteworthy that an amplicon was obtained from isolate 
E49 (E. cloacae) in only one of the two assays performed on this isolate, which 
indicates, yet again, the inconsistent nature of the PCR assay in this study. 
No amplification product was obtained usmg the pnmers (SHV-C and SHV-D) 
described by Nuesch-Inderbinen et al. (1996). This is in contrast to the work done by 
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these workers where the assay was successfully used both to detect SHV -related genes 
and to distinguish genes coding non-ESBL enzymes from those coding for ESBLs. The 
fact that the primers anneal to sequences flanking the structural SHY gene and not the 
gene itself may, at least to some extent, be part ofthe explanation. 
Taken together, these data suggest that PCR could be useful for the detection of SHV-
related genes in Enterobacteriaceae other than K. pneumoniae. The technique is more 
"user friendly" than DNA-DNA hybridisation and would be suitable for use in a 
diagnostic laboratory with the caveat: PCR may be a quick and easy technique but it 
can also be unreliable if not adequately optimised, and optimisation itself is not always 





Transfer of genetic information from one bacterial species to another can occur by 
transformation, transduction or conjugation. Transformation is the uptake of free DNA 
from the environment by naturally competent cells (Davis, 1980). 
Transduction is a process whereby bacteria acquire DNA through the action of a 
bacteriophage. These viruses specifically infect bacterial cells and utilise the organism's 
own cellular "machinery" to synthesise new viral protein coats as well as viral nucleic 
acid. When viral particles are reassembled, fragments of bacterial DNA may be 
accidentally incorporated into the viral genome and can subsequently be introduced 
into other bacteria (Boyd & Marr, 1980b). 
Conjugation relies on the presence of transmissible plasmids within orgamsms to 
transfer DNA from one cell to another. Following cell to cell contact, plasmid DNA is 
transferred through a pilus from one organism to another. It is important to remember 
that the transfer is unidirectional i.e. one organism acts as a donor and the other as a 
recipient. Self-transmissible plasmids, which contain the genes required for 
conjugation, including synthesis of a pilus, also often contain antibiotic resistance 
determinants and are a major cause of the spread of resistance, especially in the 
hospital environment. Conjugation is the commonest mechanism of gene transfer 
among members of the Enterobacteriaceae (Boyd & Marr, 1980b; Davis, 1980). 
Resistance to beta lactams mediated by plasmid mediated TEM- and SHV -related 
ESBLs has frequently been shown to be transferable. (Jarlier et al., 1988; Nicolas et 
al., 1989; Petit et al., 1990; Barguellil et al., 1995; Sirot, 1995). Conjugation 
experiments were carried out in order to ascertain whether the TEM- and SHV -related 
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genes identified in this study are carried on self-transmissible plasmids. Since equivocal 
results were obtained when looking for SHV -related genes in isolates of K. 
pneumoniae, all these isolates were included. 
5.2 MATERIALS AND METHODS 
5.2.1 Conjugation 
5. 2.1.1 Bacterial strains 
i) Recipient 
E. coli J53 (NalR) was used as the recipient organism in the conjugation experiments. 
ii) Donors 
All the isolates containing either TEM- or SHV -related genes (demonstrated by PCR 
or hybridisation) were used as donors in the conjugation experiments. As mentioned, 
all the isolates of K. pneumoniae were included in the experiments. A total of 29 
isolates were used as donor strains. Sensitivity of the donors to nalidixic acid was 
confirmed by inoculating all the donors onto YT agar containing nalidixic acid at 
50J.!g/ml and lOOJ.!g/ml and assessing growth after 18 hours incubation at 37°C. 
5.2.1.2 Bacterial Conjugation 
Conjugation studies were carried out to determine whether resistance to ampicillin 
could be transferred from the donors to the ampicilllin-sensitive E. coli recipient. An 
overnight culture of E. coli J53 was diluted 1:100 in YT broth and incubated at 37°C 
for 4 hours with agitation. Overnight cultures of the donors were diluted 1: 10 in YT 
broth and incubated for 2 hours at 37°C without agitation. Four drops of each donor 
and 5 drops of the recipient were combined on MH agar and left undisturbed for two 
hours at room temperature to allow conjugation to take place. This was followed by 
incubation for 18 hours at 37°C 
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The cells were washed off the agar with physiological saline (1 Oml), harvested by 
centrifugation at 3 OOOrpm for 15 minutes (Beckman GS-6 centrifuge with bucket 
rotor) and resuspended in 0,5ml physiological saline. Aliquots (100!11) of this 
suspension were inoculated onto selective media containing ampicillin (200!lg/ml) and 
nalidixic acid (100!lg/ml) and incubated overnight at 37°e. 
The transconjugants were identified on the basis of the distinctive colonial morphology 
of E. coli on Maceonkey agar and single colonies were inoculated into YT broth and 
incubated at 37°e. When growth was confluent and discrete colonies were not evident, 
a sweep of organisms was inoculated into YT broth containing ampicillin (1 OO!lg/ml) 
and nalidixic acid (100!lg/ml) and incubated at 37°e overnight, followed by inoculation 
onto Maceonkey agar and incubation at 37°e. After 18 hours the Maceonkey agar 
was examined for the presence of single colonies and these cultured as above. 
5.2.2 Characterisation of Transconjugants by DNA-DNA 
Hybridisation 
5.2.2.1 Transfer of DNA to a Stable Matrix 
DNA was transferred from agarose gels to a nylon membrane (Hybond ~, Amersham 
UK) by capillary transfer (Southern, 1975; Smith & Summers, 1980) as described 
below. The agarose was soaked twice in 0,25M Hel for 15 minutes to depurinate the 
DNA and thereby aid the transfer oflarge fragments of DNA The DNA in the gel was 
then denatured by soaking it twice in a solution of 1,5M Nael 0,5M NaOH and 
neutralisation was achieved by soaking the gel twice in 1,5M Nael 0,5M Tris-Hel pH 
7,4. 
The DNA was transferred to the nylon membrane by means of capillary transfer using 
20xSSe as the transfer buffer and filter paper as a wick. A strip of Whatman 3M filter 
paper was placed on a perspex sheet in a bath of 20xSSe with its free ends submerged 
in the SSe. The gel was placed on top of this filter paper, with the gel not in contact 
with the SSe. An appropriately sized piece of nylon membrane (Hybond N+) was 
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placed on top of the gel and then covered by three pieces of Whatman 3M filter paper 
soaked in 20xSSC. Folded up paper towel about 5 em thick was placed on top, and the 
whole covered by a second piece ofperspex and a brick (Fig 5.1). DNA transfer was 
allowed to occur overnight. The following day the apparatus was dismantled and the 
DNA cross linked to the nylon membrane by exposure to 254nm UV light [3 .2.2.1]. 
Where necessary, the membranes were stored in sealed plastic at 4°C until such time as 






'------- filter paper 
'-----------box 
Fig 5.1 Set-up of apparatus used for Southern transfer of DNA The nylon membrane, covered with 3 pieces of 
filter paper, lies between the gel and the folded up paper towel. 
5.2.2.2 DNA-DNA Hybridisation 
The probe specific for TEM-related genes [3.2.3] was hybridised to the DNA 
transferred to the nylon membranes. Similarly, the PCR generated probe [3 .2.4] 
labelled with the ECL chemiluminescent label [3.2.5.1] was used in hybridisations to 
detect SHV -related genes. 
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5.3 RESULTS 
5.3.1 Bacterial Conjugation 
As expected, the recipient, E. coli J53 NaiR, did not grow on the selective medium 
containing ampicillin and nalidixic acid. None of the donors grew on agar containing 
nalidixic acid at lOO!J.g/ml. However, after conjugation, 3 of the 29 donor isolates 
showed scanty growth (maximum of 11 colonies) on the selective media. The 
morphology of these isolates was sufficiently distinct from that of E. coli J53 to make 
selection of transconjugants possible. 
Following conjugation, putative transconjugants were isolated from each of the 29 
crosses. Single colonies were successfully cultured from 20 of the transconjugants, but 
despite repeated attempts, the remaining 9 transconjugants could not be cultured 
further in broth suggesting that the plasrnids may be unstable in E. coli. 
5.3.2 - Antibiotic Susceptibility of Transconjugants 
To determine the beta lactam resistance profile of the transconjugants, ceftazidime, 
cefotaxime and ceftazidime/clavulanic acid MICs were determined using E-strips [2.2] 
as shown in Table 5.1. 
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Table 5.1 
ISOLATE CEFOTAXIME CEFTAZIDIME CEFTAZICLA V ESBL 
R~4 S.58J1glml R~2 S.58J1glml PRESENCE 
donor tconj donor tconj donor tconj donor tconj 
K4 K. pneumoniae 1,5 0,75 8 0,75 0,75 0,75 Yes No 
K8 K. pneumoniae >256 R 0,38 >32 R 1,5 >8 1,5 No A No 
Kll K. pneumoniae 3,0 0,25 12 I 1,5 0,75 1 Yes No 
K16 K. pneumoniae 12 I 0,25 12 I 1 0,75 1 Yes No 
K29 K. pneumoniae 2,0 2,0 >32 R >32 R 0,38 1,5 Yes Yes 
K42 K. pneumoniae 0,5 1,5 >32 R >32 R 0,5 4 Yes Yes 
K43 K. pneumoniae 12 I 6 8 8 0,125 0,75 Yes Yes 
K46 K. pneumoniae 16-24 I 4 >32 R >32 R 0,75 1,5 Yes Yes 
K50 K. pneumoniae 4 2 >32 R 6 1-1,5 1,5 Yes B 
K54 K. pneumoniae >256 R 0,25 >32 R 1,5 0,75 1,5 Yes No 
K63 K. pneumoniae 3 1,5 >32 R >32 R 0,5 6 Yes Yes 
K68 K. pneumoniae 2 0,25 24 I 1,5 1,5 1,5 Yes No 
K69 K. pneumoniae 6-8 0,5 >32 R 0,5 0,5 0,5 Yes No 
M26 K. pneumoniae 1,0 1,5 2,0 0,75 0,38 0,5 Yes No 
M30 K. pneumoniae 8 1,5 12 I 6 0,5 0,5 Yes Yes 
M40 E. cloacae 4 1,5 >32 R >32 R 1,0 1,5 Yes Yes 
M44-1 Salmonella sp. 16 I 0,19 >32 R 0,5 . 0,75 0,38 Yes No 
M44-2 Salmonella sp. 16 I 0,19 >32 R 0,5 0,75 0,5 Yes No 
M46 S. marcescens 64 R 1,5 12 I >32 R >8 1,5 No Yes 
E49 E. cloacae 4 1,0 8 0,75 0,25 0,5 Yes No 
E coli J53 0,032 <0,5 0,125 No 
MICs in Jlg/ml Unless stated, the MICs represent sensitivity to cefotaxime or ceftazidime. No 
criteria exist for the ceftazidime/clavulanate combination 
I = intennediate susceptibility 
Tconj = transconjugant 
R = resistant 
A- Section 2.5 for discussion of the ESBL in isolate K8 
B -Ratio of ceftazidime to ceftazidime/clavulanate =4, borderline for presence ofESBL. 
The results of the MIC testing show a number of interesting features. Firstly, 
comparison of the MICs of various beta lactams for the transconjugants and the 
corresponding donors shows very little correlation. This may reflect the altered 
expression of the genes in the different hosts, or be due to differences in membrane 
permeability (Podbielski et al., 1991 ). 
What can be seen from the MIC results is that 6 of the transconjugants are resistant to 
ceftazidime (MIC>32!J.g/ml), and the Etest ESBL test shows that these 6 
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transconjugants contain an ESBL. In addition, another 2 transconjugants that produce 
an ESBL (based on the Etest ESBL test), have ceftazidime MICs of 8!J.g/ml and 
6!J.g/ml. Another transconjugant (from the cross with KSO), with a ceftazidime MIC of 
6!J.g/ml, has a ratio of ceftazidime MIC to cefaztidime/clavulanate MIC of 4, which is 
the cut-off value for determination ofESBL activity. 
Although ceftazidime MICs of 8!J.g/ml or less indicate clinical susceptibility of the 
organism to the antibiotic, this does not exclude the presence of an ESBL. As 
discussed in chapter 1, an organism may be sensitive to a beta lactam in vitro, but still 
display in vivo resistance due to the production of an ESBL. It is precisely this problem 
that makes detection ofESBLs so difficult and so clinically important. 
The 11 transconjugants without detectable ESBL activity have ceftazidime MICs of 
1,5 !J.g/ml or less. These MICs are higher than the ceftazidime MIC of the recipient, E. 
coli J53, and this is most probably due to the transfer of a beta lactamase gene 
encoding an enzyme without extended spectrum activity (e.g TEM-1 or SHV-1). The 
presence of such an enzyme, however, can result in some hydrolysis of ceftazidime, 
which is reflected in the slightly elevated MIC. 
The nine transconjugants with ESBL activity, determined by the Etest ESBL test, 
(including the transconjugant from the cross with KSO) have cefotaxime MICs ranging 
from 1,5!J.g/ml to 6!J.g/m1. These MICs indicate susceptibility of the organisms to 
cefotaxime, and this again illustrates the problem of correlating the results of in vitro 
testing to in vivo effect of an antibiotic. It is interesting that, with one exception (from 
the cross with M26), the cefotaxime MICs of those transconjugants with no ESBL 
activity are lower than the cefotaxime MICs of the ESBL producing transconjugants. 
These MICs are still higher than the cefotaxime MIC of the recipient E. coli J53, again 
reflecting the acquisition of a beta lactamase, which, although not an ESBL, still has 
some activity against cefotaxime. 
One transconjugant, from the cross with isolate M46 (S. marscecens), contains an 
ESBL while the donor strain does not. This is in itself unusual, and suggests that the 
gene, if present in isolate M46, was not expressed in the donor. Another, and more 
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likely, explanation hinges on the fact the S. marscecens produces a chromosomal beta 
lactamase (AmpC) which is resistant to the effects of clavulanic acid and may mask the 
presence of the ESBL in the donor. Since AmpC is chromosomally mediated, it would 
not be transferable to E. coli while a plasmid containing an ESBL gene would be 
transferable, and the enzyme could then be detected in the transconjugant. This again 
illustrates the difficulties in detecting ESBL activity, using both the double disc test 
and theE-test ESBL test. 
5.3.3 Characterisation of Plasmids from Transconjugants 
To study the plasmid content of the transconjugants, plasmid DNA was extracted 
[3.2.3.4.vi] from 19 of those transconjugants that were successfully cultured. The 19 
transconjugants from which plasmids were successfully purified were from 
conjugations with the donors K4, K8, K16, K29, K42, K43, K46, K50," K54, K63, 
K68, K69, M26, M30, M40, M44-1, M44-2, M46 and E49. Plasmid DNA was 
digested with BamHI (Boehringer Mannheim) and the fragments separated by agarose 
gel electrophoresis (Fig 5.2 (i & ii)). 
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2 3 4 5 6 7 8 9 10 11 12 13 
Fig 5.2 Digestion of p1asmids extracted from the transconjugants, using BamBI (5 units), at 37°C for 6 hours. 
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Electrophoresis carried out on 0,8% agarose at 2 -3 V/cm for 18 hours and stained after electrophoresis 
with EtBr (lOmg/ml), using 11-11 EtBr per 100ml TAE [3 .2.3.2]. 
(i) lanes 1- 6: Plasmid from transconjugants ofK4, K8, K16, K29 , K42, and K43 , respectively. 
lane 7: Molecular weight marker (10kb BioMarker) 
lanes 8- 11: Plasmids from transconjugants ofK46, K50, K54 and K63. 
lane 12: Genomic DNA from E. coli DH5a 
lane 13: pUC19 
2 3 4 5 6 7 8 9 10 11 12 
Fig 5.2 (ii) lanes 1-6: Plasmid from transconjugants ofK68, K69, M26, M30, M40 & M44-1 respectively. 
lane 7: Molecular weight marker (lOkb BioMarker) 
lanes 8- 10: Plasmids from transconjugants ofM44-2, M46 & E49 
lane 11: Genomic DNA from E. coli DH5a 
lane 12: pUCl9 
Analysis of the restriction patterns generated (Fig 5 .2) shows two predominant 
restriction profiles, 1 and 2. Profile 1 is present in transconjugants from crosses 
involving K4, K8, K16 and K54 and profile 2 was obtained from the crosses involving 
K50, K68 and K69. The sizes of the DNA fragments present in these two profiles are 
shown in Table 5.2 . 
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Table 5.2 


















Profile 1- Present in plasmids from transconjugants ofK4, K8, Kl6, K54 
Profile 2- Present in plasmids from transconjugants ofK50, K68, K69 
kb = kilobases. 
Although the restriction profiles of the other plasmids are umque, a number of 
fragments are common to some of the profiles. A ~3,5kb fragment, present in profiles 
1 and 2, can also be seen in the profiles ofplasmids from donors K43, K46, M26, M30 
and E49. The plasmid profiles from the transconjugants of M26 and E49, while not 
identical, share a number of similarities. In addition to the ~3,5kb fragment, BamHl 
fragments of ~5,5kb, ~4,6kb, ~4,5kb, ~4kb are present in both plasmids. 
It is noteworthy that the plasmids from the transconjugants of the two Salmonella 
strains have slightly different restriction patterns. Specifically, the plasmid from the 
transconjugant of M44-2 is larger than that from M44-l, with 2 extra fragments of 
~5kb and ~2kb. Since M44-2 was isolated 5 days after M44-l, it is possible that the 
; 
plasmid in M44-l acquired additional genetic material. 
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5.3.4 DNA-DNA Hybridisations 
To characterise the plasmids further, the DNA fragments generated after digestion with 
BamHl were transferred to nylon membranes and the TEM and SHV probes were 
hybridised to these membranes in separate experiments. 
5. 3. 4.1 Hybridisation with TEM Probe 
When the membranes were hybridised with the TEM probe, a positive signal was 
obtained from the control, pUC19 and no signal was obtained from the negative 
control, E. coli DH5a genomic DNA. A positive signal was obtained from 8 of the 20 
samples (K42, K43, K54, K63, M40, M44-l, M44-2 and M46) (Fig 5.3 (i & ii)) 
indicating the presence of a TEM-related gene. The probe hybridised to large (>15kb) 
fragments in these plasmids, and examination of the plasmid profile suggests that the 
fragments to which the probe hybridised may be undigested DNA. 
Importantly, a TEM related gene was identified in all but two of the donor strains by 
hybridisation and PCR [chapters 3 & 4]. No evidence of a TEM related gene by either 
hybridisation orPCR was detected in donors K54 or M40. Curiously, a signal was not 
obtained from the plasmids isolated from transconjugants involving crosses between 
K29, K50, K68 and K69, although TEM-related genes had been demonstrated in each 
of these donors by hybridisation and PCR 
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lOkb __. 
Fig 5.3 Ci) Hybridisation ofTEM probe to BamHl digested plasmid DNA extracted from the transconjugants. 
1 2 3 4 5 6 7 8 9 10 11 12 
A BamHl Restriction profiles following electrophoresis ~ Autoradiograph of DNA shown in A Membrane exposed to Curix X-ray film for 2 hours 
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lanes 1-6: plasmid from transconjugants ofK4, K8, K16, K29, K42, and K43, respectively. 
lane 7: Molecular weight marker (1 Okb BioMarker). The position of the 1 Okb fragment is indicated. 
lanes 8- 11: Plasmids from transconjugants ofK46, K50, K54 and K63, respectively. 
lane 12: Genomic DNA from E. coli DH5a (negative control) 
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Fig 5.3 (ii) Hybridisation of TEM probe to BamHI digested plasmid DNA extracted from the transconjugants. After hybridi sation the membranes were washed under high stringency 
condidions, and exposed to Curix X-Ray film for 2 hours. 
A BamHI Restriction profiles following electrophoresis ]! Autoradiograph of DNA shown in A. Membrane exposed to Curix X-ray film for 2 hours 
lanes 1-6: Plasmid from transconjugants ofK68, K69, M26, M30, M40 & M44-1 respectively 
lane 7: Molecular weight marker (10kb BioMarker). The position of the 10kb fragment is indicated. 
lanes 8- 10: Plasmids from transconjugants ofM44-2 , M46 & E49, respectively. 
lane 11 Genomic DNA from E. coli DH5a (negative control) 
lane 12: pUC 19 (TEM positive control) 
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The hybridisation studies were repeated: plasmids from these transconjugants and 
genomic DNA from the corresponding donors was digested with BamHl , transferred 
to a nylon membrane and hybridised with the TEM probe. The original donor M40 
could not be cultured from the glycerol stocks in order to extract fresh genomic DNA, 
and the hybridisation on this donor could thus not be repeated. 
As shown (Fig. 5.4) a strong signal was obtained from the positive control (E. coli 
DH5a(pUC19) genomic DNA). Strong signals were obtained from the genomic DNA 
from the donors K29, KSO, K68 and K69, as well as from fragments in the plasmids 
from crosses involving K29 and K54. Weak signals were obtained from fragments in 
the plasmids from crosses involving the donors KSO, K68 and K69. These weak signals 
were interpreted as non-specific hybridisation based on the observation that a strong 
signal was obtained from the corresponding donor' s genomic DNA No signal was 
obtained from the genomic DNA of isolate K54. In the case of genomic DNA from 
donor K29 and the corresponding plasmid, the fragment of genomic DNA to which the 
probe hybridised is larger than the fragment from the plasmid, suggesting incomplete 
digestion of the genomic DNA 
The discrepancy between the hybridisation to genomic DNA of isolate K54 and 
hybridisation to the plasmid from the corresponding transconjugant is worrying. No 
signal was obtained when the TEM probe was hybridised to genomic DNA from the 
donor, and it appears that the plasmid from this transconjugant did not originate from 
the purported donor K54. Consequently, all results pertaining to the transconjugant of 
isolate K54 were ignored. Similarly, the results pertaining to the transconjugant of 
isolate M40 were ignored, since a second hybridisation could not be performed on the 
donor to clarify the discrepancy between the results of the hybridisations on the donor 
and recipient. 
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Fig 5.4 Legend overleaf 
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Fig 5.4 Hybridisation ofTEM probe to Bamill digested DNA extracted from transconjugants (plasmid DNA) and respective donors (genomic DNA). 
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A Restriction profiles following electrophoresis. Digestion was carried out with 5 
units of enzyme at 37°C for 6 hours. DNA was separated by electrophoresis on a 
0,8% agarose gel at 2-3 V/cm 
~ Autoradiograph of DNA shown in A. After hybridisation the membranes were washed 
under for 18 high stringency conditions, and exposed to Curix X-Ray film for 2 hours. 
Lane 1: Plasmid DNA from transconjugant ofK29 
Lane 2: Genomic DNA from isolate K29 
Lane 3: Plasmid DNA from transconjugant ofKSO 
Lane 4: Genomic DNA from isolate KSO 
Lane 5: Plasmid DNA from transconjugant ofK54 
Lane 6: Genomic DNA from isolate K54 
Lane 7: lOkb BioMarker 
Lane 8: Plasmid DNA from transconjugant ofK68 
Lane 9: Genomic DNA from isolate K68 
Lane 10: Plasmid DNA from transconjugant ofK69 
Lane 11: Genomic DNA from isolate K69 
Lane 12: Genomic DNA from E. coli DH5a 
Lane 13: Genomic DNA from E. coli DHSa(pUC 19) 
5.3.4.2 Hybridisation with SHV Probe 
When the SHV probe was hybridised to the membranes, a strong signal was obtained 
from the positive control (E. coli K12 (SHV-1)) and no signal obtained from the 
negative control (pUC19) using the membrane containing only the controls (Fig 
5.5(i)). However, a weak signal was obtained from the same negative control on those 
membranes containing the plasmid DNA from the transconjugants (Fig 5.5 (ii & iii)). 
Although this suggests hybridisation ofthe SHV probe to the TEM-1 gene in pUC19, 
this is surprising since sequence alignment of SHV -1 and TEM-1 shows that there is 
60% DNA homology between the two genes. Under the stringency conditions used in 
this hybridisation, the SHV probe should not have remained annealed to the TEM-1 
gene, and the fact that it may have cannot be easily explained. Alternatively, the probe 
may have hybridised to a different pUC19-related sequence. 
A weak signal, of similar intensity to the signal from the negative control, was obtained 
from the plasmids of 3 of the transconjugants - those resulting from crosses with M44-
1, M44-2 and M46. In view of the fact that these plasmids contain TEM-related genes 
[5.3.4.1], it would be tempting to assume that the probe had annealed to the TEM 
genes in these plasmids. The autoradiographs (Figs 5.3 & 5.5), however, show that the 
SHV and TEM probes hybridised to different BamHI generated fragments. As the 
signal was of similar intensity to that obtained from the negative control, it was 
assumed that these transconjugants do not contain an SHV -related gene. 
The probe hybridised to BamHI generated fragments of the plasmids extracted from 13 
of the transconjugants- those resulting from crosses with isolates K4, K8, K16, K29, 
K43, K46, K50, K68, K69, M26, M30, M40 and E49. The signals obtained from these 
fragments were of a similar intensity to the signal obtained from the positive control. 
The probe hybridised to an approximately 3,5kb fragment in 11 of the 13 plasmids, 
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Fig 5.5 (i) Hybridisation of the SHY probe to BamHI digested pUC 19 and plasmid DNA extracted from E. coli 
Kl2 (SI-IV-1). After hybridisation the membrru1es were washed tmder the srune stringency conditions 
applied to the membrru1es with the plasmid DNA from the transconjugants. The membrru1e was 
exposed to Curix X-Ray fi lm for 2 hours. 
A Restriction profiles fo llowing electrophoresis 
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lane 1: Molecular weight marker ( lOkb BioMarker) 
lane 2: DNA from Kl2 (SI-IV-1) 
lane 3: pUC 19 





Fig 5.5 Cii) Hybridisation of SHV probe to BamHI digested plasmid DNA extracted from the transconjugants. 
3 4 5 6 7 8 9 10 ·11 12 . 13' 
A Bam HI restriction profiles following electrophoresis .!! Autoradiograph of DNA shown in A After hybridisation the membranes were exposed to Curix X-Ray film for 2 
hours. 
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lanes 1-6: Plasmid from transconjugants ofK4, K8, K16, K29, K42, and K43 , respectively. 
lane 7: Molecular weight marker (1 Okb BioMarker). The position of 2 of the fragments is illustrated. 
lanes 8- 11: Plasmids from transconjugants ofK46, KSO, K54 and K63 , respectively. 
lane 12: Genomic DNA from E. coli DH5a (negative control) 
lane 13: pUC19 (negative control) 
---. 
3kb 




Fig 5.5 (iii) Hybridisation of SHY probe to BamHI digested plasmid DNA extracted from the transconjugants. 
3 4 5 6 7 8 9 10 11 12 
A BamHI restriction profiles following electrophoresis !! Autoradiograph of DNA shown in A After hybridisation the membranes wereexposed to Curix X-ray film 
for 2 hours. 
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lanes 1- 6: Plasmid from transconjugants ofK68, K69, M26, M30, M40 & M44-l , respectively 
lane 7: Molecular weight marker (10kb BioMarker). The position of2 of the fragments is illustrated. 
lanes 8- 10: Plasmids from transconjugants ofM44-2, M46 & E49, respectively. 
lane 11 . Genomic DNA from E. coli DH5a (negative control) 
lane 12 pUC 19 (negative control) 
Correlating these results with the results of both the slot blot hybridisation studies and 
the PCR assays is difficult, firstly because of the problems experienced with the 
chromosomal beta lactamase genes in K. pneumoniae, and secondly because of the 
difficulties encountered in performing the PCR assay itself [chapters 3 and 4]. 
However, the results of the studies on donor isolates other than K. pneumoniae 
correlate with the results obtained with this hybridisation. Specifically, the plasmid 
from the transconjugant of an isolate of E. cloacae (E49) was shown to contain an 
SHY -related gene as was the respective donor. 
5.4 DISCUSSION 
After excluding the donors K54 and M40, ampicillin resistance was transferred from all 
27 donors to the recipient, although 9 of the transconjugants could not be cultured 
further. It is interesting that of the remaining 18 transconjugants, only 8 were shown to 
produce an ESBL, and it is assumed that the ampicillin resistance acquired by the other 
10 transconjugants is due to the acquisition of a TEM- or SHY-relat~d gene without 
extended spectrum activity. Given that all the donors, apart from M46, were shown to 
contain ESBLs [chapter 2], it is perhaps surprising that as many as 10 of them contain 
a non-ESBL TEM- or SHY-related beta lactamase as well as an ESBL. The finding of 
ESBL transfer in only 8 of the 18 (44%) conjugation experiments is slightly higher 
than described in other work. Hibbert-Rogers et al. (1995) demonstrated transfer of 
ceftazidime resistance from only 31% of clinical isolates of Enterobactericeae. It must 
be remembered that 9 of the transconjugants in this study could not be cultured, and 
i 
the figure of 44% may be falsely elevated. 
The transfer of ampicillin resistance from all 27 of the donors in this study is 
inconsistent with other published work. Gaur et al. (1992) demonstrated ampicillin 
resistance transfer in 14,7% thermotolerant coliforms (including Klebsiella spp. and E. 
coli.). In a study of multiply antibiotic resistant members of the Enterobacteriaceae, 
ampicillin resistance (with or without other antibiotic resistance determinants) was 
transferred from 20 of the 35 isolates (Levy et al., 1985). A study by Leung et al. 
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(1997) showed transfer of beta lactam resistance from only 5 out of 80 strains of K. 
pneumoniae. The beta lactamase genes that were transferred encoded both ESBLs 
(SHV-5 and SHV-2 or -7) and non-ESBLs (SHV-1 and TEM-2). The fact that 
ampicillin resistance was transferred from all of the donors in this study may have been 
influenced by the selection of donors based on the presence of either a TEM- or SHV-
related gene. Additionally, 9 of the transconjugants could not be subcultured, so stable 
resistance transfer was only demonstrated in 18 of the 27 conjugations. 
As mentioned previously [3.4], P. agglomerans, S. marscecens and E. cloacae have 
chromosomal beta lactamase genes, which would not ordinarily be transferable. The 
finding, therefore, of self-transmissible beta lactam resistance determinants in these 
isolates (M46 and E49) is surprising since the presence of extra beta lactamase genes 
seems superfluous. 
Hybridisation showed that plasmids from 12 of the transconjugants contained SHV 
related genes. The plasmids from the transconjugants of K42 and K63 (both K. 
pneumoniae) were not shown to contain SHV related genes while the hybridisation 
and PCR studies on the donors demonstrated the presence of these genes. This 
supports the supposition that chromosomal SHV -related genes as well as plasmid 
mediated SHV -related genes in the K. pneumoniae donors were detected by the PCR 
assay (with primers SHV-A and SHV-B) [4.3.5] and hybridisation with the SHV probe 
[3.4]. Of course, it is possible that these two donors (K42 and K63) may contain SHY-
related beta lactamases that are not on self-transmissible plasmids, explaining the 
failure to detect such genes in the transconjugants. 
Of the 8 transconjugants with demonstrated ESBL activity (using the Etest ESBL 
test), 3 were shown to contain only an SHV-related gene. This is highly suggestive of 
the fact that the SHV -related gene in these plasmids encodes a beta lactamase with 
extended spectrum activity, bearing in mind the caveat that a different beta lactamase 
(unrelated toTEM or SHV) may be responsible for the resistance to ceftazidime. The 
ceftazidime MIC of 1 of these transconjugants (from the cross with K46) is >32J.1.g/rnl, 
while the ceftazidime MICs of the other two (from crosses with K50 and M30) are 
6J.1.g/rnl. Although a ceftazidime MIC of 6J.1.g/rnl does not indicate resistance to this 
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antibiotic, the Etest ESBL test does indicate the presence of an ESBL in these 2 / 
transconjugants (albeit on a borderline level in transconjugant KSO). 
With respect to the 9 transconjugants which did not express ESBL activity, 7 were 
' found to contain only an SHY-related gene (or genes). This suggests that the donors 
(K4, K8, K16, K68, K69, M26 and E49) contain a self transmissible plasmid encoding 
SHY-1, and an additional gene, which was not transferred, encoding an ESBL. Two of 
these 7 donors, K68 and K69, contain both TEM- and SHY-related genes, and it is 
possible that the TEM-related genes, which were not transferred, encode the enzymes 
with extended spectrum activity in these 2 strains. However, the presence of a second, 
non-transmissible SHY -related ESBL in these 2 donors cannot be excluded, and the 
presence of 2 SHY -related enzymes in K. pneumoniae isolates has been described 
Johnson et al., 1992). 
It is gratifying that the results of the hybridisation with the TEM probe to the plasmid 
DNA correlated well with the results of the PCR and hybridisations performed on the 
donor strains, although the discrepancies in the results of isolates K54 and M40 are 
disappointing. TEM-related genes were shown to be present in 7 of the plasmids 
extracted from the transconjugants. 
Only TEM-related genes were found in 3 of the plasmids :from the 9 ESBL producing 
transconjugants, which, again, strongly suggests that these TEM-related genes encode 
enzymes with extended spectrum activity. All 3 of these transconjugants (:from crosses 
with K42, K63 and M46) have ceftazidime MICs of >32J.!g/ml. Of the 9 
transconjugants with no ESBL activity, 2 had only TEM-related genes demonstrated, 
indicating that these genes were probably encoding either the TEM-1· or -2 beta 
lactamase. These 2 donors (M44-1 and M44-2, both Salmonella sp.) contain both 
TEM- and SHY-related genes, and in this situation it would seem likely that the SHY-
related genes in the donors encode the ESBLs. Hammami et al., (1991) described the 
presence of both TEM-1 and SHY-2 genes in isolates of Salmonella wien, although 
neither of these genes was shown to be transferable. A variety of SHY -related ESBLs 
have been described in Salmonella species (Garbarg-Chenon et al., 1989; Hammami et 
al., 1991), and the presence ofTEM-1 in both typhoidal and non-typhoidal Salmonella 
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isolates is also well described (Kariuki et al., 1996; Shanahan et al., 1998). Again, the 
possible presence of another, non-TEM or -SHV -related enzyme should also be 
considered in these Salmonella isolates, as was described by Gazouli et al. (1998). 
The plasmids from 2 of the transconjugants (from crosses with K29 and K43) contain 
both SHV- and TEM-related genes, and ESBL activity was demonstrated in both of 
these transconjugants. It is again highly probable that the ESBL gene in these 2 
transconjugants is either TEM- or SHY-related, although it would be impossible to 
deduce which gene encodes the ESBL. The results of the hybridisation studies on the 
transconjugants, along with the PCR and hybridisation study results on the respective 
donors, are shown in Table 5.3. 
Table 5.3 
Results ofPCR and hybridisation studies on the donors, and hybridisation studies on 
the respective transconjugants. 
Original Isolate Donor Transconjugant 
Presence of Hybridisation PCR Presence of Hybridisation 
ESBL ESBL 
K4 K. pneumoniae Yes SHV SHV No SHV 
K8 K. pneumoniae No SHV SHV No SHV 
Kl6 K. pneumoniae Yes SHV SHV No SHV 
K29 K. pneumoniae Yes SHV TEM SHV TEM Yes SHV TEM 
K42 K. pneumoniae Yes SHV TEM SHV TEM Yes TEM 
K43 K. pneumoniae Yes SHV TEM SHV TEM Yes SHV TEM 
K46 K. pneumoniae Yes SHV SHV Yes SHV 
K50 K. pneumoniae Yes* SHV TEM SHV TEM Yes SHV 
K54 K. pneumoniae Yes SHV SHV No SHV TEM 
K63 K. pneumoniae Yes SHV TEM SHV TEM Yes TEM 
K68 K. pneumoniae Yes SHV TEM SHV TEM No SHV 
K69 K. pneumoniae Yes SHV TEM SHV TEM No SHV 
M26 K. pneumoniae Yes SHV SHV No SHV 
M30 K. pneumoniae Yes SHV SHV Yes SHV 
M40 E. cloacae Yes SHV SHV Yes SHV TEM 
M44-l Salmonella sp. Yes SHV TEM SHV TEM No TEM 
M44-2 Salmonella sp. Yes SHV TEM SHV TEM No TEM 
M46 S. marcescens No TEM TEM Yes TEM 
E49 E. cloacae Yes SHV SHV No SHV 
* -The result of the ESBL Etest on isolate K50 was borderline for ESBL presence. 
The results of the conjugation studies on isolate K54 and M40 (italicised) have been ignored 
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The results of the hybridisation indicate that SHY -related genes are more common in 
the clinical isolates, particularly K. pneumoniae, than TEM-related genes. Of 13 K. 
pneumoniae isolates, 11 contain plasmid encoded SHY -related genes and 4 contain 
plasmid encoded TEM-related genes. Ofthese, 3 of the SHY-related genes, and 2 of 
the TEM-related genes might encode ESBLs. In addition, the TEM related gene 
originating from the transconjugant of donor M46 may also encode an ESBL. 
Although TEM-1 is the commonest plasmid mediated beta lactamase found in the 
Enterobacteriaceae (Du Bois et a!., 1995), SHY-related ESBLs have on occasion 
been shown to be more common than their TEM-related counterparts (Jacoby & Han, 
1996). 
BamHI mapping showed some similarities amongst the transferred plasmids, in that 2 
different profiles were common to some of the plasmids [5.4.3]. Some similarities 
could be observed between those plasmids that did not share a common profile, most 
notably a ~3,5kb BamHI generated fragment. The SHY probe hybridised to this 
fragment in plasmids from 11 of the transconjugants. It is interesting that the plasmid 
extracted from the transconjugant of isolate E49 (E. cloacae) showed some similarities 
[5.4.3] to the plasmid extracted from the transconjugant of isolate M26 (K. 
pneumoniae). However, the focus of this research was not to determine the relatedness 
of the plasmids, and further studies on the plasmids were not carried out. 
While transmissibilty of resistance, as demonstrated by the conjugation sudies, would 
be strong evidence in support of a plasmid located resistance gene, it must be 
remembered that non-transmissability does not necessarily exclude a plasmid-related 
resistance determinant. Resistance geJ:Ies may be present on plasmids that need to be 
mobilised, and these studies were not performed as part of this research. It is 
interesting that in 9 of the conjugation experiments in our study, transconjugants could 
not be cultured further in selective media, suggesting that these plasmids may be 
unstable in E. coli. 
It is also important to bear in mind that the beta lactamase genes may be located on 
transposons, either on plasmids or integrated in the chromosome. Conjugation 
experiments (as performed in this study) may not necessarily demonstrate transfer of 
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resistance carried on transposons, although, in vivo, such elemens may well be 
transferred (on plasmids). A variety of beta lactamase genes, encoding both extended 
spectrum and non-extended spectrum beta lactamases, have been described on 
transposons. Heritage et al. (1992) described the occurrence of a TEM-12 gene on a 
transposon (Tn841). Similarly, an SHV-3 gene has been found on a plasmid containing 
genes for aminoglycoside and tetracycline resistance, and the authors postulated that 
this association may indicate that the genes are located on a transposon (Nicolas et al., 
1989). The ability of resistance to be transferred may also be due to a conjugative 
transposon rather than a plasmid, although this is probably less likely since no ESBLs 
have yet been described on conjugative transposons. Although no TEM- and SHY-
related ESBLs have yet been described on integrons, it seems unlikely that this 
situation will last, considering that at least one ESBL gene (TEM-3) has been 
described in close association with an integron (Mabilat et al., 1992). Given the 
association between integrons and the dissemination of antibiotic resistance genes (Hall 
& Collis, 1995), the possible movement ofESBL genes onto integrons would be most 
unsettling. 
From the point of view of the isolates in this study, what is important is that 
transmissability in vitro is a good pointer to resistance being transferrable in vivo with 
consequent spread of resistance. As mentioned previously this can have profound short 
and long term clinical implications. In the short term it would open the door to further 
infection or colonisation by resistant organisms in the presence of selective antibiotic 
pressure. The long term clinical importance of transferable resistance is related to the 
increased incidence and spread of multi-drug resistant organisms, with potentially 




The major aim of this study was to evaluate and compare the use of 2 different 
molecular methods for the detection ofTEM- and SHV-related beta lactamase genes in 
clinical isolates of Gram negative bacilli. The methods evaluated in the study were 
hybridisation and PCR. In addition, during the course of the study, non-molecular 
methods for detecting ESBL production wer~ assessed, and the self-transmissibility of 
resistance from those isolates shown to contain either TEM- or SHV-related beta 
lactamase genes was investigated. 
The standard test used to detect the presence of an ESBL in clinical isolates is the 
double disc diffusion test [1.4.4.1-i]. This test was performed on all 45 isolates in this 
study, and the results compared to those of the Etest ESBL test, which has been 
shown to be more sensitive in detecting ESBL production (Cormican et al., 1996). Of 
the 45 isolates tested, 27 were shown to produce ESBLs. Using the double disc test as 
it is performed in the clinical laboratory at Groote Schuur Hospital, the double disc test 
detected 19 ESBL producers. On repeating the test with the discs closer together, an 
additional 5 were detected. By and large, however, this test would not be repeated in a 
clinical laboratory, and the production of ESBLs in a proportion of isolates may go 
undetected by the double disc test. this is in contrast to the Etest method, which failed 
to detect only one ESBL producer, which, interestingly enough, was detected using the 
double disc test. These findings support previous work which has shown that the 
double disc test is not 100% sensitive (Cormican et al., 1996). The findings also 
suggest that an alternative method may be required in the clinical laboratory to 
maximise ESBL detection. 
Using a probe amplified from the TEM-1 gene and specific for TEM related genes, 12 
isolates were shown to contain the corresponding gene/sin genomic DNA which had 
been transferred to a nylon membrane. When similar experiments were carried out on 
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colony blots, equivocal results were obtained, suggesting that such blots are not useful 
for hybridisation assays. A PCR assay, using primers specific for TEM-related genes, 
was performed on the 45 isolates, and TEM-related genes were consistently 
demonstrated in 11 of the isolates. A TEM-related gene was demonstrated in a 12th 
isolate, but in only 2 of the 3 assays. These 12 isolates correspond perfectly to the 12 
isolates shown by hybridisation to contain TEM-related genes, although the failure of 
PCR to detect the gene in one of the isolates, in one assay, illustrates that this 
technique may not be as reliable as hybridisation. However, the PCR assays, and the 
preparation of the template in particular, are far easier to carry out than hybridisation 
studies, and thus more suitable for use in a clinical laboratory. The only equipment 
required is a PCR thermocycler, apparatus for agarose gel electrophoresis and a 
transilluminator for visualisation ofDNA in the gels. 
ESBL activity was present in 10 of the 12 isolates shown to contain TEM-related 
genes suggesting that the TEM-related genes may encode an ESBL. However, the 
presence of another ESBL-encoding gene in these isolates cannot be excluded. The 2 
non-ESBL producing isolates (P. agglomerans and S. marcescens) may contain a 
TEM-1 or TEM-2 gene. Alternatively, an ESBL (related or unrelated toTEM), which 
was not detected due to the activity of AmpC, may be present in one or both of these 
isolates. 
These 12 isolates were conjugated with E. coli (NalR), and resistance to ampicillin was 
transferred from all 12 to the recipient. In 1 instance, the transconjugant could not be 
cultured further, suggesting instability of the plasmid in E. coli, and plasmid DNA 
could not be extracted from a second transconjugant. Plasmids from the remaining 1 0 
transconjugants were characterised using Southern hybridisation, and TEM-related 
genes were detected in 7 of these. The fact that ESBL activity was detected in 5 of 
these 7 transconjugants is highly suggestive of a TEM-related ESBL. On the other 
hand, the TEM-related genes in the 2 transconjugants that did not produce an ESBL 
would be either TEM-1 or TEM-2. Interestingly, one ofthe transconjugants shown to 
produce an ESBL was derived from a cross with S. marcescens, which did not have 
detectable ESBL activity. The failure of both the Etest and double disc test to detect 
an ESBL in this donor was thought to be due to the activity of AmpC, as mentioned 
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earlier. The 3 transconjugants that did not contain TEM-related genes were all derived 
from crosses with K pneumoniae isolates. 
Using PCR and hybridisation techniques to detect SHY-related genes in the clinical 
isolates, the results were not as clear-cut. The presence of chromosomal genes such as 
LEN-1, very similar to SHY-1, inK pneumoniae complicated both the hybridisation 
and PCR studies. Efforts to design an oligoprobe that would not hybridise to LEN-1, 
the known chromosomal gene, were unsuccessful and equivocal studies were always 
obtained in hybridisation studies involving K pneumoniae. However, 4 of the other 
isolates (2 Salmonella spp. and 2 E.. cloacae) were shown to contain SHY-related 
genes using this technique. All 4 of these also produced an ESBL. This suggests that 
the ESBL produced by each of the 2 E. cloacae isolates may be encoded by an SHY-
related gene. The same conclusion cannot be reached with regard to the 2 Salmonella 
isolates, since each ofthese also contained a TEM-related gene. 
The PCR assay, using primers specific for SHY -related genes, was also complicated by 
chromosomal SHY-related genes in K pneumoniae. The assays did indicate the 
presence of SHV -related genes in the same 4 non-Klebsiella isolates shown by 
hybridisation to contain SHY -related genes. However, parameters resulting in a 
reliable assay could not be determined, and further work is necessary. 
Three of the isolates (M40 being excluded) shown to contain SHY -related genes, and 
22 K. pneumoniae isolates were conjugated with E. coli J53 (NaiR). Ampicillin 
resistance was transferred from all these isolates to the recipient, but 8 of the 
transconjugants could not be cultured further. Hybridisation studies on the plasmids of 
the remaining 16 (no plasmid could be extracted from 1 transconjugant) showed the 
presence of SHY-related genes in 12 of the transconjugants. The Etest ESBL test 
demonstrated ESBL activity in 5 of the 12, again strong evidence that the ESBL is 
encoded by the SHY-related gene. No ESBL activity was present in the other 7 
transconjugants, indicating that the SHY -related gene detected in the plasmids from 
these organisms is SHY -1. The 4 transconjugants that did not contain SHY -related 
genes arose from crosses with 2 isolates of K. pneumoniae and the 2 Salmonella spp. 
151 
Taken toge~her, 17 transconjugants were studied, 8 of which had detectable ESBL 
activity. Both TEM- and SHY-related genes were detected in 2 of the 8. In this 
instance it is impossible to deduce which gene is encoding the ESBL, notwithstanding 
the fact that the ESBL in one or both of them may in fact be related to the presence of 
a non-TEM non-SHY gene. The remaining 6 ESBL-producing transconjugants 
contained either a TEM- or an SHY-related gene, suggesting that the ESBL in these 
organisms is encoded by the respective gene. Of the 9 transconjugants without ESBL 
activity, 7 contained an SHY -related gene (presumably SHY -1) and 2 contained a 
TEM-related gene (either TEM-1 or TEM-2). 
Both TEM- and SHY -related beta lactamase genes were identified in clinical isolates of 
the Enterobacteriaceae from Groote Schuur Hospital, and some encode ESBLs. Of 
the 45 isolates studied, 12 (26,7%) contained TEM-related genes. Although these 
genes were commonest in isolates of K. pneumoniae, they were also present in other 
members of the Enterobacteriaceae. Plasmid mediated SHY-related genes could not 
be reliably detected in all the isolates. However, combining the results of the studies 
performed on the 22 non-Klebsiella pneumoniae isolates as well as the studies on the 
transconjugants derived from K. pneumoniae, 15 out of 3 5 isolates ( 42,8%) contained 
SHY -related genes. Of these 15 SHY -related genes, 11 were found in K. pneumoniae 
isolates. This, combined with the identification of most of the TEM-related genes inK. 
pneumoniae, is consistent with the fact that SHY- and TEM-related beta lactamases, in 
particular ESBLs, appear to have a predilection forK. pneumoniae (Philippon et al., 
1989; Livermore, 1995; Stratton, 1996b). However, the presence of plasmid mediated 
TEM- and SHY-related beta lactamases in other members of the Enterobacteriaceae 
should not be ignored. 
The results showed that PCR can be easily and reliably used, as an epidemiological 
tool, to detect TEM-related genes in Gram negative bacilli in a clinical laboratory. 
More work is needed to develop a reliable PCR assay for the detection of SHY -related 
genes: with respect to both reproducibility as well as ability to differentiate between 
plasmid and chromosomally located SHY-related genes inK. pneumoniae. A recent 
study showed numerous chromosomal genes in different strains of K. pneumoniae, 
most having a very high degree of homology to a plasmid mediated SHY -1 gene 
152 
(Hregmann et al., 1997). Given this, designing a PCR assay which discriminates 
plasmid from chromosomal SHV -related genes may well prove to be a Herculean task. 
An alternative would be to utilise the PCR assay that discriminates SHV -related ESBL 
genes from the non-ESBL encoding counterparts (Nuesch-Inderbinen et al., 1996). 
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APPENDIX A 
SOLUTIONS AND MEDIA 
All solutions were made up volumetrically unless otherwise indicated. 
50% Acrylamide/2,5% N-N bismethyleneacryalmide (bis-acryalamide) 
Work wearing gloves and in a fume hood. 
Dissolve 250g acrylamide and 12,5g bis-acrylarnide in 500ml sterile water and filter 
through Whatman filter paper. Store at 4°C protected from light. 
Ammonium Persulphate 10% 
Dissolve lg of ammonium persulphate in lOml of sterile water. Store aliquots at 4°C 
protected from light. 
Choloroform-Isoamyl Alcohol 
Mix choloroform and isoamyl alcohol in a ratio of 24: 1 (chloroform :isoamyl alcohol) 
Store protected from light at room temperature. 
Denaturing Solution (l,SM NaCI; O,SM NaOH) 
Mix 300ml 5M NaCl and 50ml of ION NaOH. Make up to lOOOml with distilled water 
and store at room temperature. 
Dorset's Egg Agar 
Dissolve 2,6g nutrient broth base in 200ml distilled water, place in a 1 litre Schott 
bottle and autoclave at 15 psi for 15 minutes. Once cooled, add about 14 eggs 
(600ml), dispense into sterile Bijou bottles and inspissate in a steamer. 
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EDTA 0,5M, pH 8,0 (Ethylenediamine tetra-acetic acid) 
Add 93,05g EDTA to about 300ml water and stir vigorously. Add NaOH pellets until 
the pH has reached 8,0. Once the EDTA has dissolved, make up the volume to 400rnl. 
Autoclave the final solution at 15 psi for 15 minutes and store at room temperature. 
Ethanol70% 
Add 350ml of 100% ethanol to 150rnl sterile water. Store at 4°C. 
Ethidium Bromide (lOmg/ml) 
Work in a fume hood and wearing gloves. 
Dissolve 0, 1 g ethidium bromide in 1 Oml sterile water by shaking well. Store at 4 oc 
protected from light. 
Hexadecyl Trimethyl Ammonium Bromide/Sodium Chloride (CTAB/NaCI) 
Add 4,1g NaCl and lOg CTAB (hexadecyl trimethyl ammonium bromide) to about 
80rnl distilled water, and heat to about 60°C to facilitate dissolution. Once the CT AB 
has dissolved, make the volume up to 1 OOrnl with distilled water and autoclave at 15 
psi for 15 minutes. Store at room temperature. The solution may need to be gently 
heated (to about 40°C) before it can be used as it is very viscous at low ambient 
temperatures. 
Hydrochloric Acid (HCI) 0,25M 
Add 20rnl concentrated HCl to 980ml sterile water and store at room temperature. 
IPTG (Isopropyl-D-thio-galactopyranoside) 200 mg/ml 
Mix 2g IPTG in about 8rnl sterile water and dissolve. Make up to 1 Oml with water, and 
aliquot 1ml volumes. Store at -20°C until needed. Add 50f!l per 100rnl agar. 
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Lithium Chloride (LiCI) 4M 
Dissolve 42,4g LiCl in 250ml water and sterilise by autoclaving at 15 psi for 15 
minutes. Store at room temperature. 
Magnesium Chloride (MgCh) 1M 
Dissolve 20,3g MgCb in a final volume of lOOml. Autoclave at 15 psi for 15 minutes 
and store at room temperature. 
Magnesium Sulphate (MgS04) 1M 
Dissolve 24,7g MgS04 in a final volume of lOOml distilled water. Autoclave at 15 psi 
for 15 minutes and store at room temperature. 
MacConkey Agar 
Add 20g peptone and 5g sodium taurocholate to IOOOml water and dissolve by 
heating. Add 20g agar and dissolve it by steaming. Adjust the pH to 7,5 and add lOOml 
lactose (10% aqueous solution) and approximately 3,5ml neutral red solution (2% in 
50% ethanol). Heat with free steam ( ~ 1 00°C) for 1 hour then autoclave at 15 psi for 
15 minutes. The agar can be poured into Petri dishes once it has cooled to about 50°C. 
Mueller Hinton agar 
Emulsify 1,5g starch in a small volume of cold water and pour this into 300ml of beef 
infusion. Add 17,5g casein hydrosylate and lOg agar and make the volume up to 
1 OOOml with distilled water. Heat at ~ 1 00°C to dissolve the constituents, then adjust 
the pH to 7,4. Autoclave at 15 psi for 15 minutes and pour into Petri dishes once 
cooled to about 50°C. 
Neutralising Solution (1,5M NaCI; 0,5M Tris-HCI pH 7,4) 
Combine 300ml 5M NaCl and 500ml 1M Tris-HCl (pH7,4). Make up to IOOOml with 
distilled water and store at room temperature. 
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NNB Buffer lOx 
Dissolve 162g Tris base, 27,5g boric acid and 9,3g EDTA in about 800ml water. Make 
the volume up to 1 OOOml with distilled water and store at room temperature. 
Phenol 
Work with gloves and in a fume hood. 
Add 600mg 8-hydroxy quinoline, 7,5ml NaOH (2M) and 6ml Tris-HCl (1M pH7,6) to 
500g crystallized phenol. Leave to liquefy overnight (or at 40°C) until the solution is 
clear. Aliquot and store at 4°C. 
Phenol/Chloroform 
Mix phenol (as prepared above) and choloroform-isoamyl alcohol in the ratio of 1: 1. 
Store protected from light at 4°C. 
Physiological saline (0,85% w/v) 
Dissolve 8,5g NaCl in about 900ml of distilled water and make up to lOOOml with 
distilled water. Autoclave at 15 psi for 15 minutes and store at room temperature. 
Potassium Acetate 5M 
Dissolve 98,2g potassium acetate in about 180ml distilled water and make up the 
volume to 200ml. Store at 4°C 
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Primary Wash Buffer 
Dissolve 180g urea in 400ml of water by gently warming the solution (about 50°C). 
Add 20ml SDS (10%) and SSC according to the stringency required (see below). 
Make up to 500ml with distilled water and store at 4°C. 






Salt Saturated Isopropanol 
Mix isopropanol with a V4 volume of 5M NaCl, and use the top phase. Store at room 
temperature. 
Sodium Acetate 3M, pH6,0 
Dissolve 204,05g sodium acetate in 400ml distilled water and adjust the pH to 6,0 with 
glacial acetic acid. Make up to a final volume of 500ml with distilled water and store at 
4oC. 
Sodium Chloride (NaCI) 5M 
Dissolve 146,25g sodium chloride in 400ml distilled water and make up the volume to 
500ml. Autioclave at 15 psi for 15 minutes and store at room temperature. 
Sodium Dodecyl Sulphate (SDS) 10% 
Work with gloves and in a fume hood. 
Dissolve 50g SDS in 400ml distilled water and adjust the pH to 7.2 with hydrochloric 
acid. Make up to a final volume of 500ml with distilled water and store at room 
temperature. 
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Sodium Hydroxide (NaOH) lON 
Dissolve 400g of sodium hydroxide pellets in about 800ml distilled water and make up 
the volume to 1 OOOml with distilled water. Store in a plastic container at room 
temperature. 
Salt Sodium Citrate (SSC) 20x 
Dissolve 175,3g NaCl and 88,2g tri-sodium citrate in about 800ml distilled water. 
After adjusting the pH to 7,0 make up to a final volume of lOOOml. Autoclave at 15 psi 
for 15 minutes and store at room temperature. Dilute with distilled water to achieve 
the required concentrations. 
Tris-Acetate-EDTA (TAE) buffer (SOx) 
Dissolve 242,0g Tris base along with 57,lml glacial acetic acid and lOO,Oml EDTA 
(0,5M) in about 800ml distilled water and make up the volume to lOOOml with distilled 
water. Autoclave at 15 psi for 15 minutes and store at room temperature. Dilute 1:50 
to make T AE running buffer for electrophoresis. 
TE (Tris-EDTA) Buffer 
Add lml Tris (1M pH 8,0) and 0,2ml EDTA (0,5M pH8,0) to 98,8ml distilled water. 
Autoclave at 15 psi for 15 minutes and store at room temperature. 
Tracking Dye 
Dissolve 25mg bromophenol blue, 4,0g sucrose and 0,4ml EDTA (0,5M pH 8,0) in 
1 Oml sterile water. Store at room temperature. 
Tris-HCllM 
Dissolve 12lg Tris in about 800ml distilled water. Adjust the pH with hydrochoric acid 
to the required level, and make up to 1 OOOml with distilled water. Autoclave at 15 psi 
for 15 minutes and store at room temperature. 
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Tryptone Water 
Add lOg tryptone and 5g NaCl to distilled water. Adjust the pH to 7,3 and make up to 
a final volume of 1 OOOml. Aliquot 5ml volumes into sterile test tubes and autoclave at 
15 psi for 15 minutes. 
TSB broth 
Add lO,Og polyethylene glycol (PEG), lml MgCh (1M), lml MgS04 (1M) to lOOml 
YT broth. Warm slightly to dissolve the PEG (about 35°C- 40°C) and allow to cool. 
Add 5ml dimethyl sulphoxide. Use fresh. 
Xgal (5-bromo-4-chloro-3-indolyl-f3-D galactoside) 20mg/ml 
Dissolve 40mg Xgal in lml of dimethylsulphoxide (DMSO) and then add lml sterile 
water. Store at -20°C. Use 0,5ml (IOmg) solution per lOOml agar. 
YT (Yeast Tryptone) broth 
Dissolve 16g tryptone, lOg yeast extract and 5g NaCl in lOOOml distilled water. 
Dispense to the appropriate containers and autoclave at 15 psi for 15 minutes. Store at 
room temperature 
YT (Yeast Tryptone) agar 
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